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ABSTRACT 
The nematode Caenorhabditis elegans is an alternative model used in biomedical 
research for the investigation of descriptive and mechanistic toxicity assessment 
of chemicals. There are considerable differences in published data, especially in 
terms of reproducibility and validation of toxicity endpoints, and the techniques 
used in the investigation of these endpoints. This thesis describes the evaluation 
of toxicological endpoints following the exposure of C. elegans to chemicals 
which include; zinc oxide nanoparticles (ZnONP), Diethylstilbestrol (DES) and 
derivatized target-specific anthelmintics.  
The results suggest that ZnONP prepared in anionic and cationic dispersants 
(AZNP and CZNP respectively) were the most toxic against the nematode 
resulting in the ‘bag of worms’ (BOW) phenotype which can be exploited as a 
marker for reproductive toxicity.  Also, worms treated with ZnONP prepared in 
0.1% FBS (FZNP), molecular grade water (WZNP) or E. coli OP50 supernatant 
(SZNP) presented three-fold embryo elongation showing fully differentiated 
tissues encapsulated within the eggshell and still within the hermaphrodite gravid 
adult. The phenotype has been named accelerated embryonic development 
(AED) and could be used as a developmental toxicity endpoint. The results 
suggest that the AED endpoint is the most sensitive while lethality endpoint 
appears to be the least sensitive despite its extensive use in the literature. Also, 
microRNA microarray expression appears to be the most sensitive molecular 
endpoint while behavioural endpoints such as speed should be interpreted with 
caution, especially when performed manually. Importantly, good C. elegans 
culture practice (GCeCP) is required for reproducible chemical toxicity 
assessment and different endpoints may be required for different types of toxicity 
assessment.  
Additionally, the thesis describes a second but related study which explores a 
potential for enhanced anthelmintic targeting. Novel fluorophore-based 
asparagine-containing oligopeptide substrate probes were used to target the 
helminth protease, legumain. These probes were selectively cleaved by legumain 
in C. elegans, Haemonchus contortus and Teladorsagia circumcincta. The 
protease-specific probes could potentially be exploited to achieve protease-
mediated prodrug activation and drug delivery.  
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Chapter One 
1 General introduction 
Toxicology can be defined as the study of the adverse effect of chemical or 
physical agents of known structure on biological systems. Research in toxicology 
entails the examination of cellular, biochemical and molecular mechanisms, and 
the functional effects of chemicals and their risk assessment. In order to 
accomplish this, there is a need to understand the relationship between the 
exposure of chemical substances and the responses they induce. One of the 
benefits of toxicological assessment is to produce risk assessments of the 
possible effects and significance of chemicals on humans and their environment. 
Since there are a variety of chemicals which include drugs, there are also 
corresponding diverse types of effects. In the current research, chemicals have 
been evaluated using:  
1. Descriptive toxicology which is toxicity testing that offers information about 
safety assessment, and 
2. Mechanistic toxicology that identifies and explains the biochemical, 
cellular and molecular mechanisms chemicals use to induce toxic effects. 
Appropriating the right toxicity model that would provide the information needed 
to evaluate potential risks of chemicals is not limited to humans but also other 
animals, plants and the environment, and this could be challenging. However, the 
current work focuses on using a singular model to develop a standardized tool 
that would not only be applicable to different chemicals based on the classification 
above but would be predictive when considering different exposed groups. 
The specialized areas of toxicology considered in this research include 
environmental toxicology, reproductive toxicology and pharmaceutical toxicology. 
For the purpose of the current research, a brief definition of these areas is stated 
below. 
 
Environmental toxicology: This investigates the adverse impact of chemical 
pollutants in the environment on biological organisms which usually excludes 
humans. Environmental toxicology should not be misrepresented with 
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Ecotoxicology which is a specialized area within the former. Ecotoxicology is 
specifically concerned with the impacts of toxic substances on population 
dynamics in an ecosystem.  
 
Reproductive toxicology: This investigates the adverse effects which can result 
from exposure of chemicals to the reproductive system of chemical or physical 
agents. Indeed, reproductive toxicology does not exist without developmental 
toxicology. Developmental toxicology refers to the adverse effects of chemicals 
on the developing organism that occurs any time through the life span of the 
organism which could result from exposure to chemicals before conception, 
prenatal development, or postnatally. 
 
Pharmaceutical toxicology: The study of the adverse effect of medicinal drugs 
on humans, plants and animals with the purpose of ensuring safety of these 
classes of chemicals following controlled administration. This aspect of toxicology 
is an interface between pharmacology and toxicology. It should be noted that the 
aspect of pharmaceutical toxicity also covers the development of drug targets 
since mechanistic evaluation is considered. 
 
All three aspects mentioned above are inter-related. For instance, Zinc oxide 
nanoparticles; one of the reference toxicants in the current research could be 
assessed either as an environmental or a reproductive toxicant. Also, 
diethylstilbestrol is a pharmaceutical agent but it is also the reference chemical 
for reproductive toxicity in this study. Furthermore, anthelmintic derivatives such 
as the ones considered in the current research can be analysed in terms of their 
pharmaceutical implications as well as their effect in the environment. 
The increasing impact of toxicology on society is accompanied by the duty to be 
ever sensitive to the ethical, social, and legal implications of research in 
toxicology. Regulatory studies using animals have been traditionally adopted for 
assessing the safety of chemicals to protect humans and the environment. 
However, there should be regular reviews as our understanding of science and 
technical processes continually improve. In 1959, Russell and Burch published 
their work on “The Principles of Humane Experimental Technique” which gave 
birth to the concept of replacement, refinement and reduction of animals in 
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research (3Rs).  It took almost half a century for this concept to be established 
with the European Registration, Evaluation, Authorisation and Restriction of 
Chemicals (REACH) legislation leading the cause. This was necessary to ensure 
that the appropriate animals are used for toxicity testing whilst consistently 
improving their predictive value and reducing their overall usage. With an 
increasing number of studies using in vitro and in silico models as predictive tools 
of chemical safety, it is expected that a good number of chemicals would be 
excluded for further evaluation, thus, reducing the need for animal testing. One 
general purpose of this research is to provide a suitable alternative model for 
toxicity testing.  
The understanding of most hereditary, physiological, developmental and 
molecular processes is a result of studies on model organisms. Experimental 
amenability to specific research interest and the phylogenetic position of 
organisms determine their choice as model organisms. In general, multicellular 
model organisms share basic biological processes with their corresponding target 
organisms. Hence, the identification of genes, biological processes or molecular 
pathways of interest in a model may create opportunities for comparative studies 
in its target organism or organisms. The major difference between the model and 
target organisms is that model organisms respond better to experimental 
manipulations. It is with qualities like this that increasing wealth of knowledge that 
relate to certain model organisms have been gained.  
The nematode Caenorhabditis elegans was first used as a model organism in 
1963 (Brenner, 2009). When compared to other multicellular organisms like 
Drosophila melanogaster, it is simpler to manipulate because it has less than a 
thousand cells that divide in conventional manner; indicating that every cell 
lineage can be traced back to the egg. Although models such as Danio rerio 
(Zebra fish) are arguably better suited for vertebrate target organisms as they are 
genetically accessible for appendage and heart regeneration, C. elegans exhibits 
all the hallmarks of a multicellular organism with complex organ systems (C. 
elegans Consortium, 1998). These include a reproductive system, a metabolically 
active digestive tract, a nervous system and an endocrine system; allowing it to 
exhibit social, sexual and learning behaviours (de Bono and aricq 2005). In order 
to justify some characteristics of C. elegans as a model, it is necessary to 
describe its classification and life cycle. 
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1.1 Classification of Caenorhabditis elegans 
C. elegans is a multicellular organism that belongs to the family Rhabditidae in 
the order Rhabditida of the class Secernentea and from the phylum Nematoda. 
The classification of C. elegans places it in a position where it is free-living, 
possesses oesophagosal functions as well as an excretory system and is also 
bilaterally symmetrical. The nematode possesses an elongated cylindrical body 
and has no appendages or segmentation. The adult worm is approximately 1 to 
1.3mm in length. C. elegans exists usually as a hermaphrodite which is self-
fertilizing and occasionally as male that can mate with the hermaphrodites to 
produce their young.  The young larva to its adult stage is transparent allowing 
morphological features of the worm to be observed with a basic stereo 
microscope or compound microscope (Figure 1.1). 
 
Figure 1.1: Transparent internal structure of the adult hermaphrodite Caenorhabditis elegans 
 
1.1.1 Life Cycle  
The common habitats of the worm include compost or rotten fruits and 
occasionally in the soil where it feeds on microorganisms for a source of nutrient. 
They thrive in moisture-rich environments and in temperate regions around the 
world. C. elegans like most round worms help in improving soil structure due to 
their burrowing activity hence, it is pivotal in the development of soil nutrient for 
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ecological balance. The life cycle of C. elegans (Figure 1.2) takes between two 
and three days depending on the temperature (16 to 25oC). The stages in the life 
cycle below are based on temperatures between 20 and 22oC. 
 
1.1.1.1 Embryogenesis 
The development of the embryo starts inside the hermaphrodite and eggs are laid 
through the vulva opening. This is subsequent to the fertilization of the oocyte by 
the spermatheca of the hermaphrodite or the spermatozoa from the male 
nematode. The complete process of embryogenesis after the eggs are laid takes 
between one and three hours and is divided into two stages.  
1.1.1.1.1 Proliferation 
This process involves the division of a single cell to over 500 undifferentiated 
cells. At 22oC, it takes up to 5 hours and 30 minutes after fertilization for this 
process to occur. The first two and a half hours of the process takes place within 
the hermaphrodite’s uterus where the zygote and the embryonic founder cells are 
formed. This is followed by the laying of the embryo outside the worm as soon as 
approximately 30-cell stage is reached at gastrulation (Bucher and Seydoux, 
1994). The final stage of proliferation is the organization of cells within the embryo 
into three germ layers known as the ectoderm, mesoderm and endoderm; these 
three develop into the neurons, hypodermis and muscles, respectively. 
1.1.1.1.2 Organogenesis 
This process involves the terminal differentiation of cells with no further cell 
division. At 22oC, it takes approximately 6 to 8 hours for the completion of 
organogenesis. The worm forms inside the egg and begins to roll around its 
longitudinal axis prior to cell cleavage. It is at this point that the pharynx begins 
to function and the egg is hatched (Sulston et al., 1983). Proliferation and 
organogenesis make up the whole process of embryogenesis and it is at the end 
of embryogenesis that the physiology and the sex of the adult worms are 
determined.  
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1.1.1.2 L1 Stage 
At this stage, five of the eight motor neurons in the adult hermaphrodite’s ventral 
cord are developed to support nervous function. Also, somatic gonad precursors 
begin to produce cells while the germ line precursors begin to divide continuously 
from the L1 through to the end of adult development. The ventral cells that 
eventually develop into the vulva in L3 and L4 stages are created at the end of 
the L1 stage. However, two dorsal coelomycytes develop from the mesoblast in 
the hermaphrodite which is not present in the male (Sulston and Horvitz, 1977). 
 
Figure 1.2: Life cycle of C. elegans. 
(Image adapted from Wormatlas)  
 
1.1.1.3 L2 Stage  
In the nervous system, two ventral ganglion neurons are formed to improve nerve 
coordination while the germ cell division in the reproductive system continues. 
The germ cells are interwoven with somatic cells until the molt phase between L2 
and L3 where the cells are arranged appropriately to establish the organization 
of the gonad. The extension of the gonad starts at the distal tip cells at both the 
posterior and anterior end of the hermaphrodite while the gonad in the male worm 
elongates only at the anterior (Kimble and White, 1981).   
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1.1.1.4 Dauer Stage 
Unfavourable environmental conditions such as lack of food, high population 
density or high temperature may prevent the L1 larva from developing into the L2 
stage (Golden and Riddle, 1984). At the dauer stage, the larva does not age 
because its duration has no effect on post-dauer life span, hence the longevity of 
the worm can be said to be increased (Kimura et al., 1997, Mihaylova et al., 
1999). There is no feeding in the dauer phase and movement is highly reduced. 
However, as soon as the environment becomes conducive, the worm exits the 
dauer and begins to feed and after approximately 10 hours, molts directly into L4 
stage skipping the L3 stage. 
 
1.1.1.5 L3 Stage  
There is extensive development in the reproductive system at the L3 stage. In 
the hermaphrodite, 143 cells that form the gonadal sheath, the uterus and the 
spermathecae are produced by the somatic gonad precursors (Kimble and Hirsh, 
1979). The anterior and posterior gonadal sheath extends continuously at the tips 
until the distal tip cells stop and slowly start arranging themselves in the dorsal 
direction. Also, 16 sex muscles are generated from the sex myoblasts. In the 
male L3 larva, the germ line that produces only meiosis and spermatozoa starts. 
The somatic gonad blast cells undergo cell division to the somatic gonads that 
differentiate into the seminal vesicle and the vas deferens. The proximal gonad 
extends and 6 male sex myoblasts are produced and the tail begins to swell as a 
result of posterior blast cell division (Sulston, 1988).  
 
1.1.1.6 L4 Stage 
The formation and development of gonads is completed in the L4 phase. During 
the L4/adult molt, the production of spermatozoa ceases while other germ line 
cells continue to undergo meiotic division and differentiation generating only 
oocytes. Tissue development increases as the vulval and uterine cell generation 
ends and the egg-laying neurons and sex muscles interact with the uterus and 
vulva to form the egg-laying apparatus (Greenwald, 1997). In the male worm, all 
sex muscles become completely developed with the inclusion of a coelomocyte 
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generated from the mesoblast. The vas deferens and the seminal vesicle 
differentiation are also completed in the male L4 worm (Antebi et al., 1997). 
 
1.1.1.7 Adult worm 
It takes C. elegans between 60 and 65 hours at temperature ranges of 22-25oC 
to develop from embryogenesis to adulthood. In the first 94 hours of adulthood, 
the hermaphrodite produces oocytes and reproduction, resulting from self-
fertilization, would produce up to 300 offspring. The adult male on the other hand 
fertilizes the oocytes to produce between 1200 and 1400 progeny (Hodgkin, 
1988). Although the adult hermaphrodite generates a total of 1090 somatic cells 
during its development, 131 of these experience apoptosis at specific stages in 
development (Driscoll, 1995) a remainder of 959 cells. Unlike the adult 
hermaphrodite, the adult male worm possesses 1031 somatic cells. The total 
number of neurons in the adult hermaphrodite is 302 while the male has an 
additional 81 (White et al., 1986).  
 
 
1.2 C. elegans and the human genome 
The entire worm from its single cell embryo to the 959 somatic cells present in 
the adult has been fully studied. C. elegans genes have more than 40% gene 
homologs that share similar functions with human genes (Kaletta and 
Hengartner, 2006) including those associated with diseases (Shaye and 
Greenwald, 2011). Despite having more than 40% gene homology with the 
human genome, it encodes over 22,000 proteins (C. elegans Consortium, 1998); 
a number slightly fewer than that in humans. In 2002, C. elegans became the first 
multicellular eukaryote to have its over 100 million bases completely sequenced. 
The sequencing project, which was funded by the National Human Genome 
Research Institute (NHGRI) and the National Institutes of Health (NIH), has an 
estimated error rate of less than 1 in 100,000. It is no understatement that C. 
elegans has transformed methodologies used in genetic studies to understand 
how regulation of genes affects cellular processes. The worm’s modest genetics, 
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transparent structure and simplicity of cultivation make it a model system for 
studies in developmental biology, neurobiology, toxicology and the molecular 
basis of some human diseases. 
 
 
1.3 History of C.elegans in biological research 
In 2002, Sydney Brenner, John Sulston and Robert Horvitz were awarded the 
Nobel Prize in Physiology or Medicine for their work on the genetics of organ 
development and programmed cell death in the nematode.  Andrew Fire and 
Craig C. Mello also received the Nobel Prize in 2006 for their discovery of RNA 
interference during translation in C. elegans.  Again, in 2008, a Nobel Prize in 
Chemistry was awarded to Martin Chalfie for his work on green fluorescent 
protein, a tool used extensively in C. elegans research.  
Apart from being a model choice for Nobel Prize winners, C. elegans has played 
key roles in biomedical discoveries. For instance, in 1993, presenilin, a 
transmembrane protein associated with Alzheimer’s disease, was discovered in 
the nematode (Sundaram and Greenwald, 1993) and in 1995, genetic alterations 
in the human presenilin-1 gene were linked to early-onset of Alzheimer’s disease 
(Levitan and Greenwald, 1995; Sherrington et al., 1995). With the discovery of 
presenilins in C. elegans, the understanding of  Alzheimer’s disease has 
advanced due to the identification of the protein as a constituent of an important 
target site in the disease known as the ƴ-secretase complex (De Strooper et al., 
1999); a prospective target in the treatment of the disease. 
Also, C. elegans has helped improve the understanding of diabetes type 2. The 
loss of function of the forkhead transcription factor FOXO was found to save the 
diabetic phenotype of insulin-resistant mice (Nakae et al., 2002). This was made 
possible based on findings five years earlier that identified the negative regulators 
of insulin signalling pathway including daf-16 gene which encodes the C. elegans 
orthologue of FOXO (Ogg et al., 1997). Again, C. elegans can be used to 
investigate mechanisms involved in pharmacological processes. An example was 
shown in the increase of serotonergic signalling in the nematode following 
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exposure to the antidepressant fluoxetine. This was possible due to the inhibition 
of the C. elegans orthologue of the serotonin re-uptake transporter SERT 
(Ranganathan et al., 2001) a monoamine transporter associated with depression. 
This finding has suggested that there are other modes of action of fluoxetine and 
has stimulated investigations to understand the molecular basis of depression. 
Having explored some previous work with C. elegans, the following sections in 
this chapter describe the focus and rationale for the current research. 
 
 
1.4 Development of a C. elegans model for the assessment of 
chemical toxicity 
As mentioned earlier, C. elegans is transparent (Figure 1.1) allowing the 
observation of morphological and developmental changes within the individual 
worm. It is an attractive option as it is capable of reproducing within three to five 
days with an approximate lifespan of three weeks (Fielenbach and Antebi, 2008) 
which would facilitate high throughput screening; these advantages make C. 
elegans a good model for toxicity. Moreover, from an ecological perspective, its 
sensitivity to a wide variety of toxicants including organic phosphates, heavy 
metals and pesticides suggests its appropriateness for toxicological screening 
(Leung et al., 2008). 
The prevalent use and release of chemical substances in the environment has 
influenced the need for the development of rapid and affordable testing 
techniques to protect humans and other living species. Similarly, pharmaceutical 
industries depend on the assessment of toxicity and safety of new chemical 
substances as a prerequisite in the development of new drugs. Accomplishing 
this task with conventional animal models such as rodents or higher animals have 
some disadvantages such as the requirement of ethical approval, high cost and 
long assessment time.  The C. elegans model system can allay these concerns.  
For the C. elegans model, as with most animal models, the most commonly used 
endpoint for the assessment of chemicals is lethality testing; however, there are 
variances in the literature that depend on lethality as an endpoint probably due to 
 11 
 
technical differences in exposure approach or the preparation of chemicals for 
exposure which may change their physicochemical characteristics.  It is as a 
result of these setbacks that better screening techniques involving a wide range 
of toxicologically applicable endpoints such as lifespan, reproduction, behaviour 
and morphology were introduced.  In the current research, the suitability of C. 
elegans for the assessment of chemical toxicity with emphasis on environmental 
as well as developmental and reproductive toxicity was investigated. For the 
purpose of the current research, zinc oxide nanoparticles (ZnONP), 
diethystilbestrol (DES) and anthelmintic derivatives that target specific organelles 
or enzymes have been selected as reference toxicants for the assessment of 
toxicity. An overview of some sub-lethal endpoints used in the current research 
for toxicity assessment using the C. elegans model system is discussed below. 
 
1.4.1 Bag of worms phenotype 
As the adult worm ages, decline in the reproductive function is imminent and this 
begins after or around five days into adulthood with cessation being around ten 
to fourteen days into adulthood (Mendenhall et al., 2011). Self-fertile 
hermaphrodites produce their highest progeny size on day 2 of becoming an adult 
and stop production with 5-6 days of adulthood as a result of self-sperm depletion 
while male-fertilized hermaphrodites produce their highest progeny size within 2-
4 days of adulthood and cease production at about the 12th day due to age-
related degeneration of the reproductive system (Hughes et al., 2007). Ideally, 
fertilized eggs are laid within approximately 12.5 hours in young and healthy 
adults.  Where the time between fertilization and egg-laying is exceeded as a 
result of loss of reproductive function, the eggs may hatch within the adult worm 
and the young larva will feed on the adult, killing it. This manifestation is referred 
to as matricidal hatching which is the intra-uterine hatching and development of 
larvae leading to the destruction of the mother worm by the larvae (Luc et al., 
1979). In C. elegans, matricidal hatching; colloquially called ‘bag of worms’ 
(BOW) phenotype or ‘bagging, was described by Pickett & Kornfeld (2013) as a 
form of cannibalism that enhances larval viability and promotes dauer formation. 
Prior to this time, Johnson (1984) had shown that high population densities could 
lead to the BOW phenotype. Chen & Caswell-Chen (2003) further showed that 
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lack of food or any form of stress could lead to BOW phenotype. They also 
showed that the condition can be reversed provided food is returned to the 
environment and stress is reduced in time. Their findings led to the suggestion 
that the condition is a form of parental influence (altruism) to protect the progeny. 
Chen and Caswell-Chen further showed that under stress, the progeny obtain 
nutrients directly from the adult parent body before becoming dauers. They 
concluded that even the production of only one stress-resistant, long-lived dauer 
instead of progeny that cannot achieve the dauer is a fitness advantage (Chen 
and Caswell- Chen, 2003). The BOW phenotype can be used as a marker for 
unfavourable conditions such as exposure to chemicals. 
While BOW is a measure of reproductive fitness, it is not an unusual phenotype 
in C. elegans, and by definition, it focuses on the viability of the adult worm rather 
than its embryo. Seidel & Kimble (2011) investigated embryo viability in terms of 
number of viable embryo produced by adult worms following starvation and 
observed that the number of embryos are reduced in starved worms; suggesting 
that unfavourable conditions may deplete embryo number. The combination of 
reproductive fitness and embryo viability can be utilized for the assessment of 
chemical toxicity and this could be possible by investigating the process that 
leads to bagging. Angelo & Gilst (2009) showed that embryos in the morphogenic 
stage of embryogenesis within starved gravid adult worms had terminally 
differentiated cells, tissues and organs which had started developing prior to egg-
laying but classified this as a process leading to bagging. In the current research, 
we examined the process of embryogenesis in chemical-exposed gravid adult 
worms to investigate the effect of chemical on their viability. 
 
1.4.2 Transgenic GFP reporter expression 
Although C. elegans has many advantages as a toxicity model, it is less sensitive 
to most environmental stressors when compared with models such as Daphnia. 
This is likely a reflection of the robust set of cellular defence pathways the worm 
utilizes occasionally as part of its opportunistic lifestyle in the terrestrial habitat. 
Nonetheless, some studies have shown that transgenic strains of C. elegans that 
are sensitive markers of stress resulting from exposure to reproductive or 
pharmaceutical chemicals can also be utilized as indicators of environmental 
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stressors (Hägerbäumer et al., 2015). The use of gene expression from 
transgenic worms is easily reproducible with minimal variability unlike endpoints 
such as worm motility which measures lethality ( Roh et al., 2006).  
One of the ways of limiting variances such as the one experienced with lethality 
testing in toxicity assessments is by taking advantage of transgenic green 
fluorescent protein (GFP) reporter strains to evaluate sublethal effect in terms of 
biochemical responses induced following exposure to chemicals. For example, 
one characteristic of the effect of toxicants is that they can induce oxidative stress 
in biological systems exposed to them. Oxidative stress is a condition involving 
the disturbance between the balance of free radicals or reactive molecules from 
oxygen (prooxidants) and the ability of a biological system to detoxify their 
damaging effects (antioxidants) in which case the free radical production exceeds 
that of the antioxidant. There are suggestions that free radicals and reactive 
molecules from oxygen collectively referred to as reactive oxygen species (ROS) 
play a role in activation and processes of cell signalling including gene expression 
(Hancock et al., 2001). This can be advantageous in the development of toxicity 
assays using C. elegans because markers of oxidative stress like superoxide 
dismutase genes can be investigated with transgenic and knockout strains. 
Superoxide dismutase (SOD) is an antioxidant or a detoxifying enzyme that 
converts or takes part in the process of conversion of ROS products to hydrogen 
peroxide and subsequently water. SOD production is an indication of self-defence 
of biological systems; hence, an increase in the production or expression of SOD 
is a function of the severe effect of toxicant exposure to the biological system. 
Also, since most of the ROS present in cells is believed to be produced in the 
mitochondria, mitochondrial viability can be investigated by measuring SOD in 
the cell. There are five SOD genes in C. elegans: 
• sod-1 encodes a Cu and Zn-containing intracellular enzyme that is 
principally localized  in the cytosol (Jensen and Culotta, 2005) and is also 
found in the mitochondrial intermembrane space. It acquires its copper 
through a gluthathione pathway. 
• sod-2 gene is responsible for the production of the main Fe / Mn SOD 
found in the cytosol based (Giglio et al., 1994) 
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• sod-3 also encodes iron and manganese-containing SOD but is a minor 
cytosolic isoform of SOD. However, over 60% of SOD produced by sod-3 
is believed to be mitochondrial-based. This could be relevant for the 
assessment of mitochondrial function (Hunter et al., 1997). 
• sod-4 encodes an extracellular Cu/Zn SOD and is believed to play a role 
in insulin /IGF-1 signalling pathway which coordinates growth, 
differentiation and metabolism in response to change in the environment 
or nutrient supply (Yoko Honda et al., 2008). It is also involved in the redox 
regulation during vulval development (Shibata et al., 2003); an advantage 
that could be useful to assess the influence of chemicals on reproduction. 
• sod-5 gene encodes an intracellular Cu/Zn SOD but very little SOD is 
found in the cytosol (Hoogewijs et al., 2008) although it effectively 
compensates for sod-1 where the latter is not functional (Yanase et al., 
2009). 
Also, a master regulator gene daf-16 which controls multiple stress-response 
pathways can be used as marker alongside the sod genes. The only C. elegans 
forkhead box O (FOXO) homologue is encoded by daf-16 which is a transcription 
factor for the insulin/IGF-1-mediated signaling pathway that regulates stress 
responses (Yen et al., 2011). Daf-16 determines the transcription of genes that 
code for enzymes which take part in immunity as part of a general stress 
response. 
The application of concurrent testing of multiple gene output would give insight 
into stress response patterns that are expressed in transgenic and knockout C. 
elegans strains with green fluorescent protein (GFP) reporters. The current 
research has utilized the conventional lethality endpoint and have included the 
investigation of sod-3::GFP  C. elegans. 
 
1.4.3 Behaviour in C. elegans as a toxicity assessment tool 
One characteristic of animals is their ability to change their behaviour in response 
to changes in their external environment and also changes in their internal 
physiological state. These behavioural alterations are achieved through the 
activities of the nervous systems. C. elegans displays robust behavioural 
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response to changes in its environment. Such changes alter the worm’s 
movement in terms of the effect on locomotion velocity (speed) and turning 
frequency (body bends per time).  The movement of C. elegans is affected by the 
presence of xenobiotics in its local environment and the worm’s neurosensory 
awareness about these environmental changes is driven by behavioural shifts 
that are central to survival. In order to understand the C. elegans behaviour, the 
knowledge of how the activity of its muscles translates into movement within the 
mechanical framework and physical environment is important. The forward 
movement of the worm is achieved by undulatory waves in a dorsal-ventral plane 
from head to tail and are affected by responses to conditions in the worm 
environment that determine the locomotory behaviour of the worm (Pierce-
Shimomura et al., 2008). The alternate contraction and relaxation of two dorsal 
and two ventral muscle groups running along the length of the body of the worm 
creates its bending characteristic (Von Stetina et al., 2005).  
 
1.4.4 MicroRNAs as biomarkers of toxicity 
A microRNA (miRNA) is a non-coding RNA of about 18 to 22 nucleotides that 
selectively bind one or more messenger RNA (mRNA) molecules to effect the 
post-transcriptional regulation of gene expression (Bartel 2009). MiRNA was first 
identified in C. elegans by Lee et al. (1993) who identified a small temporal RNA 
named lin-4 which was shown to be a regulator of the lin-14 mRNA which is 
important in the timing of the development of L1 larva to the L2 stage in the worm. 
It was concluded that lin-4 resulted in reduced protein expression by lin-14. Seven 
years later Reinhart et al. (2000) identified another small RNA; let-7 which is 
involved in the timing and development of C. elegans L4 stage to adult worm. In 
the same year, Pasquinelli et al. (2000) also found that let-7 was conserved in 
Drosophila and in humans. By 2001, more miRNAs had been identified in C. 
elegans (Bartel et al., 2001; Lee and Ambros, 2001) and other animals (Lagos-
quintana et al., 2001). While the number of miRNAs encoded by the human 
genome is about 1000, the number of mRNAs are estimated at approximately 
30,000 (Pritchard et al., 2012) which suggests that single or multiple mRNAs can 
be targeted by miRNA genes.  
 16 
 
The biogenesis of miRNA starts with the transcription of mRNA from miRNA-
encoding genes by the influence of RNA polymerase II and III. The primary mRNA 
transcripts are referred to as pri-miRNA and are about 100 to 1000 nucleotides 
in length. In the nucleus, the pri-miRNA is cleaved by a ribonuclease III enzyme 
known as Drosha and its co-factor; DGCR8, to form a precursor miRNA called 
pre-miRNA. Exportin 5 in the nucleus transports the pre-miRNA to the cytoplasm 
where it interacts with another ribonuclease III enzyme known as Dicer. Dicer 
cleaves the pre-miRNA to a short miRNA duplex of approximately 20 base pairs. 
The duplex is then bound by an argonaute protein known as AGO2. AGO2 is part 
of the RNA induced silencing complex (RISC) which responsible for the activity 
and transport of miRNA to its target site. AGO2 interacts with dicer to unwind the 
strands of the duplex and allow one of the strands to be selectively retained within 
the RISC (Rüegger and Großhans, 2012). The retained strand is called the guide 
strand because it guides the RISC to its mRNA target where it either inhibits 
translation or degrades the mRNA of the target gene. 
Previous studies have shown that miRNA is implicated in human pathology such 
as diabetes (Trajkovski et al., 2011) and cancer (Iorio and Croce, 2012). The 
stability of miRNA and its protection from endogenous RNAse in plasma (Mitchell 
et al., 2008) have encouraged its use as a biomarker of liver drug-induced toxicity 
(Wang et al., 2009). These findings coupled with its association with specific 
cellular pathways (Arzate-Mejía et al., 2011) including those implicated in 
diseases would help improve our understanding of the role miRNA plays in 
mechanisms involved in toxicity. In the current research, we investigate the use 
of miRNA as indicators of toxicity in C. elegans. 
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1.5 The use of C. elegans as a representative model of parasitic 
helminths 
1.5.1 Parasitic Helminths and their Economic Importance 
Parasitic helminths are known to be major infectious agents of humans and 
livestock, especially in developing nations. Current data suggests that over 1.4 
billion people worldwide suffer from helminthiasis; majorly from poor communities 
of developing Africa, Asia and the Americas (Caffrey, 2012). In the agricultural 
sector, many nations of the world have arranged projects for nematode control; 
however, anthelmintic resistance has been on the increase. Many parasites of 
domestic livestock resist broad spectrum anthelmintic drugs (Kaplan and 
Vidyashankar, 2012) and there is also a growing concern that the mass 
administration of these drugs may not sustain human parasite control programs 
in the near future (Prichard et al., 2012). Thus, it is imperative that new methods 
of managing these parasites be discovered. Unfortunately, the challenge is not 
being met as new anthelmintic medicines are not developed based on the 
consideration that agricultural livestock industries are minor markets for these 
drugs. Yet, recent reports have suggested that multiple-anthelmintic resistance 
is growing fast among major agricultural livestock producers (Geurden et al., 
2014). C. elegans as a model in this thesis focuses on two of the major 
economically important gastrointestinal parasites of sheep, Haemonchus 
contortus and Teladosargia circumcincta. These two helminth parasites were 
utilized for some of the experiments in chapter five of this thesis. 
 
1.5.2 Haemonchus contortus 
Haemonchus contortus is a stongylid nematode that infects millions of sheep and 
goats worldwide (Scott & Sutherland, 2010). Barber’s pole worm, as it is also 
called, feeds on blood from the capillaries in the stomach mucosa of its host 
leading to haemorrhagic gastritis, oedema, anaemia and other related 
complications. Ultimately, the infected host dies where infection is severe and in 
the absence of treatment or presence of resistant strains (Nikolaou and Gasser, 
2006). 
The minimum life cycle of H. contortus is between four to six weeks. The adult 
male resides in the abomasum of its ruminant host where it mates with the female 
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to produce eggs which are excreted in the faeces into pasture. In the faeces, 
embryogenesis takes place and the eggs hatch producing the L1 larva which is 
the first larval stage of development. The L1 larva develops and molts to the L2 
stage and then the L3 stage. Larval stages 1 to 3 all take place in the faeces. At 
the L3 stage, the larva migrates on to the pasture where it is ingested by grazing 
ruminants. 
In the rumen of the ruminant, the retained L2 cuticle known as the exsheath is 
shed and allows the L3 larva to move to the abomasum where it develops into 
the L4 larval stage. Following successful migration and development of the L4 
larva in the abomasum, the nematode develops into the adult worm between 14 
and 21 days (Prichard, 2001). 
An adult female is capable of producing about 10,000 eggs a day (Waller et al., 
2004) and one host may harbour thousands of such females. Although H. 
contortus infections occur rapidly in tropical regions, the L4 larva can undergo 
arrested development in order to evade adverse conditions such as prolonged 
drought or cold winters (Hoberg et al., 2004). This ability coupled with the 
movement of livestock from place to place has encouraged global distribution and 
survival of the parasite despite having its etiology from sub-Saharan Africa 
(Blouin et al., 1995).  
 
1.5.3 Teladorsagia circumcincta 
About a decade ago, T. circumcincta was recorded as the dominant parasitic 
nematode affecting sheep in the United Kingdom (Nieuwhof and Bishop, 2005). 
The life cycle of T. circumcincta is similar to that of H. contortus in that it is also a 
gastrointestinal strongylid nematode. Like Haemonchus, the eggs develop in 
faeces and hatch within 24 hours to release the L1 larva which is the first stage 
of larval development. The L1 develops through L2 to the third larval stage known 
as the L3 larva which is the infective stage. The period of larva development from 
L1 to L3 takes about a week and the process takes place in the faeces. The L3 
moves on to the pasture and is ingested by a ruminant host. In the 
rumenorecticulum of the host, the L3 exsheath is shed and the larva moves 
through the abomasum to the gastric glands where it moults to the fourth larval 
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Figure 1.3: General life cycle of gastrointestinal parasitic worms.  
(Adapted from SCOPS, 2012) 
 
stage of development (L4). It is in the gastric gland that the L4 develops into either 
the male or female adult parasite which mates with the opposite sex to produce 
more parasites. The adult T. circumcincta; like Haemonchus can live for up to 12 
weeks before dying; a time frame that is capable of decimating the host. T. 
circumcincta infection can lead to poor productivity in livestock resulting from 
deaths and failure to reproduce (O’Connor et al., 2006).  
 
1.5.4 Overview of Anthelmintics 
Many drugs and chemicals are available to combat helminth parasites but with 
regards to host-parasite interaction, a drug requires high selectivity for a parasite 
in order to meet the criteria for the definition of an anthelmintic. The margin 
between the minimal therapeutic dose and the minimal toxic dose of most 
anthelmintics is wide and these drugs often have a broad spectrum of activity. 
Having said this, in principle, the utility of an anthelmintic can be restricted by its 
pharmacokinetic properties, its mechanism of action and the characteristic of the 
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infected host. Moreover, the increased use of available anthelmintics is 
accompanied by increasing frequency of parasite resistance to them (Sutherland 
and Leathwick, 2011). Since most anthelmintics are classified either based on 
their chemical structure, their site of action or their biochemical mechanisms, 
resistance of a parasite to any member of a class may also mean resistance to 
other members of that class. Therefore, it is important to synthesize better 
targeted anthelmintics that can circumvent such resistance. Any mention of 
parasites here on refers to helminth parasites. 
 
1.5.5 Anthelmintic resistance 
Although there is a growing public, media and political attention on antimicrobial 
resistance, it does not seem that anthelmintic resistance is seen as equally 
important. For more than two decades, no new antimicrobials have been 
produced but two novel anthelmintics; monepantel (Sager et al., 2009) and the 
oral derquantel-abamectin formulation (Little et al., 2011) have been made in the 
last five years. It is probable that new antimicrobials are carefully guarded 
because of their public health implications. Unfortunately, it could be damaging if 
such approach is used for anthelmintics because the available number of 
anthelmintics are fewer compared to antimicrobials and the attempt to wait until 
available drugs become ineffective as a result of resistance may increase the 
selection pressure on the new anthelmintics for resistance when they become 
available for use. Moreover, the use of new anthelmintics in the absence of 
resistance would achieve an effective kill rate on both organisms that are or not 
resistant to existing anthelmintics; as a result the overall level of resistance in 
worm parasite population would be reduced. Regrettably, there is a thin line 
between the use and management of anthelmintics, like antimicrobials. The 
affordability and availability of the drugs have led to their rapid routine use and 
this has caused the development and increase of anthelmintic resistance. 
Prior to the introduction of amino-acetonitrile derivative monepantel (AAD) in 
2009, the three major classes of broad spectrum anthelmintic drugs were 
macrocyclic lactones, benzimidazoles and levamisoles. Most worm parasites 
were usually controlled with a combination of the anthelmintic administration and 
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management strategies. However, the emergence of resistance to these drugs 
has compromised effective control as multiple drug resistance is on the increase 
in Europe and North America (Falzon et al., 2013; Martínez-Valladares et al., 
2013; Sargison et al., 2007). Furthermore, multiple drug resistance has been 
reported in temperate and tropical regions of the world. Even more challenging is 
the report of the case of resistance to monepantel in New Zealand last year (Scott 
et al., 2013). It is becoming clearer that the current chemical control strategies 
may not be sufficient any more. Hence, there is a need to adopt new approaches 
of targeted selective treatments with the novel exploitation of legumain in this 
case.  
 
 
1.6 Application of C. elegans in anthelmintic drug discovery 
The classification of nematodes into two classes; Adenophorea and Secernentea 
by the Catalogue of Life (Roskov et al., 2014) seems to be an easy sorting as it 
is based on morphology. However, morphological characteristics are not enough 
to reflect the relationship between free-living and parasitic nematodes as the 
sharing of characters by a set of species which are not present in their common 
ancestry (homoplasy) are widespread. Hence characters cannot be used, without 
ambiguity, to determine how related free-living nematodes are to their parasitic 
counterparts. A more suitable approach for comparison would be molecular 
phylogenetics which involves the use a gene or genes from different taxa to 
construct a dataset of homologous traits. Specifically, C. elegans small subunit 
rRNA (18S rRNA) analysis suggests that the worm is closely related to parasitic 
nematodes in the order Strongylida (Fitch and Kelly-Thomas, 1997) which 
includes Teladorsagia and Haemonchus.  
As an experimental model system, the genome of C. elegans has been 
completely sequenced with the inclusion of expressed sequence tags (ESTs) 
which are DNA found in the coding region of a gene used to identify full gene 
lengths and which is also important in gene mapping. These C. elegans ESTs 
have been used as reference points for the generation of most human nematode 
parasite ESTs (Mitreva et al., 2005). The success of the C. elegans genome 
 22 
 
project inspired scientists like Blaxter et al. (1999) to start the Filarial Genome 
Project where parasite genome research is ongoing. Blaxter et al. (2002) worked 
on Brugia malayi; the causative agent of elephantiasis, which is similar to C. 
elegans in many respects. The size of their base size is similar (100Mb), although 
B. malayi has higher adenine-thymine ratio (Rothstein et al., 1988). Also, the main 
features in the organisation of genes in both organisms are alike. With reference 
to ESTs, the closest homologue to most B. malayi EST genes is a C. elegans 
gene and a good number of parasite and free-living worms gene pairs do not 
have any other homologues. More so, because of the evolutionary gap between 
B. malayi and C. elegans, any common motif would possibly be of functional 
importance and it would be appropriate to examine the operation of such already 
known sequence in C. elegans in the Brugia species. 
As a result of successful molecular study on C. elegans, similarities based on 
nematode morphology can be revisited. For instance, collagen is a common 
feature in members of the class Secernentea and although C. elegans collagen 
is more complex than that of parasitic worms, its complexity makes it an important 
model for the study of developmental regulation in the parasitic worms (Kingston, 
1991).  
The process of dauer formation in C. elegans can also help in understanding how 
parasitic worm infection can be controlled. This is possible because for some 
parasites, the infective form is the dauer stage (Riddle and Albert, 1997). 
Pheromone produced by peroxisomal fatty acid β-oxidation in the C. elegans 
environment is the first signal in the process of dauer formation (Bucher and 
Seydoux, 1994) and it is proportionate to population density or other stress 
producing conditions. Although pheromones are also present in parasitic worms 
(Braendle 2012), they have extensively conserved pathways. However, the 
understanding of C. elegans dauer gene cascade can help understand how the 
cascades work in parasitic worms. Hence, pheromone-mediated activities in 
parasitic worm life cycle may become drug design targets as chemosensory 
drugs could disrupt the dauer formation pathway.  
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1.6.1 Legumain: A potential target for anthelmintic delivery 
In 1993, legumain was identified in leguminous seed and classified as a cysteine 
protease (Kembhavi et al., 1993). It requires asparagine in the P1 position 
adjacent to the C-terminus to cleave protein substrates (Jinq-may Chen et al., 
1997). In mammals, legumain was first identified in the lysosome/endosome 
systems (Chen et al., 1998) and it can also be found on cell surfaces (Liu et al., 
2003) and in the nucleus (Andrade et al., 2011; Haugen et al., 2013). In the 
lysosome, legumain plays an important role in MHC class II-mediated antigen 
presentation (Maehr et al., 2005; Manoury et al., 2003) with studies showing that 
its activities are highly correlated with activation of macrophages and that it is an 
ideal marker for primary tumour inflammation as well as early stage metastatic 
lesions (Edgington et al., 2013). It has been shown to be an important enzyme in 
the regulation of cathepsins B, H and L activities in the immune system 
(Shirahama-Noda et al., 2003). The activation of legumain is triggered by acidic 
pH and has been shown to be autocatalytic (Berven et al., 2013).  
There are suggestions that the localisation of legumain expression can be used 
to predict the outcome of a patient’s survival from cancer (Ohno et al., 2010). 
Also, studies have shown that legumain can be used as a component of 
therapeutics in the treatment and management of certain cancers. Some cancer 
therapy studies are focused on taking advantage of the expression of legumain 
in diseased individuals (Guo et al., 2013, Haugen et al., 2013, Ohno et al., 2010, 
Wang et al., 2012). Helminths have been shown to possess legumain 
(Adisakwattana et al., 2007; Ju et al., 2009; Oliver et al., 2006; Skelly and 
Shoemaker, 2001; Wawrzyniak et al., 2012). 
Within the School of Applied Sciences in Edinburgh Napier University, Dr. David 
Mincher’s group have spent over a decade in the area of cancer research, 
prodrugs and molecular probes targeting legumain associated with cancer cells. 
His team showed that prodrugs can enhance drug delivery and efficacy by 
exploiting the expression of legumain in cancer cells to identify with high accuracy 
and precision; the release of the active drug at the cancer site whilst sparing 
normal cells (Ding 2014). Hence, the current research intends to explore 
legumain in C. elegans and trichostrongylid nematodes with a view to improving 
the targeting of anthelmintic drugs. In theory, drugs attached to aspargine-
 24 
 
containing tripeptide substrates (prodrugs) which can be cleaved by legumain 
would release the active drugs into the locality of the enzyme. Dr. David Mincher’s 
group has developed fluorescent-based probes containing tripeptide conjugates 
to prove this concept. We intend to show that the interaction of the probe with 
legumain would result in the cleavage of the tripeptide and the release of the 
fluorophore which would fluoresce (Figure 1.4).  
 
 
Figure 1.4: Delivery mechanism of anti-cancer drug. 
The fluorophore-based prodrug is linked to the quencher and cleaved by legumain expressed 
in the tumour region.  
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1.7 Aim of research 
1. To development and standardize techniques for chemical evaluation using 
the C. elegans model system. 
2. To use C. elegans as a representative model in the application of 
anthelmintic treatment for parasitic helminth infections. 
 
1.7.1 Objectives of aim 1 
1. To develop a high-throughput and reliable technique for toxicity 
assessment of zinc oxide nanoparticles, diethylstibestrol and tubulin-
targeting derivatized anthelmintics. 
2. To utilize transgenic GFP reporter strains for descriptive and mechanistic 
toxicology evaluation. 
3. To differentiate bag of worms and embryo development phenotypes as 
two different endpoints of reproductive toxicity. 
4. To standardize behavioural assay as an endpoint for toxicity 
5. To investigate the suitability of microRNA expression as a marker for 
toxicity 
 
1.7.2 Objectives of aim 2 
1. To proof the concept that the legumain cysteine protease can be exploited 
as a potential for enhanced anthelmintic targeting using C. elegans as a 
representative model of parasitic helminths. 
2. To investigate the anthelmintic and enhanced anthelmintic properties of 
colchicine derivative and their TPP conjugate respectively. 
The research work addresses the challenges of documented toxicity assessment 
of emerging chemical substances such as nanoparticles and this would help 
achieve the objectives of the European Union’s Registration Authorization and 
Restriction of Chemicals (REACH) project of attaining the replacement, reduction 
and refinement of animals used for toxicity testing. Also, the success of the 
research on the use of C. elegans as a model for parasitic helminths would also 
open new doors to the development of anti-parasite drugs including protozoan 
parasites. 
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Chapter Two 
2 Materials and Methods 
2.1 Maintenance of C. elegans Strain 
Wild-type (N2 strain) C. elegans from the Caenorhabditis Genetics Centre, 
University of Minnesota, USA was originally collected from J. Hodgkin of Oxford 
University in 1993. The superoxide dismutase III Green Fluorescent Protein (sod-
3::GFP ) – CF1553 strain was originally collected from Kenyon, C. of the 
University of California, San Francisco, USA in 2004. The worms were 
maintained at 20oC on nematode growth medium (NGM) seeded with Escherichia 
coli OP50 in 60mm diameter Petri dishes (VWR, UK) or in 100mm diameter Petri 
dishes (Thermo Fischer Scientific, UK). E. coli OP50 was purchased from the 
Leibniz Institute DMSZ- German collection of microorganisms and cell cultures. 
The nematode strain was maintained by chunking (Stiernagle 2006) where a 
portion of agar from a previous plate was cut out using a sterilized scalpel into an 
NGM plate already seeded with E. coli OP50 (see page 179 for synchronization 
protocol). Regular transfer of nematodes to fresh plates prevents overcrowding 
and subsequent stress or formation of the resistant dauer forms. 
Freezing was also used to store C. elegans by transferring starved L1 or L2 larvae 
into vials of soft agar freezing solution and storing in a -80oC freezer (Stiernagle,  
2006).  
 
 
2.2 Stage specific synchronization 
Mixed culture or age-synchronized populations were prepared for the 
experiments. The age-synchronized worms were for the analysis of stage-
specific assessment of endpoints investigated and included L1, L3, L4/ young 
adults (L4YA) and gravid adult (GRA) worms. An adaptation of the 
synchronization protocol as described by Sulston & Hodgkin (1988) was used for 
the current research (See appendix). All the exposures were performed in S 
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medium (see appendix); which is a liquid medium for worm maintenance, with or 
without treatments for 4 or 24 hours at 20 °C in the presence of E. coli OP50 as 
food source.  
 
 
2.3 Toxicity assessment of zinc oxide nanoparticles 
 
2.3.1 Preparation of zinc oxide nanoparticle treatments 
Zinc oxide nanoparticle (ZnONP) in proprietry dispersants (colloidal dispersion 
with anionic or cationic dispersants) were produced by Alfa Aesar (ZnO 
NanoShield™ ZN-3014A or ZN-3008C respectively). The manufacturer’s 
preparation contained 50% ZnONP in water. ZnONP (ZnO NanoShield™) and 
bulk zinc oxide (−325 mesh powder = 44μm) in powdered form were also 
obtained from Alfa Aesar. The average particle size of the ZnONP was 70nm 
(data provided by the manufacturer). Reagent-grade ZnCl2 for Zn ion (Zn2+) was 
purchased from Sigma Aldrich.  
We prepared two dispersants; 0.1% foetal bovine serum (FBS) and E. coli OP50 
supernatant as our in-house dispersants for ZnONP dispersion. The working 
stocks of powdered ZnONP and bulk ZnO were prepared by adding an equal 
volume of S basal to a mixture of one part of 1M ZnONP or bulk ZnO  (prepared 
in molecular grade water)  and four Parts 10% FBS , E. coli OP50 supernatant or 
molecular grade water. The resulting 100mM ZnONP was used as the working 
stock for ZnONP. For the preparation of the working stocks of ZnONP in 
proprietary dispersants, molecular grade water was used for the preparation of 
1M ZnONP from the readily available suspension ZnONP containing 6.14175M 
ZnO (see appendix for details). This was followed by adding one part of the 1M 
ZnONP to nine parts of S basal to give a working stock of 100mM ZnONP. 
Summarily, the five stocks of ZnONP in dispersant were prepared and these 
include; ZnONP dispersed in FBS (FZNP), ZnONP dispersed in E. coli OP50 
supernatant (SZNP), ZnONP dispersed in molecular grade water, ZnONP 
dispersed in propriety anionic dispersant (AZNP) AND ZnONP dispersed in 
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propriety cationic dispersant. The stock suspensions of all ZnONP and bulk ZnO 
were sonicated (Grant Ultrasonic Bath XB6; Grant Instruments, Cambridge, UK) 
for 30 minutes to enhance dispersion and homogeneity of suspensions. The zinc 
ion (Zn2+) stock solution (100mM) was prepared by dissolving ZnCl2 in molecular 
grade water. All treatment applications were in staggered time points (Kaszuba, 
2015). 
 
2.3.2 Zinc oxide nanoparticle characterization 
 
2.3.2.1 Scanning Electron Microscopy (SEM)  
The SEM was used for capturing images of the ZnONP to identify their shape, 
arrangement and the measurement of size. The working stocks described above 
(Section 1.3.1) were diluted in filtered molecular grade water (0.2µm) to a 
concentration of 1.25mM and centrifuged (1500rpm) onto round glass coverslips 
using a Shandon Cytopsin 3 (Thermo Scientific). The 1.25mM sample 
concentrations are required for easy viewing on the SEM as higher concentration 
(3.125 to 25mM) will make microscopic viewing difficult due to saturation of 
particles. The ZnONP on the coverslips were allowed to air-dry and mounted onto 
stubs using silver paint to hold the coverslips firmly. The stubs were placed in a 
sputter coater (Emitech K550X, Quorum Technologies, Kent) and sputter-coated 
with gold at a coating current of 15mA for 2 minutes. This is important to help 
form an even coat on the surface of the prepared ZnONP suspension in order to 
inhibit charging and reduce thermal damage to the sample. It also helps improve 
the secondary electron emission of the ZnONP suspension for easy viewing on 
the SEM. Images were captured using a Hitachi S4800 Ultra High Resolution 
Field Emission Scanning Electron Microscope at an accelerating voltage of 
10000 volts and a calibration scan speed of 25. 
 
2.3.2.2 Dynamic Light Scattering (DLS) 
DLS was used to establish the effect of dispersants on ZnONP size and the 
distribution of the size following dispersion. The technique measures the diameter 
of a hypothetical spherical and rigid particle, which diffuses at the same speed as 
the ZnONP. This measurement represents an equivalent of the irregular shaped 
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NP and is known as the hydrodynamic diameter. A Malvern Zetasizer Nano ZS 
was used to measure the hydrodynamic diameter presented as Z average at 25 
°C. ZnONP in dispersants from working concentrations described above (Section 
1.3.1) were used to prepare 12.5mM ZnONP samples, which were sonicated for 
30 minutes and analysed by taking three measurements per sample at 3 minute 
intervals.  
 
2.3.3 Dose response for ZnONP toxicity 
Due to variations of ZnONP concentrations in available literature, pilot 
experiments were conducted in order to choose the appropriate range for ZnONP 
concentrations. The concentrations considered included those relevant to 
ecotoxicology (Ma et al., 2013) as well as cosmetics and industrial  exposure 
scenarios as documented in the Scientific Committee on Consumer Safety 
opinion (SCCS, 2012) of the European Commission. Based on results from the 
pilot experiments on wild type C. elegans strain, the concentrations chosen for 
the study ranged from 3.125mM to 25mM. Although, these concentrations were 
seemingly high (LC50 > 25mM) they were within the remits of possible exposure 
scenarios such as accidental spillage in the environment. More so, the research 
focus is to evaluate methodologies to ensure the model organism is well suited 
for toxicity assays, so high concentrations would be useful in understanding toxic 
effects. 
A detailed description of the preparation of the treatment concentrations is in the 
appendix.  Liquid media was chosen over solid media for the toxicity experiments 
because ZnONP and bulk particles do not disperse evenly on solid media, 
restricting worm exposure to the toxicants.  
 
2.3.4 Zinc oxide nanoparticles lethality test 
For the lethality test, synchronized L4 worms were exposed to treatments for 4 
or 24 hours in 24-well tissue culture plates. Each test consisted of 12.5mM or 
25mM ZnONP in dispersant (FZNP, SZNP, WZNP, AZNP or CZNP), a negative 
control which is the untreated group and a Zn2+ ion control (12.5mM or 25mM 
ZnCl2 [ZN]). A 700µl volume of synchronized L4 worms in liquid culture (S 
medium) and in the presence of food (E. coli OP50) was added into each of the 
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wells in the 24-well plate. For the untreated worms, 300µl of S medium was added 
to the well to make up a final volume of 1ml. For the treated samples, 175µl or 
50µl of S medium was added to each of the wells to make up a volume of 875µl 
or 750µl respectively. A 125µl or 250µl of 100mM ZnCl2, ZnONP in dispersant or 
bulk ZnO in molecular grade water (BZ) was added to the treatment wells to make 
a concentration of 12.5mM or 25mM respectively, in a final volume of 1ml in the 
wells. All treatment and controls were run in three replicate wells and repeated 
three or four times with changes to the positions of treatment in the 24-well plate 
for each repeat experiment. Figure 2.1 below shows a schematic representation 
of the treatment plan. The 24-well plate was incubated for 4 or 24 hours at 20°C 
and all treatments were in staggered time. Following exposure, counts were read 
from samples in each well that were diluted with M9 buffer and aliquoted into 
clear empty Petri dishes to allow for visible counting under a stereomicroscope 
(Leica Microsystems, Germany) with a 6.3:1 zoom and 6.3X-40X magnification.  
Worms that did not respond to gentle probing under the microscope were scored 
as dead. Percentage survival was calculated as number of living worms per count 
divided by total number of worms per count (dead and alive) and multiplied by 
100. 
 
Figure 2.1: Schematic representation of treatment plan for ZnONP assay  
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2.3.5 Morphological analysis of ZnONP-treated worms 
In order to investigate the effect of ZnONP on worm size, synchronized L4 worms 
were exposed to treatments for 24 hours in 24-well tissue culture plates at 20oC. 
Each test consisted of 12.5mM ZnONP in dispersant, a negative control and a 
Zn2+ ion control which were prepared as described in section 1.3.1. Following 
exposure, worms were anaesthetized with 25mM levamisole to prevent 
movement and digital images of the worms were taken using a compound 
microscope equipped with a camera (Olympus DP25) and analysed with ImageJ 
(Fiji) software (Schindelin et al., 2012). The body length of the worms was 
measured from the tip of the worms’ mouth through the centre of the body to the 
tip of the tail. The width measurement was calculated from a perpendicular cross 
through the middle of the vulva. The morphology assay was repeated twice for 
each treatment and the mean measurement (n=15) per treatment was calculated. 
 
2.3.6 Reproductive analysis of ZnONP-treated worms  
The current research utilized an embryogenic assay instead of the conventional 
brood size assay as the reproductive toxicity endpoint. This was because our pilot 
experiments indicated that there was a broad variation in fecundity results. Based 
on a previous experiment (not shown) the bag of worms (BOW) phenotype, which 
is the internal hatching of eggs in the worms, was observed to occur under 
unfavourable conditions such as overpopulation and exposure to high 
concentration of ZnCl2 (25mM). We decided to utilize this as a marker for toxicity.  
Synchronized L1 larvae from first feed following hatching in liquid medium were 
incubated for 72 hours (20OC). After 72-hour incubation, the adult worms were 
treated with the test solutions in the presence of food (E. coli OP50) and in S 
medium for 24 hours. The treatment plan was as described above and the test 
solutions consisted of either 12.5mM FZNP, SZNP, WZNP, AZNP or CZNP. The 
controls also included untreated negative control and the Zn2+ control (12.5mM 
ZN). Following exposure, gravid worms were anaesthetized with 25mM 
levamisole, which importantly also induced the release of eggs allowing clear 
visibility of embryonic development. Worms were then analysed for the BOW 
phenotype using a compound microscope equipped with a camera (Olympus 
DP25) to take videos in form of sequence frame shots. Gravid worms containing 
completely hatched worms within them were scored as BOW phenotypes while 
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those with 3-fold embryo development within the eggs were termed accelerated 
embryonic development (AED) phenotypes. 
 
2.3.7 SOD expression of ZnONP-treated worms 
Superoxide dismutase (SOD) is a natural antioxidant produced in biological 
systems in order to detoxify free radicals or reactive molecules from oxygen by 
converting them to peroxides and water molecules. There are five types of SOD 
in C. elegans and one of this is the mitochondrial-based iron-manganese SOD 
known as SOD-3. To study the effect of ZnONP on SOD-3 transgenic C. elegans 
strain CF1553 (sod3::GFP) was used. Synchronized CF1553 eggs were 
transferred into S medium in the presence of E. coli OP50 as food source and 
L1, L3, L4 and adult hermaphrodite worms that developed from the eggs were 
treated with the test samples described in section 1.3.1 for 4 or 24 hours at 20oC.  
Living sod-3::GFP  worms from treatments were briefly centrifuged (30 seconds) 
and mounted on microscope slides with 3% agarose pads, anaesthetised with 
25mM levamisole and capped with cover slips. Fluorescence images were 
collected from a Laser Scanning Confocal Microscope (Carl Zeiss microscopy, 
USA) suited with an enhanced GFP channel set (excitation, 385 nm; emission, 
495 nm) using a x10 objective and / or an epifluorescence microscope (Carl Zeiss 
microscopy, USA) using x5, x10 or x20 objectives. Both microscopes were 
equipped with ZEN-lite freeware (Zeiss). Subsequent to observation of uniform 
intensity patterns among worms in the same field of view (x5 magnification), the 
expression of the sod-3::GFP  reporter was examined on a worm by worm basis 
for each treatment.   
 
2.3.8 RNA extraction from ZnONP-treated worms 
While the methods described in sections 1.3.4 to 1.3.7 above were used for 
investigating physiological and phenotypic responses following chemical 
exposure, molecular responses at genomic level were also important in 
reinforcing the establishment of the effect of the chemicals on C. elegans. High-
quality RNA from treated C. elegans RNA is required to generate sensitive and 
relevant results from molecular analysis. A modification of the RNeasy mini kit 
(Qiagen) technique was used for the RNA extraction as described below. 
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Having cultured C. elegans on NGM plates containing E. coli OP50, nine 5-day 
old plates were washed into 900ml S. medium in a 5L flask. This was incubated 
(20oC) for 120hrs in an incubator shaker (Innova 44 series, New Brunswick 
Scientific) at 160rpm. A 296.25ml volume of the mixed population culture was 
aliquoted into three 2L flasks with 3.75ml of 1M ZnONP in cationic dispersant 
(CZNP) added to one of flasks making a final 300ml worm culture treated with 
12.5mM CZNP. A 3.75ml volume of S medium was added to each of the 
remaining two 2L flasks to make up a final volume of 300ml culture. One of the 
two flasks was incubated for 2 hours at 37oC for the heat shock control while the 
other was incubated at 20oC along with the CZNP-treated worms for 24 hours as 
the untreated control and treated sample respectively.  Following incubation and 
exposure the contents in the flasks were transferred into 50ml falcon tubes and 
centrifuged at 4000rpm (1520g) for 3 minutes using a benchtop centrifuge 
(Universal 320, Hettich Zentrifugen) and left for 2 minutes at room temperature 
to allow most bacteria to settle at the bottom of the tube while the worms remained 
mixed with the supernatant. The centrifugation and aspiration was repeated twice 
with the final centrifugation at 12000rpm (11750g) for 6 minutes in a Mikro 200 
centrifuge (Hettich Zentrifugen) allowing the worms settle at the bottom of the 
tube. The supernatant was carefully aspirated leaving no more than 2ml residue 
which was transferred into an already weighed 2ml Eppendorf tube to help in 
calculating the wet weight of worms in the tube. The tube was centrifuged at 
12000rpm (11750g) for 1 minute and the supernatant was aspirated leaving in 
the tube about 0.2-0.3ml pellet. The worms were washed twice by filling the 
Eppendorf tube with M9 buffer, vortexing for 5 seconds and centrifuging at 
13500rpm (17136g) for 1 minute in a perfect spin 24R refrigerator centrifuge 
(Peqlab) before aspirating the supernatant leaving a final wet weight of no more 
than 300mg. Lysis buffer [Buffer RLT (600µl) or qiazol (1.1ml)] was added to the 
Eppendorf tube and vortexed for 15-20 seconds to ensure proper mix. The tube 
was placed in a tissue-lyser and homogenized for 6 minutes at 50 oscillations per 
second (50Hz). Following homogenization, the lysate was centrifuged for 3 min 
at 13500rpm (17136g); the supernatant was removed and transferred to a new 
Eppendorf tube. An equal volume of 70% ethanol was added to the cleared lysate 
and mixed immediately by pipetting. 700µl of the sample was transferred into an 
RNeasy spin column placed in a 2 ml collection tube and centrifuged for 20 
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seconds at 13500rpm (17136g). The flow-through was discarded and the 
collection tube was reused by adding 700µl Buffer RW1 to the RNeasy spin 
column and centrifuging for 20 seconds at 13500rpm (17136g) to wash the spin 
column membrane. The flow-through was discarded and buffer RPE was added 
to the RNeasy spin column, centrifuged for 20 seconds at 13500rpm (17136g) to 
wash the spin column membrane before 500µl Buffer RPE was added to the 
RNeasy spin column again and centrifuged for 2 minutes at 13500rpm to wash 
the spin column membrane. The RNeasy spin column was placed in a new 2 ml 
collection tube, centrifuged at full speed for 1 minute and placed in a new 1.5 ml 
collection tube adding 30µl RNase-free water directly to the spin column 
membrane. The column was centrifuged for 1 min at 13500rpm (17136g) to elute 
the RNA and the sample was stored at -80oC for nucleic acid measurement. 
 
2.3.9 sod-3 gene expression and protein analysis of ZnONP-treated worms 
 
2.3.9.1 Real time PCR 
The integrity and concentration of RNA (extraction described above) was 
evaluated using a Nanodrop 2000 spectrometer (Thermo Scientific) and an 
Agilent 2100 bioanalyzer (Agilent technologies). Total RNA was reverse 
transcribed using the Precision nanoScriptTM 2 Reverse Transcription kit 
(Primerdesign).  
2.3.9.1.1 cDNA synthesis 
Using the protocol provided by the manufacturer, each of the RNA samples was 
diluted in RNAse free water to make 5µl of 1µg RNA in a 0.2ml PCR tube. RT 
primer (1µl) and RNAse free water (4µl) were added sequentially to the PCR tube 
to make a final volume of 10µl. A lid was applied to the sample which was heated 
to 65oC for 5 minutes followed by immediate cooling on ice.  To complete the 
reverse transcription (+RT) reaction, 5µl nanoScript 2 4X buffer, 1µl dNTP mix, 
3µl RNAse free water and 1µl nanoScript enzyme were mixed together to give a 
final volume of 10µl. Also, a 10µl negative control (-RT) was prepared by mixing 
5µl nanoScript 2 4X buffer, 1µl dNTP mix, 4µl RNAse free water without 
nanoScript. The 10µl of +RT or -RT was added to the 10µl sample on ice and the 
tube was mixed briefly by vortexing for 10 seconds followed by pulse spinning. 
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Using a thermal cycler (Peqlab), the samples were incubated at 25oC for 5 
minutes, followed by a change in temperature to 42oC for 20 minutes and 
subsequent heat inactivation at 75 oC for 10 minutes. The resulting cDNA was 
then stored at -20 oC for qPCR experiments.  
2.3.9.1.2 Selection of C. elegans reference genes 
In order to quantify gene expression, a relative analytic method in which the 
amount of the gene transcript is calculated in relation to a pre-defined gene is 
required. This requirement is necessary to correct the differences between gene 
expressions in different samples. The pre-defined gene is known as the reference 
gene (RG) and its expression is usually unaffected by factors that influence the 
expression of genes of interest. In order to select the reference genes for the sod-
3 gene expression experiment, six C. elegans RG (Actin, EIF3C, MDH1, CANX, 
TUBULIN and UBC3) were chosen based on previous use in literature (Zhang et 
al., 2012). From the six RG, three were selected based on their stability. As 
decribed in the protocol, RG primer mix with SYBR green (Primerdesign) were 
suspended in RNAse free water (220µl), briefly centrifuged, vortexed, left for 5 
minutes and centrifuged again. In each well of a 96-well plates (ABI optical 
plates), a primer master mix was prepared by adding 1µl of the RG primer mix to 
10µl PrecisionPLUSTM master mix (Primerdesign) and making up 15µl with 4µl 
RNAse free water. cDNA from section 1.3.9.1.1 above was diluted (10µl cDNA in 
90µl RNAse free water) and 5µl of the diluted cDNA was added into wells of the 
96-well plate. For each RG considered, 26 wells were needed which included 
duplicates of four untreated control samples, four heat shock-treated samples, 
four CZNP-treated samples and a RNAse free water control. The plate plan is as 
described in table A1 in the appendix. The plate was placed in StepOne PlusTM 
Real-Time PCR System (Applied Biosystems) and the enzymes in the wells were 
activated for 10 minutes at 95°C and, then denaturation and, amplification using 
40 cycles of 10 seconds at 95 °C and 60 seconds at 60°C, respectively. The 
amplification was quantified using a melting curve analysis post run.  
2.3.9.1.3 sod-3 qPCR analysis 
Based on the result of the three most stable RG tested in section 1.3.9.1.2 above 
(see Figure A1 of the appendix for average expression stability graph), actin, 
CANX and MDH1 were chosen as reference genes for the sod-3 gene expression 
normalization. The designed primers used for sod-3 qPCR (Chun et al., 2015) 
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were 5’-TATTAAGCGCGACTTCGGTTCCCT-3’ for the forward primer and 5’-
CGTGCTCCCAAACGTCAATTCCAA-3’ for the reverse (Eurofins genomics). The 
primers were reconstituted to 100pmol/µl and 6µl of the forward and 6µl of the 
reverse primers were diluted in 88µl of RNAse free water give a concentration of 
300nM in 20µl reaction (This concentration is the same for the reference genes). 
Similar to the description in section 1.3.9.1.2 above, in each well of a 96-well plate 
(ABI optical plates), a primer master mix was prepared by adding 1µl of the RG 
primer mix or sod-3 primer mix to 10µl PrecisionPLUSTM master mix 
(Primerdesign) and making up to 15µl with 4µl RNAse free water. cDNA from 
section 1.3.9.1.1 above was diluted in 10-fold (10µl cDNA in 90µl RNAse free 
water) and 5µl of untreated, CZNP-treated or heat shock-treated cDNA was 
added into wells of the 96-well plate. For each gene considered, 12 wells were 
needed which included a negative control (-RT) and triplicates (+RT) of untreated 
control samples, heat shock-treated samples and CZNP-treated samples; for 
each of the four genes (sod-3 and the three RG) considered. The experiment was 
carried out on four sets of samples (n=4). The plate plan is as described in table 
A2 in the appendix. The plate was placed in StepOne PlusTM Real-Time PCR 
System (Applied Biosystems) and the enzymes in the wells were activated for 10 
minutes at 95°C and, then denaturation and, amplification using 40 cycles of 10 
seconds at 95°C and 60 seconds at 60°C, respectively. This was followed by 
quantification using a melting curve analysis post run.  
For the normalization of data (∆Ct) the mean Ct in each condition for sod-3 gene 
was subtracted from that of actin, CANX and MDH1. Subsequently, the derived 
∆Ct for sod-3 under CZNP or heat shock exposure conditions was subtracted 
from that in untreated controls to get the ∆∆Ct and the fold changes were 
calculated as 2-∆∆Ct. An increase in gene expression by at least 1.5-fold was 
considered upregulation while a decrease by at least 0.5-fold was considered 
significantly down-regulated. 
2.3.9.1.4 Immunoblot analysis of SOD-3 protein expression 
Mixed populations of worms from 100µl liquid culture that had been treated with 
either CZNP at 20oC for 24 hours or heat shock at 37oC for 2 hours, or an 
untreated population were homogenized in 2ml Eppendorf tubes with a bead 
using 400µl lysis buffer (1ml of 20% SDS, 800ul of 1M, 500ul β-mercaptoethanol, 
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1.5ml glycerol and 6.2ml deionized water) in a tissue lyser (Qiagen) at 50Hz for 
2 minutes. The tubes were heated at 97oC for 2 minutes and samples were 
allowed to cool on ice. Following centrifugation of the samples for 2 minutes at 
15000rpm, the total protein concentration in the supernatant was quantified using 
Bradford reagent (Biorad) and equal amounts (20µg in 20µl) were loaded on the 
gel. Before loading the samples, the gel cassette was filled with running buffer 
(30g Tris Base, 144g Glycine, 10g SDS diluted in a 1L final volume of deionized 
water) and 5µl ladder was added to one well while 20µl of untreated, heat shock-
treated or CZNP-treated samples was added into each of the subsequent wells. 
The sample buffer was pipetted unto an empty well and the gel was run at 120V 
for 60 minutes. The gel was transferred to a nitrocellulose membrane using a 
transfer buffer (30g Tris Base and 144g Glycine in a 1L final volume of deionized 
water) at 270V for 60 minutes. The nitrocellulose membrane was blocked using 
a 2% milk blocking solution; 2g milk powder in 100ml of 0.1% PBS tween (5 PBS 
tablets (Sigma-Aldrich) dissolved in 9.99L deionized water added to 10ml of 10% 
Tween) for 60 minutes on a shaker at room temperature.  After pouring off the 
blocking solution, the membrane was incubated with 1:1000 primary MnSOD 
antibody (S8060-10B-USBiological) raised in rabbit against rat as previously 
used by (Doonan et al., 2008) and 1:1000 human actin antibody raised in goat 
(C-11: sc-1615-Santa Cruz) in 10ml fresh blocking solution overnight on a shaker 
at 4°C. The membrane was then washed three times in PBS tween for 20 minutes 
for each wash. This was followed by incubation with 1:20000 anti-rabbit produced 
in goat (Green- Licor 926-32211) and anti-goat produced in donkey (Red-Licor 
926-68024) secondary antibodies for SOD and Actin respectively at room 
temperature for 2 hours using a foil to cover the dish to prevent photo bleaching 
due to light. The membrane was washed twice with PBS tween and once with 
PBS before scanning with the Licor Odyssey machine and quantifying 
immunofluorescence with Licor image studio lyte imaging system (Li-cor 
Bioscience).  
 
2.3.10 Microarray analysis of MicroRNA expression 
MicroRNAa (MiRNAs) are non-coding small RNAs processed from primary RNA 
transcripts. MiRNAs are important in the regulation of genes. In the current 
research, miRNAs were used as biomarkers to investigate the effect of ZnONP 
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exposure on C. elegans by using miRNA microarray to help elucidate expression 
patterns that could be ascribed to chemical toxicity. RNA samples from section 
1.3.8 above were sent to Dr. Emma Marczylo of Public Health England, Oxford, 
United Kingdom for microarray analysis of miRNA expression. This was part of a 
collaboration with Public Health England. The experiments were performed by 
Dr. Emma Marczylo and the heatmap visualization of miRNA expressions of 
hybridization intensities with a cut off fold change of two and four were recorded. 
 
 
2.4 Toxicity assessment of Diethylstilbestrol 
 
2.4.1 Diethylstilbestrol lethality test 
In order to investigate the lethal effect of Diethylstibestrol (DES) on C. elegans, 
1M DES (D4628-Sigma Aldrich, Germany), was prepared by diluting 268.35mg 
of DES in 1ml DMSO. A working stock of 100mM DES was prepared from the 1M 
solution using a 10-fold dilution.  10-fold serial dilutions were made from the 
working stock (100mM) and a 10mM treatment concentration was prepared by 
adding 100µl of 100mM DES to 900µl S. medium containing synchronized L4 
worms. Other resulting dilutions from the 100mM stock were used to prepare the 
lower treatment concentrations in that order. Each concentration of DES was 
vortexed immediately before use. Controls included 0.1%, 1%, DMSO prepared 
with M9 as diluent. The different concentrations of DES were similar to real life 
exposure doses. Following exposure, counts were read from samples in each 
well under a stereomicroscope (Leica Microsystems, Germany) with a 6.3:1 zoom 
and 6.3X-40X magnification.  As described by Chalfie & Sulston (1981) and 
Sulston et al. (1975), worms that did not respond to gentle probing under the 
microscope were scored as dead. Percentage survival was calculated as number 
of living worms per count divided by total number of worms per count (dead and 
alive), and multiplied by 100. 
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2.4.2 Behavioural analysis of DES-treated worms 
The behavioural assessment of worms exposed to DES was investigated using 
a computer tracking. In this experiment, synchronized L4 worms were exposed 
to DES concentrations ranging from 1nM to 10mM in a final volume of 1ml 
treatment in a 24-well plate setting. The controls included untreated synchronized 
L4 worms in S medium and L4 worms in 0.1%. 1% and 10% DMSO. The worms 
were monitored using a computer tracking system composed of a Leica M125 
dissecting microscope (Germany) equipped with a 5 Megapixel Olympus DP5 
camera (United Kingdom) interfaced with a Windows computer. Following 
exposure, 500µl of each treatment containing worms was transferred onto empty 
petri dishes. Behavioural tracking was monitored on liquid medium and not solid 
medium because worms that burrow into the agar prevent clear frame capture. 
Also, desiccation resulting from dry solid agar surface might influence movement 
of the worms if tracking was monitored on agar. Digital captures tracking worm 
movement were acquired for 15 seconds at approximately five frames per second 
using Cellsens Life Science imaging software. The speed (length covered in 
pixels per second) and thrashing frequency (body bend per second) of the worms 
were recorded using ImageJ (Fiji) software and the wrMTrck plugin as described 
by Nussbaum-Krammer et al. (2015). The thrashing frequency was converted to 
body bends per minute to normalize the data. The wrMTrck permits the 
concurrent tracking of the worms by recording their rate of movement. A 
description of the steps for the manipulation of wrMTrck parameters can be found 
in the supplementary document provided by Dr. Jesper Pederson (See Pederson 
in the references).  
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2.5 Toxicity assessment of derivatized tubulin-targeting 
anthelmintics  
 
2.5.1 Anthelmintic derivative treatments 
The anthelmintic derivatives; GEO1, GEO2, MB2, MB2-TPP, NU:UB 238 and 
SH1 used in this study were supplied by Dr David Mincher of Edinburgh Napier 
University, Edinburgh, United Kingdom. Aiman Rehan of Edinburgh Napier 
University graciously supplied AM1 and AM2. GEO1, AM1 and MB2 are 
colchicine derivatives while GEO2, AM2 and MB2-TPP are their respective 
triphenylphosphonium (TPP) conjugates. NU:UB 238 is an anthraquinone 
derivative and SH1 is its TPP conjugate. The structures and molecular details of 
the anthelmintic derivatives can be found in the appendix (Section B).  
 
2.5.2 Derivatized anthelmintics lethality test 
Concentrations of colchicine (Sigma Aldrich), TPP (Sigma Aldrich), GEO1, 
GEO2, AM1, AM2, MB2, MB2-TPP, NU:UB 238 and SH1, ranging from 0 to 
400µM were considered for the toxicity assessment. Untreated L4 worms in S 
medium was used as negative control. Other controls included the DMSO (0.1%. 
1% and 10% DMSO) which was the solvent used in the preparation of treatment 
suspensions. All samples containing the worms and their food (E. coli OP50) 
were exposed to the treatments in a total of 1ml in a 24-well plate setting. 
Exposure times were either 4 or 24 hours at 20oC incubation temperature with all 
treatments run in staggered time. Experiments were repeated at least once. 
Following exposure, counts were read from samples in each well and percentage 
survival was calculated as described in section 1.4.1 above. 
 
2.5.3 Behavioural analysis of derivatized anthelmintic-treated worms 
Whilst the major aim of studying the toxicity of derivatized anthelmintics in C. 
elegans is to investigate their helminticidal properties, the effect of the derivatives 
on worm behaviour was necessary to give a broader descriptive toxicity 
assessment. In order to investigate the effect of derivatized anthelmintics on C. 
elegans behaviour, synchronized L4 worms were exposed to treatments as 
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described in section 1.5.2 above. The worms were monitored using the same 
computer tracking system described in section 1.4.2 above. Behavioural video 
tracking was accomplished by capturing images for 20 seconds at approximately 
6 frames per second using Cellsens Life Science imaging software. The wrMTrck 
plugin on ImageJ (Fiji) was used to compute the speed and thrashing frequency 
of the worms as described in section 1.4.2 above. 
 
 
2.6 Assessment of legumain-specific targeting in helminths 
 
2.6.1 Fluorophore-based probes 
For the investigation of the potential for legumain-specific anthelmintic targeting, 
Ding Y., Turnbull A. and Mathur S. from the Department of Chemistry and Drug 
Design, Edinburgh Napier University synthesized and graciously provided the 
probes TL11, LS9 and SM9 respectively. TL11 is a fluorescein-labelled probe 
while LS9 and SM9 are rhodamine-based. The structure and details of the probes 
can be found in section C of the appendix. 
 
2.6.2 Parasite Homogenates and Sheep Plasma  
Homogenates of the sheep parasites, Haemonchus contortus and Teladorsagia 
circumcincta (both containing 1mg/ml protein) were provided by Dr Alasdair 
Nisbet of Moredun Research Institute, Edinburgh, United Kingdom while sheep 
plasma was provided by Dr Mick Rae of Edinburgh Napier University Edinburgh, 
United Kingdom. 
 
2.6.3 Preparation of somatic fractions 
A protocol for the preparation of somatic fractions in C. elegans was developed 
to identify whether legumain was water soluble (S1), membrane-associated (S2) 
or membrane-bound (S3). The protocol was originally designed by McAllister et 
al. (2011) for the preparation of trematode somatic fractions and was modified in 
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our laboratory for C. elegans. For the preparation of the somatic fractions, equal 
volumes of C. elegans pellet (wet weight) and homogenizing buffer (HB; PBS, 
2mM EDTA 1mM phenylmethylsulphonyl fluoride (PMSF) pH7.4) were mixed and 
the worms were homogenized using a tissue-lyser for 4 minutes at 50 oscillates 
per second followed by centrifugation at 20,000g for 20 minutes at 0oC. The 
supernatant was removed but retained as S1 fraction. The pellet was 
resuspended in HB with 0.1% Tween-20 and homogenized with the tissue-lyser 
for 30 seconds at 50 oscillates per second. This was followed by centrifugation 
at 16,500g for 20 minutes at 2oC before aspirating the supernatant (S2) for 
retention. The Tween-20 extraction was repeated before aspirating the 
supernatant which was discarded this time. The pellet from the repeated 
extraction was resuspended in 0.5ml 2% w/v reduced Triton X-100 in PBS pH7.4 
and homogenized with the tissue-lyser for 30 seconds at 50 oscillates per second. 
The homogenate was stirred for 30 minutes using a shaker at 4oC (160rpm). This 
was followed by centrifugation at 50,500g for 30 minutes at 2oC before aspiration 
and retention of the supernatant (S3). 
 
2.6.4 Removal of detergent from somatic fractions 
Whilst Tween 20 and Triton X-100 were used to solubilize, stabilize and 
disaggregate the protein content to produce S2 and S3 somatic fractions 
respectively (see section 1.6.3 above), the detergents in the somatic fractions 
seem to interfere with legumain activity as observed in a pilot legumain activity 
assay.  Therefore, it was important to remove non-bound detergents from the 
somatic fractions. The Pierce detergent removal resin column (87778-Thermo 
Scientific) was used for the detergent removal. As described in the 
manufacturer’s protocol, after the loosening the resin column cap and removing 
its bottom closure, the resin column was placed into a 15ml collection tube and 
centrifuged at 1000g for 2 minutes to remove the storage solution in the column. 
In order to wash the resin column free of the storage solution, 2ml phosphate 
citrate buffer (pH5) was added to the column which was subsequently centrifuged 
at 1000g for 2 minutes. The buffer and storage solution in the collection tube was 
discarded and the 2ml phosphate citrate buffer wash, centrifugation and 
discarding of the content in the collection tube was repeated twice. The resin 
column was placed in a new 15ml collection tube and 400µl the somatic fraction 
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(S2 or S3) was carefully pipetted unto the compact resin bed in the column. The 
column was incubated for 2 minutes at 25oC. This was followed by centrifugation 
at 1000g for 2 minutes to collect the detergent-free somatic fraction for legumain 
assay. 
 
2.6.5 BCA Protein Assay 
To estimate the total protein concentration in homogenates, Bovine Serum 
Albumin (BSA) standards were prepared from 2mgml-1 stock solution. BCA 
working reagent was prepared by combining 20µl copper (II) sulphate 
pentahydrate 4% solution with1ml bicinchoninic acid. 10µl of homogenate or 
Bovine Serum Albumin (BSA) standard was added into a 96 well micro plate 
followed by 80µl of the BCA working reagent and the mixture was mixed carefully 
for 30 seconds before incubating at 37oC for 30 minutes. The plate was allowed 
to cool for 5 minutes and the absorption was measured at 600nm using an 
LT5000 ELISA plate reader. After taking the average of replicate values, a 
standard curve was generated by plotting mean standard values against their 
respective concentrations. The standard curve was used to interpolate the 
concentration of each nematode parasite homogenate sample based on its mean 
absorbance value.  
 
2.6.6 Legumain activity  
The legumain assay involved the determination of legumain in worms (C. 
elegans, H.contortus or T. circumcincta), sheep plasma and sheep liver tissue 
based on the selective cleavage of the fluorophore-based substrate attached to 
a quencher to release fluorescence. The probes use the Fluorescence 
Resonance Energy Transfer (FRET) application to measure fluorescence. For 
the experiment, homogenates of C. elegans, H. contortus, T. circumcincta, sheep 
liver tissue or sheep plasma samples were treated with 10µM of either TL11 or 
LS9 in a final volume of 100µl in a 96-well plate. Each treatment well of the 96-
well plate contained the sample diluted in either MES buffer (pH5) or phosphate 
citrate buffer (pH4, 5, 6, or 7). The buffers were necessary to allow for activation 
of legumain as this is pH-dependent (see section D of appendix for buffer 
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preparation). A 3.5µl, 3.6µl or 3.7µl volume of protease inhibitors; N-
phenylmaleimide (1mM), E-64 (100µM) or Iodoacetamide (1mM) respectively, 
were added to 95.4µl, 95.3µl or 95.2µl respectively, of sample in buffer. This was 
followed by the addition of 1.1µl of the provided working stock solution of TL11 
(902.5µM) or LS9 (895.75µM) to make a final volume of 100µl treatment 
containing 10µM probe in each well. E-64 is a general cysteine protease inhibitor 
which has no inhibitory effect on legumain (Barrett et al., 1982 and Chen et al., 
1997), while N-phenylmaleimide and Iodoacetamide inhibit legumain activity. The 
negative control included 98.9µl each of MES (pH5) or phosphate citrate buffer 
with 1.1µl of the LS9 or TL11 probe (10µM concentration of the probe) while the 
positive control included 98.9µl recombinant legumain in buffer (2.5ng/µl) with 
1.1µl probe. Details of the preparation of treatment samples can be found in 
section D of the appendix. The 96 well plates were analysed in the fluorimeter 
(Fluorostar Omega – BMG Labtech) for 2 hours at excitation spectrum of 544nm 
and emission of 590nm for treatments containing LS9 or excitation spectrum of 
485nm and emission of 520nm for treatments containing TL11. 
 
2.6.7 Legumain localization  
SM9 probe was employed to investigate whether the probe is permeable to  the 
worms. This was important to establish the possible interaction of the rhodamine-
based probe, and identify the legumain localized region(s) in the worm following 
the cleavage of tripeptide group from the probe. For the experiment, an adult 
population of worms was exposed to 1µM SM9 in a final volume of 100µl and 
incubated (20oC) in a shaker incubator for 18 or 24 hours. Controls included 
worms that were untreated with the SM9 probe and the SM9 probe alone. Worms 
from the treatments were washed with M9 buffer and centrifuged briefly (30 
seconds). The worms were mounted on microscope slides with 3% agarose, 
anaesthetised with 25mM levamisole and capped with cover slips. Fluorescence 
images were captured using a Laser Scanning Confocal Microscope (Carl Zeiss 
microscopy, USA) suited with an enhanced multiple channel set using a x10 
objective and / or an epifluorescence microscope (Carl Zeiss microscopy, USA) 
using x5, x10 or x20 objectives. Both microscopes were equipped with ZEN-lite 
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freeware (Zeiss). Imaging analysis was performed using the ImageJ (Fiji) 
software. 
 
 
2.7 Data analysis 
Significant differences among treatment groups or concentrations and their 
controls were compared for one or two exposure times. For lethality test 
experiments involving one time exposure, One-way ANOVA was calculated. 
Where two exposure times were compared within different groups of treatments, 
Two-way ANOVA was calculated for the experiments. Also, One-way ANOVA 
was used for statistical evaluation of experiments involving cumulative data. 
Where data from individual worms was used for toxicity assay data analysis, 
graphs were developed from contingency tables with 95% confidence intervals. 
Statistical significance from pairwise comparison was established as p < 0.05 for 
biological replicates. All statistical analysis was performed with Sigmaplot 12 
(Systat Software, Inc., San Jose California USA). 
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Chapter Three 
3 Toxicity assessment of zinc oxide nanoparticles 
3.1 Introduction 
The term nanotechnology describes the manipulation of materials by one atom 
or one molecule to dimensions as small as 100nm. Hence, the word nanomaterial 
describes materials between 1 and 100nm size ranges (Boholm and Arvidsson, 
2016). The physical and chemical properties of nanomaterials encourage their 
application in engineering (Ahn et al., 2014), textile industries (Ilanchezhiyan et 
al., 2015), food industries (Danza et al., 2015), cosmetics industry (Fakhravar et 
al., 2015) and medicine (Fan et al., 2015). The global economy currently benefits 
from the lucrative application of nanotechnology and nanomaterials, and is 
predicted to be worth about £140.84 billion by 2025 (Global Nanotechnology 
Market Analysis & Trends, 2016). 
One of the common nanomaterials used in various industries is zinc oxide 
nanoparticles (ZnONP). ZnONP are used in food additives, paints, cosmetics and 
personal hygiene products. More specifically, they are constituents of body 
moisturizers and sunscreens because of their translucence and ability to prevent 
exposure to ultraviolet A and B (UVA and UVB) radiation (Nohynek et al., 2007). 
Again, ZnONP protection against UV light makes it a necessary ingredient in 
painting and coating materials used in building and construction (Steele et al., 
2009). ZnONP in the form of a dietary Zn supplement can improve the growth 
performance and red blood cell counts in fish. Their antibacterial properties also 
make them useful in mouthwashes, toothpastes and ointment production for the 
prevention of microbial growth (Jones et al., 2008). 
The small size, large surface area and increased surface reactivity due to high 
percentage of atoms on the particle surface and quantum effects, are 
characteristics that make ZnONP different from their bulk equivalents. Concerns 
have been raised regarding the implications of these characteristics on human 
health and the environment because of increasing manufacture, use and 
exposure to ZnONP (Nowack and Bucheli, 2007). Although ZnO is generally 
recognized as safe by agencies like the FDA in the United States, in its 
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nanoparticulate form, it can develop new toxic characteristics. Consequently, its 
toxicity evaluation is important. 
There have been a number of in vitro studies on ZnONP toxicity assessment. In 
the lung epithelial cell culture assay, ZnONP induced intracellular Ca2+ (George 
et al., 2010), mitochondrial damage caused by the generation of reactive oxygen 
species (ROS), and increase in the pro-inflammatory cytokine IL-8 (Saptarshi et 
al., 2015). ZnONP have also been found to induce antioxidant activities as well 
as altering cell viability in adipocytes and mouse myoblast cell lines 
(Pandurangan et al., 2014).  Similarly, the investigation of the effect of ZnONP on 
mouse macrophages revealed that non-cytotoxic concentrations of the NP in 
consumer products elicited cellular pro-inflammatory responses and resulted in 
significant cell death following 24-hour exposure to the NP (Giovanni et al., 2015). 
Prach et al. (2013) investigated the cytotoxic effect of ZnONP on the human 
monocyte cell line; THP1. Their results showed that ZnO cytotoxicity was 
dependent on size and charge of the NP. Zijno et al. (2015) investigated the 
induction of oxidative stress (OS) by ZnONP on human colon carcinoma cells. 
Their study revealed that ZnONP caused micronucleic and DNA damage. They 
further compared the genotoxic abilities of ZnONP to titanium oxide (TiO2) NP 
and realized that while TiO2 could repair oxidative DNA through the involvement 
of 8-oxoguanine glycosylase, Zn NP could not. Hence ZnONP are suggested to 
also affect repair pathways as Zijno et al. (2015) and (De Angelis et al., 2012) 
suggest that their fast dissolution when compared to TiO2 is a major factor which 
contributes to their toxicity.  
Although a substantial amount of study on ZnONP has been done in vitro, in vivo 
assays are needed to understand their long-term effects in biological systems 
and to investigate their fate; if they indefinitely remain in the systems; dissolve 
and/ or get cleared from the system. Moreover, in vivo screening authenticates 
the initial in vitro assay in order to allow the latter to be used as a primary toxicity 
assessment method. Some researchers have studied ZnONP in organisms like 
bacteria (Read et al., 2016), algae (Bhuvaneshwari et al., 2015), crustaceans 
(Xiao et al., 2015), Zebra fish (Wehmas et al., 2015) and mice (Gosens et al., 
2015). Wehmas et al. (2015) showed that the toxicity of ZnONP in zebra fish was 
stage specific. This is likely, as physiological zinc levels play a crucial role in 
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growth and development, including the immune system through the regulation of 
various enzymes (Truong-Tran et al., 2001). While some mammalian in vivo 
models may be preferred for toxicity assessments, they are relatively expensive 
in comparison to some invertebrate models and their assessments may also be 
time-consuming. For example, the assessment of one chemical for reproductive 
toxicity would involve the use of many animals and such processes require time. 
Hartung & Rovida (2009) estimated that 54 million vertebrate animals and testing 
costs of £6.8 billion would be required to implement the European Registration, 
Evaluation, Authorisation and Restriction of Chemicals (REACH). The REACH 
was initiated to minimize the use of animals in chemical testing through the 
implementation of the 3Rs (reduction, refinement or replacement of animal use). 
Such challenges as mentioned above have encouraged the development of more 
accessible and acceptable models for in vivo screening. One of such models is 
the nematode Caenorhabditis elegans. A detailed overview of C. elegans was 
included in chapter one of the current research. 
The aim of the current research was to develop a C. elegans model system for 
ZnONP toxicity assessment and to gain more understanding of the 
physicochemical characteristics of ZnONP that influence toxicity. In order to 
accomplish the goals, wild-type and transgenic C. elegans strains were exposed 
to ZnONP nanoparticle prepared in five different types of dispersants; molecular 
grade water, 0.1% FBS, E. coli OP50 supernatant, anionic and cationic colloidal 
dispersants that allowed us to investigate the effect of dispersion on worm 
response. The potential toxic effects of ZnONP were investigated using lethality, 
morphology, reproduction, green fluorescent protein (GFP) reporter expression, 
gene and protein expression, and miRNA expression analysis to elucidate a new 
perspective to ZnONP toxicity assessment. 
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3.1. Results  
In order to investigate viability of the worms following exposure to zinc oxide 
nanoparticles (ZnONP), physicochemical properties of the ZnONP and endpoints 
that are measures of toxicity were investigated. We characterized ZnONP in 
different dispersants using direct light scattering (DLS) and scanning electron 
microscopy (SEM) to determine effect of the dispersants on the ZnONP size, 
distribution, shape and arrangement. 
 
3.2.1. Zinc oxide nanoparticle characterization 
3.1.1.1 Scanning Electron Microscopy analysis of ZnONP 
The SEM was used for capturing images of the ZnONP to identify their shape, 
arrangement and the measurement of size. ZnONP dispersed in molecular grade 
water (WZNP), 0.1% FBS (FZNP), E. coli OP50 supernatant (SZNP), anionic 
dispersant (AZNP) or cationic dispersant (CZNP) all had irregular shapes and the 
particles were majorly clustered (Figure 3.1, panels A-E), however; WZNP, FZNP 
and SZNP seemed to have more clusters while AZNP and CZNP appeared to 
have more uniform side by side alignment of the particles (Figure 3.1, panels F-
J). Furthermore, although the details from the commercially produced ZnONP 
datasheet state that the ZnONP used is approximately 70nm, the size range of 
the ZnONP in all the dispersants were between 27nm and 451nm. 
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Figure 3.1:  Scanning electron micrograph of ZnONP in different dispersants. 
All samples for characterization were prepared at a concentration of 1.25mM in molecular grade water 
represented by WZNP (A & F), 0.1% FBS represented by FZNP (B & G), E. coli OP50 supernatant 
represented by SZNP (C & H), anionic dispersant represented by AZNP(D & I) or cationic dispersant 
represented by CZNP (E & J). The samples were mounted on aluminium pin mounts and coated with gold 
for electrical conductivity in a plasma chamber for 2 minutes to prevent particle distortion.  
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3.1.1.2 Dynamic light scattering analysis of ZnONP  
DLS was used to establish the effect of dispersants on ZnONP size and the 
distribution of the size following dispersion. The technique measures the diameter 
of a hypothetical spherical and rigid particle which diffuses at the same speed as 
the ZnONP. This measurement represents an equivalent of the irregular shaped 
NP and it is known as the hydrodynamic diameter. Assessment of the ZnONP in 
dispersants with the DLS produced the Z-average diameter which is the intensity 
weighted mean size or cumulant mean of the collective total ZnONP 
hydrodynamic diameter in each dispersant.  In Figure 3.2, ZnONP prepared in 
molecular grade water WZNP had the highest Z-average diameter (1256 ± 
134.1nm) while ZnONP prepared in cationic dispersant CZNP had the lowest 
(197.6 ± 1.504nm). Figure 3.2 also detail point blots of the triplicate readings from 
the bar graph. The order of size of the triplicate Z-average values was required 
to establish aggregation or sedimentation in the ZnONP preparations. The 
difference among the Z-average measurements is expected to be within 2% of 
one another. The first Z-average reading was taken (red) 3 minutes before the 
second reading (green) and the third reading (blue) was taken 3 minutes after the 
second reading for each of the dispersed ZnONP samples. There was a 
decreasing Z-average diameter (≥6%) in WZNP suggesting ZnONP 
sedimentation while SZNP, FZNP and AZNP had increasing Z-average values, 
however; these were within acceptable threshold. The differences in Z-average 
values obtained from the repeats of CZNP were within less than 1% of one 
another suggesting that CZNP was the most stable of all ZnONP investigated. 
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Figure 3.2: Z-average diameter of ZnONP in dispersants. 
12.5mM ZnONP was prepared in molecular grade water (WZNP), E. coli OP50 supernatant (SZNP), 0.1% 
FBS (FZNP), anionic dispersant (AZNP) or cationic dispersant (CZNP). DLS was used to analyse the 
samples with three readings taken for each sample at 3 minute intervals. First reading is represented by the 
red dot, second reading is represented by the green dot and the third reading is represented by the blue dot. 
Temperature was maintained at 25oC while light scattering angle was 173o.  
 
 
To reinforce the finding above, the ZnONP size distribution was also evaluated 
(Figure 3.3) and the result revealed that WZNP was excessively polydispersed 
with its size ranging between 450 to 6500nm. The occurrence of particles of 
around 712nm in diameter was the highest (38%) of the WZNP distribution. On 
the other hand, the highest peak of CZNP was around 220nm (14.7%) and the 
range of distribution was between 78nm and 620nm. Also, CZNP was the only 
sample that had all three readings imposed on one another with a monomodal 
peak for each reading (Figures 2 and 3) suggesting that it is the most stable of all 
ZnONP samples. 
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Figure 3.3: Particle size distribution of ZnONP in dispersants. 
12.5mM ZnONP was prepared in molecular grade water (WZNP), E. coli OP50 supernatant (SZNP), 0.1% 
FBS (FZNP), anionic dispersant (AZNP) or cationic dispersant (CZNP). DLS was used to analyse the samples 
with three reading taken for each sample at 3 minute intervals. First reading is represented by the red dot, 
second reading is represented by the green dot and the third treading is represented by the blue dot. 
Temperature was maintained at 25oC while light scattering angle was 173o. Polydispersity index (PdI) which 
is a measure of the width of the distribution was within acceptable threshold (0.05-0.7). Count rate per second 
was within acceptable threshold (117.8-460.1 kilo count per second) 
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3.2.2. Effect of ZnONP on the survival of C. elegans 
L4 adults from synchronized cultures of wild-type worms were exposed to varying 
concentrations of ZnONP in two different dispersants (anionic and cationic) to 
investigate the lethal effect of the NP on the worms. The concentrations chosen 
for the pilot study ranged from 3.125mM to 25mM. Although, these concentrations 
were high, they were within the remits of possible exposure scenarios. More so, 
high concentrations were included to give informed understanding of suitable 
concentrations to be considered for subsequent experiments. A negative control 
(S medium) and a Zn2+ control (ZnCl2) were included as part of the experiment. 
Following a 4-hour exposure time to ZnONP treatments, the results revealed that 
more than 95% of all treatment groups and control groups survived (data not 
shown). After 24-hour exposure, about 95% of worms exposed to all treatment 
groups below 12.5mM survived with no significant difference between the 
untreated group and other treatment groups. At 25mM, more than 60% of worms 
exposed to ZnCl2 (ZN) for 24 hours died, while about 16% and 10% death was 
recorded among worms exposed to ZnONP dispersed in anionic dispersant 
(AZNP) and cationic dispersants (CZNP) respectively (Figure 3.4A). The viability 
observed at 12.5mM was similar for 25mM AZNP and CZNP-exposed worms but 
about 95% of the ZN-treated worms survived (Figure 3.4B). The results described 
above reveal that the lethal effect of ZnONP is dose-dependent. 
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Percentage of live and dead synchronized L4 worms following exposure to (A) 25mM or (B) 12.5mM ZnCl2 (ZN), ZnONP in anionic dispersant (AZNP) or cationic dispersant 
(CZNP) for 24 hours where the untreated group and ZN-treated group were the negative and positive controls respectively. Counts were read under a stereomicroscope (Leica 
Microsystems, Germany) with a 6.3:1 zoom and 6.3X-40X magnification.  Worms that did not respond to gentle probing under the microscope were scored as dead. Percentage 
survival was calculated as number of living worms divided by the total number of worms (dead and alive) multiplied by 100. Chi-square analyses of the contingency table from 
the experiments were used for statistical analysis. For graph A, chi-square= 236.198 with 3 degrees of freedom (P = <0.001) where a total of 703 worms were analysed over 
three separate experiments with each treatment containing between 148 and 215 worms and power of chi-square test = 1. For graph B, chi-square= 30.237 with 3 degrees of 
freedom (P = <0.001) where a total of 850 worms were analysed over three separate experiments with each treatment containing between 205 and 220 worms and power of 
chi-square test = 0.999.  
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Figure 3.4: Effect of ZnONP on wild-type C. elegans survival. 
 56 
 
Following on from the pilot study, ZnONP in three other dispersants were 
investigated added to the previously considered treatment groups (SM, ZN, 
AZNP and CZNP). The three additional treatments included ZnONP prepared in 
molecular grade water (WZNP), 0.1% fetal bovine serum (FZNP) and E. coli 
OP50 supernatant (SZNP) to attempt investigating the effect of dispersants 
alone. The worms were exposed to 12.5mM concentrations of the ZnONP for 24 
hours. The results in Figure 3.5 showed that there was no significant difference 
observed among all the treatment groups and the controls with less than 5% 
death recorded in all cases. 
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Figure 3.5: Effect of 12.5mM ZnONP exposure on survival of wild type C. elegans. 
Percentage survival of synchronized L4 worms exposed to 12.5mM ZnCl2 (ZN), ZnONP prepared in 
molecular grade water (WZNP), E. coli OP50 supernatant (SZNP), 0.1% fetal bovine serum (FZNP), anionic 
dispersants (AZNP) or cationic dispersant (CZNP) at 20oC for 24 hours where untreated group and ZN-
treated group were the negative and positive controls respectively. The controls for dispersants used in the 
preparation of AZNP and CZNP were unavailable due to manufacturer’s proprietary confidentiality. Survival 
counts were read under a stereomicroscope with a 6.3:1 zoom and 6.3X-40X magnification.  Worms that did 
not respond to gentle probing under the microscope were scored as dead. Percentage survival was 
calculated as number of living worms divided by the total number of worms (dead and alive) multiplied by 
100.  ANOVA on ranks was used for statistical analysis with error bars representing ± SD where n>155 over 
three separate experiments. 
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3.2.3. Effect of ZnONP on worm morphology 
The effect of ZnONP treatments prepared in different dispersants with a final 
concentration of 12.5mM, on individual worm morphology was investigated by 
measuring the body length and body width of worm post treatment (Figure 3.6). 
Following a 24-hour exposure to the ZnONP in different dispersants, the results 
revealed that the length of worms exposed to SM was significantly longer than 
ZN-treated worms (p<0.02). AZNP-treated worms were significantly shorter than 
untreated worms (p<0.001) suggesting that AZNP affect the length of the worms. 
SM and SZNP treatments had similar length averages suggesting that the length 
of untreated worms and SZNP-treated worms are not affected by the treatments. 
Also, there was a significant difference between the width of untreated worms 
and ZN-treated worms with the former having a broader width (p < 0.001). 
Furthermore, the width of the AZNP-treated worms and CZNP-treated worms 
were significantly narrower than the untreated control group (p<0.001 and 
p=0.004 respectively). Interestingly, the SZNP-treated group were significantly 
broader than FZNP (p<0.019), WZNP (p<0.048), AZNP (p<0.001), CZNP 
(p<0.001) and ZN (p<0.001) -treated groups. The results indicate that worm 
morphology is not affected by SZNP treatment; hence, the type of dispersants 
may have an effect on worm morphology. Again, the possible effect on worm 
morphology observed in AZNP and CZNP-treated worms could implicate the 
dispersants used in the preparation of the treatments. 
 
 58 
 
 
Figure 3.6: Effect of ZnONP on worm morphology. 
(A) Worm length and (B) worm width of synchronized L4 worms exposed to 12.5mM ZnCl2 (ZN), ZnONP prepared in molecular grade water (WZNP), E. coli OP50 
supernatant (SZNP), 0.1% fetal bovine serum (FZNP), anionic dispersants (AZNP) or cationic dispersant (CZNP) at 20oC for 24 hours were measured using imageJ 
analysis of camera-captured images. The untreated group and ZN-treated group were the negative and positive controls respectively while controls for dispersants 
used in the preparation of AZNP and CZNP were unavailable due to manufacturer’s proprietary confidentiality. The length measurement was taken from the tip of the 
worms’ mouth through the centre of the body to the tip of the tail. The width measurement was calculated from a perpendicular cross through the middle of the vulva. 
One-way analysis of variance (ANOVA) was used for statistical analysis with error bars representing ± SEM where n=15 for each treatment group analysed over 3 
separate experiments. All pairwise multiple comparisons were investigated and the degree of significance was represented by * where p<0.05, ** where p<0.01 and *** 
where p<0.001. Asterix directly above bars represent degree of significance of comparisons between the negative control (untreated) and other treatments, while asterix 
connecting two bars represent the significance between the two connected bars. 
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3.2.4. Effect of ZnONP on reproduction 
3.1.1.3 Bag-of-worms (BOW) Phenotype 
Endotokia matricida, also known as bagging or bag-of worm (BOW) phenotype is 
the internal hatching of eggs in the worms. Although the condition is believed to 
be a worm fitness advantage (Chen and Caswell-Chen, 2003), the phenotype is 
in response to a change in environmental conditions hence, its utility as a marker 
of toxicity was attempted.  Worms exposed to 12.5mM ZnONP in different 
dispersants were investigated for BOW phenotype (Figure 3.7). Untreated and 
SZNP-treated worms had similar responses with 1% untreated worms exhibiting 
the BOW phenotype and no worm exposed to SZNP presenting the phenotype. 
At least, 20% of worms exposed to FZNP, AZNP and CZNP had BOW phenotype. 
This suggests that SZNP-treated worms are not affected to the same extent as 
other types of dispersants for ZnONP. 
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Figure 3.7: Egg-laying phenotype following exposure of wild-type adult C. elegans to ZnONP.  
Adult worms (60 hours after first feed) from synchronized populations were exposed to 12.5mM ZnCl2 
(ZN), ZnONP prepared in molecular grade water (WZNP), E. coli OP50 supernatant (SZNP), 0.1% 
fetal bovine serum (FZNP), anionic dispersants (AZNP) or cationic dispersant (CZNP) at 20oC for 24 
hours where untreated group and ZN-treated group were the negative and positive controls 
respectively. The controls for dispersants used in the preparation of AZNP and CZNP were 
unavailable due to manufacturer’s proprietary confidentiality. Chi-square analyses of the contingency 
table from the experiments were used for statistical analysis. Chi-square= 47.532 with 6 degrees of 
freedom (P = <0.001) where n=474 over three separate experiments and power of chi-square test = 
0.997. 
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3.1.1.4 Effect of ZnONP on embryogenesis 
Under favourable conditions, worms lay their eggs with the embryo intact within 
the eggshell as expected immediately after the generation of embryonic founder 
cells. This is the second phase of proliferation process during embryogenesis. 
The effect of ZnONP on the proliferation process was investigated by exposing 
the adult hermaphrodite worms to 12.5mM ZnONP treatments prepared in 
different dispersants. Representative screenshots from videos highlighting the 
effect of ZnONP in different dispersants on worm reproduction revealed that the 
untreated worm lays its eggs in short bursts (<1 second) with the embryo intact 
within the eggshell (Figure 3.8, panel A) as expected immediately after the 
generation of embryonic founder cells. On the other hand, worms treated with 
FZNP presented three-fold embryo elongation showing fully differentiated tissues 
encapsulated within the eggshell and still in the hermaphrodite gravid adult 
(Figure 3.8, panel B). This phenotype was consistent in worms treated with 
WZNP (not shown) and SZNP (Figure 3.9). We have named the phenotype 
accelerated embryonic development (AED). Figure 3.8, panel C highlights a 
representative image of worms exposed to CZNP. The images reveal larvae 
within the hermaphrodite adult worm; the bag of worm (BOW) phenotype. The 
BOW phenotype was also present in worms treated with AZNP (data not shown 
but observed in n=4). In SZNP-treated worm (Figure 3.9), the short bursts of egg 
release during the process of proliferation occurs at the three-fold elongation 
stage of egg development and the worm bursts out of the eggshell as seen in the 
top panels. This was not always the case in the same worm as some three-fold 
elongation stage worms were still intact when released from the adult worm 
(lower panel); however, the bursting of the eggshell was observed in several AED 
phenotypes. This result implies that the type of ZnONP dispersion or dispersant 
may affect the process of embryogenesis in the worm. 
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Panel A: Untreated worm (control) laying eggs. Yellow arrows show the process movement of an egg during egg-laying. Panel B: A worm that has been treated with 
ZnONP dispersed in 0.1% FBS (FZNP). The yellow lines show the change in curling size due to movement of larvae within the egg enclosure (accelerated embryonic 
development). Panel C: A worm that has been treated with ZnONP dispersed in cationic dispersant (CZNP) showing the body filled with hatched worms (Bag of worms 
phenotype). Worms used in each experiment were from the same synchronized population. The worms were exposed to 12.5mM treatments for 24 hours before image 
capture using a compound microscope connected to an Olympus camera and cellsens image analysis application. Conditions are consistent in repeated experiments 
(n=4). 
Figure 3.8: Representative images of ZnONP effect on worm embryogenesis. 
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Image is taken from worms exposed to 12.5mM ZnO NP dispersed in E. coli OP50 supernatant (SZNP). Yellow ovals in upper panels reveal simultaneous hatching as egg 
is laid. Lower panels reveal hatching of AED egg. Note that AED is not scored as bag of worm phenotype unless complete hatching occurs within the gravid adult worm. The 
worms were exposed to 12.5mM treatments for 24 hours before image capture using a compound microscope connected to an Olympus camera and cellsens image analysis 
application. Conditions are consistent in repeated experiments (n=4). 
          1.21 sec                                                                      1.41sec                                                                  1.61sec             
Figure 3.9: Representative images depicting egg laying in accelerated embryonic development (AED) phenotype. 
          0.20 sec                                                                      0.40sec                                                                  0.60sec              
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3.2.5. sod-3::GFP expression in ZnONP-treated C. elegans  
A characteristic effect of toxicants is that they can induce oxidative stress in 
biological systems; therefore, analysing changes in stress-responsive genes can 
be useful for the assessment of toxic responses. This can be assessed in 
C.elegans by using the transgenic sod-3::GFP  C. elegans strain. Superoxide 
dismutase 3 (sod-3) is a natural antioxidant that takes part in the conversion of 
reactive oxygen species products to hydrogen peroxide and subsequently water 
and is upregulated in response to oxidative stress.  Transgenic sod-3::GFP  C. 
elegans strain was employed to measure  stress in worms exposed to ZnONP; 
however, in order to effectively utilize the sod-3::GFP  strain, it was important to 
repeat lethality assays performed on wild type worms on the transgenic strain.  
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Figure 3.10: Effect of 12.5mM ZnO NP exposure on survival of transgenic sod-3::GFP C. elegans 
strain. 
Percentage of live and dead synchronized L4 worms following exposure to 12.5mM ZnCl2 (ZN) or 12.5mM 
ZnONP prepared in anionic dispersants (AZNP), cationic dispersant (CZNP) or 12.5mM bulk ZnO in 
molecular grade water (BZ) at 20oC for 24 hours where untreated group and ZN-treated group were the 
negative and positive controls respectively. The controls for dispersants used in the preparation of AZNP 
and CZNP were unavailable due to manufacturer’s proprietary confidentiality. Chi-square analyses of the 
contingency table from the experiments were used for statistical analysis. Chi-square= 14.008 with 4 
degrees of freedom (P = <0.007) where a total of 539 worms were analysed with each treatment containing 
between 68 and 128 worms over three separate experiments and the power of chi-square test = 0.873.  
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Results (Figure 3.10) revealed that sod-3::GFP  strain exposed to 12.5mM 
ZnONP in dispersants showed a different result from that observed in their wild-
type counterparts previously investigated ( see Figure 3.4B). There was no death 
recorded for worms exposed to anionic dispersants (AZNP), 
Subsequent to the lethality assay, transgenic sod-3::GFP  C. elegans strain was 
employed to investigate oxidative  stress in worms exposed to 3.125mM ZnONP 
prepared in anionic dispersants (AZNP), cationic dispersant (CZNP), and bulk 
ZnO (BZ). The lower concentration was chosen to investigate the effect of the 
prepared ZnONP samples at the sublethal level. In the L1 larval stage, worms 
exposed to CZNP appeared to have the highest fluorescence intensity (Figure 
3.11). L3 larvae exposed to ZnONP had higher fluorescence intensity than BZ-
treated L3 larvae. L4/young adults and gravid adult stages all had relatively high 
fluorescence intensities post exposure to ZnONP. Fluorescence intensities were 
characteristically found in the pharynx region of the head and at the tail post 
ZnONP treatment. CZNP induced the highest fluorescence intensities across 
each developmental stage.  
We investigated the egg-laying phenotypes in transgenic sod-3::GFP worms 
exposed to 3.125mM ZnONP in different dispersants (Figure 3.12) and examined 
whether ZnONP influenced oxidative stress response in the worms during the 
proliferation stage of embryogenesis. While less than 3% of untreated worms had 
BOW phenotype, about 60% of the ZN-treated worms were BOW while over 80% 
of CZNP-treated worms became BOW (Figure 3.12). Also, about 30% of AZNP-
treated worms resulted in BOW. These results were different from the 
observations in wild-type worms which were exposed to a higher concentration 
(Figure 3.7). The results suggest that ZnONP have a higher toxic effect on 
transgenic sod-3::GFP worms than their wild-type counterparts.  
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Transgenic sod-3::GFP worms from synchronized populations were exposed 3.125mM ZnCl2 (ZN), ZnONP 
dispersed in anionic dispersants (AZNP), or in cationic dispersant (CZNP) or bulk ZnO dispersed in 
molecular  grade water (BZ) for 24 hours where the untreated group and ZN-treated group were the 
negative and positive controls respectively. The controls for dispersants used in the preparation of AZNP 
and CZNP were unavailable due to manufacturer’s proprietary confidentiality. All images are 
representative images of each treatment group and were taken with a LSM 880 using Zeiss plan 
apochromat 10 x/0.45 Ph1 M27 microscope objectives. Detection wavelength was between 493-598nm. 
The enhanced green fluorescent protein (EGFP) channel with an excitation and emission wavelength of 
488 and 546nm respectively was used. The parameters were the same for all images.  
Figure 3.11: Comparison of sod-3::GFP  expression in four developmental stages of worms. 
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Figure 3.12: Egg-laying phenotype observed following exposure of sod-3::GFP  adult C. elegans to 
ZnONP. 
Adult worms from synchronized populations were exposed to 3.125mM ZnCl2 (ZN), ZnONP prepared in 
anionic dispersants (AZNP) or cationic dispersant (CZNP), or bulk ZnO prepared in molecular grade water 
(BZ) at 20oC for 24 hours. The untreated group and ZN-treated group were the negative and positive controls 
respectively while controls for dispersants used in the preparation of AZNP and CZNP were unavailable due 
to manufacturer’s proprietary confidentiality. Chi-square analyses of the contingency table from the 
experiments were used for statistical analysis. Chi-square= 52.957 with 4 degrees of freedom (p = <0.001) 
where a total of 147 worms were analysed with each treatment containing between 19 and 45 worms and 
the power of chi-square test = 1.0. 
In Figure 3.13A, an untreated gravid worm had its egg intact eggs within the worm; 
however, a relatively higher fluorescence intensity was observed in larvae within 
the BOW of a ZN-treated gravid worm that also contained AEDs (Figure 3.13B). 
Representative images of worms exposed to 12.5mM ZnONP in dispersant 
revealed that hatched larva within a worm exposed to 12.5mM CZNP (Figure 
3.13D) seemed to have the highest relative fluorescence intensity in comparison 
to other groups of treated worms.  Furthermore, a comparison between worms 
exposed to AZNP for four and 24 hours (Figure 3.13C and F) revealed that eggs 
released from four hour treated worms had relatively low fluorescence intensity. 
Each representative image in Figure 3.13 was consistent with the phenotypes in 
the treatment groups
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Fluorescence images of (A) untreated worms, and worms exposed to (B) 12.5mM ZnCl2 [ZN], (C) 12.5mM ZnONP prepared in anionic dispersant [AZNP], (D) 12.5mM ZnONP 
prepared in cationic dispersant [CZNP]  and (E) 12.5mM bulk ZnO prepared in molecular grade water [BZ] following 24 hours at 20oC. (F) Fluorescence image of a worm 
following a 4h exposure to AZNP. Worms used in each experiment were from the same synchronized population. Conditions are consistent in repeated experiments (n=3). 
Figure 3.13: Effect of ZnONP on sod-3::GFP expression  during embryogenesis. 
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L1 larvae that were successfully hatched from gravid adults exposed to 12.5mM 
ZnONP prepared in dispersants were observed (Figure 3.14). The pattern of 
fluorescence expression in the larva from ZN-treated adult (Figure 3.14B) 
revealed that GFP expression was clear from below the pharynx region down to 
the tail of the larva and this was consistent with the pattern observed in larva 
within a ZN-treated gravid adult (see Figure 3.13B). Similarly, consistency was 
observed in successfully hatched L1 larva from CZNP-treated adults (Figure 
3.14C) and L1 larva within CZNP-treated gravid adult (Figure 3.13D) with the 
expression pattern appearing in the whole larva body.   
 
Figure 3.14: Stress response in first filial generation of ZnONP-treated sod-3::GFP worms. 
Less than18 hour old hatched larvae from (A) untreated adult sod-3::GFP  transgenic worm and worms 
treated with 12.5Mm (B) ZnCl2 [ZN], (C) ZnONP prepared in cationic dispersant [CZNP] and (D) bulk ZnO 
prepared in molecular grade water [BZ] over a 24h period were captured using a compound microscope 
connected to a camera. Conditions are consistent in repeated experiments (n=3). Adult worms were from 
the same synchronized population.  
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3.2.6. Molecular analysis of sod-3 gene and protein expression. 
Experiments such as real-time PCR and microarray analysis require pure nucleic 
acids with high concentration yield for molecular analysis. Table 3.1 reveals that 
higher amount of starting C. elegans sample yields higher concentration of nucleic 
acid. Lysis involving the use of RLT buffer yielded 0.61µg/µl nucleic acid while the 
use of trizol yielded 2.42µg/l. The values of the yield revealed that the trizol-
treated sample was higher than the RLT buffer-treated sample suggesting that 
trizol is more effective for RNA extraction than the RLT buffer in kits. Table 3.1 
also revealed that both RLT buffer-treated or trizol-treated samples yielded 
nucleic acids that were free from protein contamination with absorbance ratios 
(260/280) in the samples (in bold) above 2.0 suggesting that both RLT buffer-
treated or trizol-treated samples were free from protein contamination. The 
260/230 ratio which is a secondary measure of nucleic acid purity also revealed 
the same value (2.4) for the two lysis agents.  
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Table 3.1: Influence of lysis agents on the quantity and quality of nucleic acid extraction in C. elegans. 
S/N Sample Wet Weight Lysing agent Nucleic acid 
conc. (µg/µl 
A260 A280 260/280 260/230 
1 Rnase-free 
water 
Not applicable Not applicable 0.4 0.01 0.037 0.24 -0.04 
2 C. elegans 181mg RLT buffer 0.61 15.2 7.141 2.12 2.4 
3 C. elegans 194mg Trizol 2.42 60.4 28.27 2.14 2.4 
*Up to 20ul of M9 buffer was present in total mass of each sample as the movement of the worms prevented total liquid removal. 
RNA was extracted by homogenizing a mixed population of C. elegans (approximately 1500 L4/ml of mixed culture) using beads in a tissue-lyser for 2 minutes at 50Hz. 
Protocol for extraction as described in commercially available kit (Qiagen) was followed with a replacement of the RLT buffer (blue above) with trizol (red).  All measurements 
were taken on the Nanodrop spectrophotometer. Absorbance ratios (260/280) in samples (bold) were above 2.0 indicating the samples were free from protein contamination. 
The 260/230 ratio is a secondary measure the nucleic acid purity and values are higher than the corresponding 260/280 values.  
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Figure 3.15: Effect of ZnONP on sod-3 gene expression. 
Mixed culture of wild-type C. elegans was exposed to heat shock (HS) for 2 hours at 37oC or 12.5mM 
ZnONP in cationic dispersant (CZNP) for 24 hours at 20oC where the untreated group is the control. 
The gene expression values were normalized with mean expression of ACTIN, CANX and MDH1 
from three separate experiments (n=3) were performed. 
 
Sod-3 encodes a mitochodrial Mn superoxide dismutase (SOD)  and as 
mentioned earlier, SOD is an antioxidant that neutralizes oxidative stress 
(OS), hence it’s production is a measure of toxicity resulting from OS in the 
worms. To examine whether ZnONP-treated worms experience an increase 
in OS, real-time PCR (qPCR) was performed in three treatment groups 
(Figure 3.15). The 12.5mM ZnONP in cationic dispersant (CZNP) was 
chosen over other ZnO NP treatment types because of the high occurrence 
of BOW phenotype  observed previous toxicity assays (Figures 3.11, 3.13D 
and 3.14D). The result revealed that there was no significant fold change 
between the sod-3 expression in CZNP-treated and untreated worms 
(Control). Also, although SOD-3 protein was detectable in the worms 
(Figure 3.16A), there was no significant difference between the protein 
expression in CZNP-treated sample and the control (Figure 3.16B). 
 72 
 
(A) Western blots of SOD-3 and actin protein and (B) Relative SOD-3 protein levels. Samples were from mixed population of C. elegans (>1500 worms/ml) and 
include untreated worms (control), heat shock-treated (HS) worms (37oC for 2 hours) or worms exposed to cationic dispersed ZnONP (CZNP) for 24 hours at 20oC. 
Four separate experiments were performed (n=4). Relative protein levels were derived using densitometry. 
Figure 3.16: Effect of ZnONP on SOD-3 protein expression.  
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Figure 3.17: Principal component analysis (PCA) of significantly altered miRNAs 
3.2.7. Effect of ZnONP exposure on miRNA expression 
Genome wide miRNA expression was profiled by microarray analysis. Principal 
component analysis (PCA) confirmed that there was significant differential 
microRNA expression between the control (untreated) and ZnONP (CZNP) 
treatment groups (Figure 3.17). PCA identifies fewer number of uncorrelated 
variables referred to as principal components (PC), from a  large data set like the 
microarray in order to reveal the maximum amount of variance from the fewest 
number of PC. CZNP induced the differential expression of approximately 90 
miRNAs at the p < 0.01, q < 0.05 significance level (q represents a multiple 
comparison correction with a false discovery rate of 5%). Those miRNAs with a 
fold change greater than 2 in three separate experiments are shown in Figure 
3.18. Despite some variability in miRNA expression levels between experiments, 
there is a trend, predominantly down regulation of miRNAs in the three tests. 
Specifically, the C. elegans miR-42-3p, miR-49-3p, miR-67-3p, miR-239a-5p and 
miR-253-3p were significantly down-regulated across the three tests. In contrast, 
C. elegans miR-76-3p and miR-42-5p were upregulated. One of the controls; 
zebra fish miR-124-3p probe was upregulated across the three experiments 
indicating cross reactivity with C. elegans miRNA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(p<0.01, q<0.05) with a fold change > 2 following treatment with CZNP (n=3). Lines 
connect nearest 4 neighbours. RNA samples were from mixed population of C. elegans 
(>1500 worms/ml) treated with CZNP (12.5 mM) or without CZNP (untreated-control) for 
24 h at 20oC. 
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Figure 3.18: Heatmap of those significantly altered miRNAs 
(p<0.01, q<0.05) with a fold change > 2 following treatment with CZNP. Expression levels represent log2 [CZNP/Control] (Log2 R), with downregulations shown in 
green and upregulations in red. RNA samples were from mixed population of C. elegans (>1500 worms/ml) treated with CZNP (12.5mM) or without CZNP (untreated-
control) for 24 h at 20oC. Experiments 1 and 2 were performed in triplicate, whilst Experiment 3 was in duplicate. 
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3.3. Discussion  
3.3.1. Zinc oxide nanoparticle characterization 
Our results revealed that the size of the commercially available   ZnONP (detailed 
as 70nm) for all the preparations ranged between 27 and 451nm when measured 
by SEM and DLS analysis revealed that the hydrodynamic Z-average was 
between 197 and 1256nm. Although these values were dependent on the 
dispersant used for the preparation of the ZnONP suspensions, data gathered 
from the instruments recorded different values for the same ZnONP in dispersant. 
Supposedly, the difference between the size reported by the suppliers and the 
measurements taken during the investigation could have been due to the fact that 
DLS measures motion of hypothetical spherical particles which is translated into 
a mean of hydrodynamic diameter of the particle movements as against the 
actual particle size. The mean hydrodynamic diameter in DLS is typically larger 
than the measurement taken from the SEM or the supplier’s specification 
because for DLS to work effectively, samples are always in liquid phase (Hradil 
et al., 2007) and the interaction of nanoparticles with liquid alters its physical 
properties. On the other hand, despite the preparation of SEM samples in 
dispersants, the samples were not in suspension as they were dehydrated and 
fixed, so the lack of a liquid phase in the SEM sample preparation could have 
been responsible for alteration in the ZnONP size (McClements and McClements 
2015). Another consideration for the difference in ZnONP sizes is that since DLS 
reports its measurement using intensity weighted averages of a collection of 
particles, the polydispersity of the sample may skew the hydrodynamic average 
diameter to favour larger particles. Although the observation of SEM images of 
ZnONP in different dispersants appear to have different cluster arrangement 
patterns (Figure 3.1, panel A), classification as agglomerates and or aggregates 
would be difficult. The reason is implied in the definitions and relationship 
between the two terms which are sometimes used incorrectly or interchangeably. 
Agglomeration is the assembly of individual particles joined together at different 
angles to one another to form a unit while aggregation is the formation of a 
common crystal structure by individual particle through the side by side alignment 
of the particles. In other words, the surface area of an agglomerate does not differ 
from the total surface area of particles in that agglomerate while the surface area 
in an aggregate is lower than the total surface area of individual particles in the 
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aggregate (Walter, 2013). Hence, the inability to capture and measure all the 
sides of the individual irregular-shaped particles on the SEM makes it difficult to 
distinguish agglomeration from aggregation. Nevertheless, whilst Sokolov et al. 
(2015) suggests the use of new techniques such as electrochemical nanoimpact; 
which gives individual particle analysis, to distinguish between agglomeration and 
aggregation, DLS with a combination of other techniques such as SEM remains 
a popular way of characterizing nanoparticles. The order of the repeat 
measurements of Z-average values and the number of peaks in a size distribution 
are indicators of aggregation where a decreasing Z-average diameter and 
bimodal or multimodal distributions suggest the presence of aggregation and an 
increasing Z-average diameter indicates sedimentation (Kaszuba, 2015). 
Although the aggregation can only be compared relatively among samples, the 
results (Figures 2 and 3) suggest that WZNP had the highest number of 
aggregates while CZNP had the least aggregate and was almost monodispersed; 
that is most of the CZNP had a uniform size. This implies that cationic dispersants 
are likely to provide better stability and dispersion of ZnONP while water is less 
likely to disperse ZnONP as the ZnONP would sediment.  
 
3.3.2. Effect of ZnONP on the survival of C. elegans 
The survival assay results reveal that the lethal effect of ZnONP is dose-
dependent. Although it is recommended that concentrations examined in toxicity 
assays must be relevant to realistic exposure scenarios and high concentrations 
should be cautiously interpreted (Oberdörster, 2010), our highest ZnONP 
concentration was 25mM (~2g/L) because LC50 was not yet achieved at this point. 
For the present study, the relatively short exposure times (4 and 24 hours) 
compensates for the high concentration used when compared to some studies 
where lower concentrations were used at the expense of longer exposure times 
of up to 72 hours (Roh et al., 2009; Jiang et al., 2016; Bhuvaneshwari et al., 2015 
and Khare et al., 2014). In fact, one study exposed L4 worms to treatments until 
the rest of their lifespan for reproductive toxicity assessment (Contreras et al., 
2014). The question that remains unanswered is that of developing an acceptable 
standard of acute or chronic exposure time versus concentration with realistic 
exposure scenarios in mind.  
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Contrary to some previously published works on ZnONP toxicity in C. elegans 
(Wu et al., 2013), ZnONP appears to be  non-toxic to the worm unless at higher 
(millimolar) concentrations where AZNP and CZNP were effective at inducing 
lethal toxicity in C. elegans. Although the assessment of ZnONP surface charge 
was not investigated, Prach et al. (2013) had previously shown that the zeta 
potential which measures the charge on the ZnONP used in our experiments 
reflected the information provided by the manufacturer. High surface charge of 
nanoparticles or particles influences the breaking down of clusters and 
nanoparticle dispersion. Nanoparticles with zeta potential between -30 and +30 
mV show a tendency to form clusters. This information coupled with our results 
implies that apart from the stability and low aggregation of AZNP and CZNP, their 
charge may influence their toxicological effect in the C. elegans model. Whilst it 
can be assumed that lethal toxicity of ZnONP is based on soluble Zn ions as seen 
in the Zn2+ control results (Figure 3.4A), it is not unexpected that the toxicity could 
be partly dependent on the dispersant used and consequently the dispersion of 
the ZnONP in preparation. This is revealed in the ZnONP characterization results 
(Figures 2 and 3) coupled with the effect of soluble Zn ions from lower ZnCl2 
concentration on the worms (Figure 3.4B). With the  consideration that 
information was not available on the composition of the proprietary dispersant in 
the commercially supplied AZNP and CZNP, our results emphasize the findings 
of  Anand & Varghese (2015) who suggested that the  quality of nanoparticles 
dispersion is dependent on the ionic composition of the dispersant. Although, in 
their work, they prepared non-ionic, anionic and cationic surfactants to disperse 
ZnONP and showed that the anionic surfactant produced the best stability, 
Dennis et al. (1997) observed that a proprietary non-ionic surfactant was more 
toxic to C. elegans than its anionic and cationic counterparts. Nonetheless, the 
strength of the ionic charge is likely responsible for the variations in the results of 
Dennis et al. (1997).  
One challenge with lethality is that subsequent to treatment, analysis is usually 
performed manually by counting live worms (reviewed by Jiang et al. (2016). This 
qualitative technique is subjective depending on a scientist’s skill of assessment 
and accuracy hence, increase in experimental error is likely. The comparison for 
sensitivity and consistency between lethality and other endpoints considered in 
 78 
 
our experiments revealed that lethality is not as sensitive as sublethal endpoints 
at indicating toxicity. This agrees with the work of Dhawan et al. (1999) who 
compared toxicological endpoints in C. elegans treated with alcohol. In their work, 
they found sublethal endpoints such as behaviour and reproduction to be more 
sensitive than lethality assessment and also, there was correlation between these 
sublethal responses. Our survival results suggest that ZnONP is lethal to C. 
elegans at high (millimolar) concentrations, and is dependent on length of 
exposure and the type of dispersant in which the ZnONP is prepared. 
 
3.3.3. Effect of ZnONP on worm morphology 
Our research suggests that the dispersant used in the preparation of ZnONP 
influenced the effect of the ZnONP on worm morphology despite the effect of 
soluble Zn ions, which resulted in both diminished growth as seen in the ZnCl2 
controls. The AZNP had the highest effect on body length, resulting in diminished 
length, and AZNP and CZNP had the highest effect on width, resulting in leaner 
larval structure (Figure 3.6). Interestingly, SZNP-treated worms were unaffected 
by the ZnONP. This may have been due to the sequestering of the ZnONP. 
Biofilm-forming secreted bacterial extracellular polymeric substances (EPS) 
could be present in the E.coli OP50 supernatant used as dispersants in SZNP 
and might have coated the nanoparticles. With the assumption that that the 
worms eat the bacteria, it is possible that the secreted EPS modulates the 
bioavailability of ZnONP, probably by sequestering it, hence preventing any 
adverse effect (Polak et al., 2014). On the other hand, a possible explanation for 
the morphological anomaly observed in the FZNP-treated worms could have 
been that the lipid content from the 0.1% FBS, whilst improving dispersion, does 
not necessarily sequester the ZnONP due to its low lipid content. Furthermore, 
ZnONP uptake could have contributed to poor morphological development in 
affected worms. There is the possibility of direct ingestion of the nanoparticles 
which could have formed clusters in the pharynx or within the worm gut making 
the worm constipated or finding it difficult to feed efficiently. There could be an 
argument that the same effect should be experienced when bulk ZnO is 
consumed but it is likely that bulk ZnO can easily be avoided by the worms as it 
is large enough to be detected easily by the worm’s sensory system while the 
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ZnONP are likely to have been attached directly to the worms food source (E. coli 
OP50) giving the worm no choice but to ingest them. 
 
3.3.4. Effect of ZnONP on reproduction 
Whilst reproduction is assumed to be a more sensitive endpoint than lethality, it 
shares a similar challenge with lethality in terms of quantification of brood size. 
For example, variability in reproducibility of brood size assay in one experiment 
was as high as 11.5% (Höss et al., 2009). The present research has addressed 
this concern by classifying the reproductive endpoint in terms of embryogenesis. 
Embryogenesis in C. elegans involves the formation and development of the 
embryo to the point of hatching. Embryonic assay proposes a semi qualitative but 
more effective way of assessing reproductive toxicity than brood size because it 
is less time-consuming (at least 18 hours) and variability in reproducibility is likely 
to be lower.  
In the present study, embryonic assessment involves the identification of Bag of 
Worms (BOW) phenotypes. BOW phenotypes or endotokia matricida (Johnson, 
1984) are a result of matricidal hatching. Matricidal hatching may occur when 
worms are starved (Seidel and Kimble 2011), transferred from solid to liquid 
medium (Shook and Johnson 1999), exposed to toxic substances (Walker and 
Tsui 1968) or have a high population density. Essentially, in BOW phenotypes, 
egg-laying ceases and embryos within the gravid hermaphrodites continue to 
develop and hatch inside their parent. Chen & Caswell-Chen (2004) suggested 
that the bagging of worms could be reversible provided the cause of the induction 
is removed before the adult worm experiences any lethal injury resulting from 
larval movement, hence; it is an adaptive response that allows progeny, from 
adults experiencing unfavourable conditions, to reach the resistant dauer stage 
following provision of sufficient nutrient and protection from their parent.  
We investigated the BOW phenotype as a marker of ZnONP toxicity and the 
results suggest that there is a correlation between the morphological and 
reproductive toxicity endpoints. SZNP-treated worms did not exhibit the BOW 
phenotype and this is probably due to the EPS-ZnONP interaction discussed 
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above (section 3.3). The relative toxicity patterns among the treatment groups 
were consistent with the patterns described in the morphological assessment.  
Interestingly, we discovered a condition prior to internal hatching which we refer 
to as accelerated embryonic development (AED) phenotype. The AED phenotype 
presents three-fold embryo elongation showing fully differentiated tissues 
encapsulated within the eggshell and still in the hermaphrodite gravid adult 
(Figure 3.8, panel B). To the best of our knowledge, it has not been classified in 
the literature. The assessment of AED phenotype augmented the sensitivity of 
the embryonic reproductive assay in that it includes a mechanistic toxicology 
approach to reproductive toxicity assessment. For example, BOW phenotype 
was not observed in SZNP-treated worms, whereas we observed AED phenotype 
in the worms. This suggests that there is a delayed toxic response in SZNP-
treated worms. In order to fully understand the reason for the delayed response, 
further analysis would be required. Although we did not investigate the presence 
of ZnONP in the embryo to determine if the nanoparticle crosses the egg barrier, 
Meyer et al. (2010) showed that AgNP was detected in unlaid C. elegans eggs.  
In zebrafish, ZnONP accumulated in the embryo and eleuthero-embryo, and also 
inhibited  hatching (Brun et al., 2014). 
One limitation that may affect the embryogenic assay technique is that the rate 
of feeding of the gravid worms with bacteria might affect their egg-laying and 
hatching (Fasseas et al., 2013) but in comparative studies such as the current 
research this is inconsequential since the feeding condition of all samples are the 
same and the worms used in each experiment are from synchronized 
populations.  
In conclusion, the evaluation of survival, morphology and reproduction as toxicity 
endpoints suggests that at the same concentration, there is a significant 
difference in the effect of ZnONP on C. elegans among these endpoints. As 
suspected, survival appears to be the least sensitive of all the endpoints because 
significant effects were only observed in ZnONP dispersed in two dispersants 
(AZNP or CZNP). On the other hand, reproduction (embryonic assessment) 
seems to be the most sensitive endpoint because significant effects were 
observed in ZnONP prepared in the five dispersants (WZNP, FZNP, SZNP, AZNP 
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or CZNP) considered. However, this reproductive toxicity effect is based on 
consideration that AED is included as a measure of ZnONP toxic effect. 
 
3.3.5. Effect of ZnONP on transgenic sod-3::GFP expression 
So far, the current research has shown that ZnONP may only be a lethal toxicant 
of C. elegans at high millimolar concentrations. This could only be a limitation 
where lethality is used as the major measure of toxicity. In our study, we 
introduced transgenic GFP reporter strains to measure gene expression as a 
more sensitive approach for toxicity evaluation of ZnONP. We utilized sod-3::GFP  
strain for our experiments knowing that in terms of fold change in gene 
expression, sod-3, a mitochondrial MnSOD is the most upregulated of all the 5 
sod genes. sod-3 only accounts for 1% of the total sod mRNA while the other 
mitochondrial MnSOD (sod-2) accounts for 18% of total sod mRNA (Doonan et 
al., 2008). The results showed that transgenic strains vary slightly in their 
responses to lethal toxicity when compared to wild-type C. elegans; however, the 
pattern of toxicity is similar. It is likely that the creation of transgenic strains with 
GFP reporters could have influenced the change. When using the transgenic 
strains for toxicity assay (specifically gene expression assay), it is worthwhile to 
run a parallel test with the wild type strain at least to compare the difference 
between lethal toxicity. 
The expression of sod-3::GFP was highest in CZNP -treated worms (Figure 3.11). 
This strengthens the findings from morphological and reproductive assays that 
suggested that the Zn2+ contents and the dispersants could have contributed to 
the toxic effect of ZnONP. More interesting is that the concentration used for the 
sod-3::GFP expression analysis was four times lower than that used for the lethal, 
morphological and reproductive assays. This suggests that sod-3::GFP 
expression is highly sensitive. Another point of note is that sod-3 expression could 
be stage-specific but this would be dependent on the type of chemical exposure 
as observed in L1 larva exposed to CZNP (Figure 3.11). 
The assessment of transgenic sod-3::GFP gravid hermaphrodite worms and their 
embryo, BOWs and AEDs suggests that ZnONP induced oxidative stress on the 
hatched embryo and 3-fold embryo of BOWs and AEDs respectively (Figure 
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3.13). This is not unlikely as the embryo and hatched larva would require a lot of 
energy to adapt to their temporary environment. In a way, the altruistic response 
of the adult worm may encourage adaptive skills to survive in unfavourable 
conditions prior to release into a safe environment. 
Although the loss of sod-3 gene function can be complemented by sod-2, the 
choice of sod-3::GFP over sod-2 was because the loss of sod-2 would prevent 
the detection of MnSOD in the worms(Honda and Honda 1999). This may alter 
the effect of ZnONP exposure by preventing the ability of the worm to function 
against severe oxidative stress thus discouraging sublethal assessment as 
worms may die due to imbalance of free oxygen radicals. One downside to the 
GFP reporter approach is that while it is feasible to cover ZnONP responses and 
oxidative stress pathways, the sod-3 gene considered here represents only a 
meagre part of an extensive array of genes that are implicated in ZnONP toxicity 
and oxidative stress. Consequently, this approach is only reliable for the quick 
measurement of stress-response gene expression where the GFP variant is 
stable as subtle responses involving internal regulatory mechanisms could be 
missed. Overall, this current research shows that the use of transgenic C. elegans 
GFP stress-reporter strains can offer an indication of the patterns of gene 
response to ZnONP toxicity. 
 
3.3.6. Effect of ZnONP on sod-3 gene and protein expression 
Increased reactive oxygen species (ROS) production may disrupt the 
functionality of the mitochondrion which results in oxidative stress responses in 
affected organisms  (Dickinson and Chang, 2012). The presence of antioxidant 
defence mechanisms such as superoxide dismutase (SOD) in biological systems 
help to counter oxidative stress.  SOD was chosen as the antioxidant analyzed 
because it is the only enzyme that directly uses free radicals as substrate; thus 
its activity is generic in organisms (Silvestre et al., 2006). In the current research, 
exposure to CZNP did not cause change in the expression and activity of SOD-
3. This finding corroborates the result of Huang et al. (2010) who investigated the 
effect of nanoparticulate ZnO on human bronchial epithelial cells and observed 
that the expression of antioxidant genes including SOD was not changed 
following exposure. In contrast, Syama et al. (2013) observed that SOD was 
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significantly elevated following exposure of mouse liver cells to ZnONP.  An 
explanation for lack of change in sod-3 gene expression is the exposure of C. 
elegans to dauer pheromone. This pheromone induces a high resistance to stress 
in active worms, so while a mechanistic basis for toxicity can be demonstrated in 
responses as observed in transgenic sod3::GFP strain, these responses cannot 
be observed beyond a threshold that can be seen at mRNA transcription or 
protein translation level  (Hunt, 2016). 
Furthermore, while the assessment of sod-3 gene regulation under oxidative 
stress could be subjective due to its dependence on relative comparison with sod-
3 gene expression levels in control samples, the inclusion of a sod-3 mutant (null 
strain) and / or a sod-2; sod-3 mutant (hypomorphic strain) as controls in the 
qPCR and protein analysis could have provided a more authentic validation of 
the analysis.  This is because these mutants are hypersensitive to oxidative 
stress (Doonan et al., 2008). SOD-2 is the major MnSOD protein and it can 
complement SOD-3, hence the suggestion for the inclusion of sod-2 mutant.  
 
3.3.7. Effect of ZnONP on microarray analysis of miRNA expression 
Descriptive assessment of ZnONP toxicity described in the current research did 
not seem to bolster the observations at the molecular level. However, the addition 
of microRNA (miRNA) expression analysis to ZnONP toxicity assessment as a 
mechanistic toxicity assay in C. elegans revealed that the miRNA expression of 
treated worms reinforced the behavioural, morphological, reproductive and 
transgenic GFP expression results.  
Because a single miRNA (especially conserved ones) has an affinity for multiple 
biological targets (Bartel 2009), the predicted targets of 38 C. elegans miRNAs 
with fold change greater than two were themed around oxidative stress and 
embryogenesis. The choice for oxidative stress was to elucidate further on SOD 
expression while embryogenesis was chosen based on the egg-laying 
phenotypes observed following CZNP treatment. The changes in miRNA 
expression observed in CZNP-treated worms were predominantly 
downregulation. Using the computational method; RNA22, developed by Miranda 
et al. (2006), over 19000 miRNA target sites were predicted for mir-253-3p which 
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was downregulated following exposure to CZNP. These include four of the five 
C. elegans SOD genes; sod-2 and sod-3 genes which encode mitochondrial 
MnSOD, and sod-1 and sod-5 that encode cytosolic Cu/ZnSOD. MiR-253-3p was 
also predicted to target let-502 which encodes a Rho-binding serine/threonine 
kinase that takes part in the regulation of nonmuscular contraction in humans. In 
C. elegans let-502 takes part in the regulation of embryonic morphogenesis 
(Piekny et al., 2003) which starts with transformation of embryo cell migration to 
pharyngeal pumping development. 
In contrast to miR-253-3p, miR-42-5p expression is upregulated following CZNP 
but it also predictively targets sod-1, sod-2, sod-3 and sod-5 as well as let-502.  
While the contrasting response between miR-253-3p and miR-42-5p should be 
carefully considered based on the uncertainty of the predictive ability of any 
computational methods, the opposite expressions could be a matter of 
perspective. For example, the purpose of SOD in biological systems is to combat 
oxidative stress (OS) by neutralizing free oxygen radicals; so the induction of OS 
could be an indication of toxicity. With this in mind, there is a possibility that miR-
42-5p is expressed to control the expression of the SOD genes which would 
degrade or silence the transcription of their mRNA.  Conversely, miR-253-3p is 
downregulated to allow the SOD genes to code for the protein. Either way, it is a 
question of regulation. Chen et al. (2011) also showed that there is a possibility 
of one miRNA to destabilize another. They showed that a let-7 miRNA can be 
targeted by miR-107 thereby decreasing its expression to promote tumor 
progression in humans and mice. Another explanation for the contrast in miR-
253-3p and miR-42-5p expression could be that the stability of the miRNAs is 
dependent on the target sites. Previous studies on C. elegans miRNA revealed 
that a reduction in the available target sites for miRNA decreased the 
accumulation of the miRNAs (Chatterjee et al., 2011). Again, some 
exoribonucleases of C. elegans can influence the expression of miRNA as their 
depletion can result in the accumulation of miRNAs (S Chatterjee and Grosshans 
2009).  
MiR-42-3p which belongs to the same family with miR-42-5p and miR-49-3p were 
downregulated and both were predicted to target only sod-4 gene out of the five 
C. elegans SOD genes.  Mir-239a-3p which is highly expressed at all larval 
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developmental stage and weakly expressed in the embryo was downregulated. 
The RNA22 prediction for miR-239a-3p included only two sod genes; sod-2 and 
sod-3. Like miR-42-5p, miR-76-3p was upregulated and it was predicted to target 
only sod-5 of the five C. elegans SOD genes. For MiR-42-3p, miR-49-3p, Mir-
239a-3p and miR-76-3p, RNA22 predicted let-502 as a potential target. The 
inclusion of Danio rerio miR-124-3 probe revealed that mir-124-3p is conserved 
across species as it was picked up by the C. elegans RNA in the microarray.  
MiR-124 is implicated in oxidative stress and increase in lipofuscin which is a 
marker for aging and the the protein responsible for autofluorescence in C. 
elegans. It also plays a vital role in the control of whole worm ATP level (Dallaire 
et al., 2012). 
The results of the microarray suggest that CZNP has an effect on C. elegans 
which can be observed at the post-transcriptional level. This is a plausible basis 
for the conflicting results between qPCR and immunoblot, and microarray 
analysis of miRNA expression. Some other advantages of the miRNA over qPCR 
and immunoblot is that mixed populations of worms can easily reveal effects in 
miRNA analysis as there are more mechanisms to analyse due to the broad 
range of miRNA in the array. Due to the limit of the number of gene expression 
analysed with qPCR, any gene of interest which is not expressed in all 
developmental stages of the worm may prove difficult to analyse; hence known 
stage-specific gene expression using synchronized population are best suited for 
qPCR analysis.  Although, the development of miRNA as biomarkers is still in its 
early stages and target sites are still not known for many miRNAs, the technique 
is highly sensitive in deciphering the effects of ZnONP. 
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Chapter Four 
4 Toxicity assessment of Diethylstibestrol 
4.1 Introduction to diethylstibestrol toxicity assessment 
Diethylstilbestrol (DES) is a synthetic nonsteroidal chemical with properties that 
interfere with the physiological effects of oestrogen in humans and animals; 
hence it is an endocrine disruptor. Between 1938 and 1971, DES was 
administered to pregnant women to prevent abortion and other pregnancy-related 
complications. However, its use was abolished later in 1971 when there were 
strong suggestions that in utero exposure to DES was closely associated with 
vaginal clear cell adenocarcinoma (Herbst et al., 1971). Further studies within the 
next four decades identified other health hazards including obesity (Newbold et 
al., 2009) and psychosexual development changes in those exposed to DES 
(Mahalingaiah et al., 2014; Harris & Waring 2012; Hoover et al., 2011) while their 
offspring had reproductive anomalies such as underdeveloped sexual organs, 
vaginal adenosis (Laronda et al., 2012) and testicular steroidogenesis (Maeda et 
al., 2013). In the United States alone, no less than 2 million women were given 
DES during the period of its use (Noller et al., 1988); thus the continuous studies 
to understand its adverse effect on the body. Studies using animal cell line 
models (Kuzbari et al., 2013) and rats (Horiguchi et al., 2014) have been 
consistent with DES in terms of the effect of DES on enzymes essential for 
hydroxylation of steroid hormones and understanding how DES suppresses 
erythropoietin; thereby inducing anaemia, respectively.  The extensive volume of 
literature verifying the adverse effects of exposure to DES collected over the last 
forty years using DES-exposed experimental animal models, combined with 
observations from DES-exposed humans, have led to the use of DES as a 
chemical of interest for the assessment of reproductive toxicity in humans and 
animals and it is also representative of environmental endocrine disruptors that 
may pollute the environment causing diseases in humans and animals.  
Steinmetz et al. (1997), Tran et al. (1997) and White et al. (1994) have used the 
identification of oestrogen-like activity as the basis for endocrine-disrupting 
compounds (EDC) detection in biological systems;  however, the inability of the 
EDCs to bind oestrogen receptors may not encourage the detection of oestrogen-
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like activities. Hence there is a need to develop an assay to identify and assess 
the toxicity of EDCs. 
In the current research, the effect of DES on C. elegans viability was investigated. 
The possible application of C. elegans as a model organism for EDC assays is 
discussed in the thesis. 
 
 
4.2 Results 
4.2.1 C. elegans viability on exposure to DES 
In order to investigate viability of the worms following exposure to 
Diethylstilbestrol (DES), three measures of toxicity were investigated. These 
endpoints include survival of worms based on lethality of DES, reproduction and 
behavioural responses to DES.  
 
4.2.2 Effect of diethylstilbestrol on C. elegans survival 
In order to investigate the lethal effect of diethylstilbestrol (DES) on C. elegans, 
synchronized L4 worms were treated with concentrations of DES ranging from 
0.001µM to 10µM. A negative control (S medium) which is the untreated group 
and a DMSO control (solvent used for treatment preparation) were included as 
part of the experiment. Following 24-hour exposure DES treatments, the results 
(Figure 4.1) revealed that more than 80% of all treatment groups and control 
groups survive with 10µM DES treatment recording the highest number of live 
worms (approximately 93%). There was no significant statistical difference 
among the DES treatment groups and the controls. The results suggest that the 
DES treatments had minimal lethal effect on the worms.  
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Figure 4.1: Effect of diethylstilbestrol on wild-type C. elegans survival. 
L4 worms from synchronized populations were exposed to 0.001µM, 0.01µM, 0.1µM, 1µM or 10µM 
diethylstilbestrol for 24 hours at 20oC in liquid medium where the negative controls included untreated 
worms and DMSO (0.1%) used in the preparation of treatments. Viable and dead worms were recorded 
after exposure to the treatment. Chi-square analyses of the contingency table from the experiments 
were used for statistical analysis. Chi-square= 9.399 with 6 degrees of freedom (P = 0.152) where a 
total of 698 worms were analysed over two separate experiments and each treatment contained 
between 62 and 136 worms. Power of performed test = 0.604. 
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4.2.3 Effect of diethylstilbestrol on C. elegans reproduction 
The reproductive endpoint considered in the investigation of DES effect on the 
worms was fecundity. Due to challenges of monitoring offspring of adult worms 
from the same synchronized population, two DES concentrations (10µM and 
100µM), a negative control (S medium - no treatment) and a DMSO control. 
Brood size from the DES and DMSO treatments were presented as percentages 
of the brood size from untreated worms. In figure 4.2, the percentage control 
brood size of worms treated with DES was higher than the DMSO control with 
10µM DES almost twice as high as the DMSO control. All the brood size from the 
three treatment groups were lower than the brood size of the untreated worms. 
Similarly, one of our undergraduate students; Hannah Bisby, repeated the 
experiment using a different approach consisting of mixed culture and her result 
(Table 4.1) showed that the brood size of worms treated with 100µM DES was 
higher than the DMSO control. 
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Figure 4.2: Effect of diethylstilbestrol on C. elegans brood size. 
Two adult worms were treated with 10µM or 100µM diethylstilbestrol for 24 hours at 20oC in liquid medium 
where worms treated with 0.1% DMSO were the negative controls and data was calculated as a 
percentage of brood size from untreated worms. The brood count was over 96 hours following exposure 
to treatment.   
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Table 4.1: Comparison between two methods used for the assessment of 
DES effect on C. elegans brood size 
Experimental design 
Developmental stage 
analyzed 
 
Synchronized L4 
 
Mixed 
DES exposure time in 
media 
 
24 hours in liquid 
medium 
 
4 hours in solid medium 
Medium in which brood 
was produced 
 
 
Solid 
 
Solid 
Worms examined per 
treatment group 
 
 
2 
 
8 
Counting period for 
brood size 
 
 
96 hours 
 
48 hours 
Brood size of untreated 
control group 
 
 
138  
 
1,2,10,12,15,19,24,53 
              𝒙𝒙� = 17  
         Med = 13.5  
           SD = 16.51 
Brood size of 0.1% 
DMSO -treatment group 
 
 
61  
 
1,1,3,4,4,9,11,29  
    𝒙𝒙� = 7.75  
         Med = 4  
 SD = 9.30 
Brood size of 100µM 
DES prepared in 0.1 
DMSO -treatment group 
  
 
93  
 
1,5,6,6,7,13,35,41  
     𝒙𝒙� = 14.25  
         Med =   6.5  
   SD= 15.11 
The table compares brood size of worms from a synchronized population of adults with a mixed population. 
For the brood size of worms from a synchronized population, two adult worms were placed on a NGM plate 
seeded with E. coli OP50 and moved to a fresh plate after 24 hours while the F1 worms were counted on 
each changed plate daily following removal of the adult worms before summing the F1 counts over a four-
day period (96 hours). For the brood size of worms from a mixed population, one adult worm was placed in 
each of eight replicate NGM plates seeded with E. coli OP50 as food source and the number of F1 worms 
in each plate was counted after 48-hour period. All plates containing worms were incubated at 20oC. ?̅?𝑥, Med 
and SD represent the mean, median and standard deviation of brood size respectively, for the mixed 
population. 
 
4.2.4 Effect of diethylstilbestrol on C. elegans behaviour   
Due to the limited effect of DES on worm survival, the effect DES on worm 
average speed and body bend per minute (BBPM) was investigated. This was 
necessary to explore sublethal effects of DES on the worms. The average speed 
and number of body bends were generated using a computer tracking system. 
Worms were treated with 0.01µM, 0.1µM, 1µM, 10µM or 100µM DES or a DMSO 
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control for 24 hours at 20oC. Visual observation showed that the worms 
experienced twitching which lasted approximately 4 minutes on exposure to DES 
treatments and the controls. This was followed by monitoring the behaviour of the 
worms using a computer tracking system (ImageJ). In Figure 4.3, the bar graph 
compares the mean of the average speed of the worms in each treatment group. 
Whilst the results in figure 4.3 revealed no statistically significant difference 
among treatment groups, there seems to be an undulating average speed with 
increasing concentration of DES with a high average speed of about 7.5px/s at 
0.01µM in comparison to the DMSO control and the 0.1µM DES. However, worms 
treated with 0.1µM, 1µM and 10µM recorded increasing speed in that order but 
worms treated with 100µM DES otherwise showed a lower than average speed. 
Again, behavioural data from a second experiment performed by Hannah Bisby 
using the manual assessment method for speed measurement (Table 4.2) 
revealed that there was no difference between the DMSO control and the 100µM 
DES-treated worms; however, the untreated worms seemed faster than both the 
DMSO control and the 100µM DES-treated worms (data not shown). 
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Figure 4.3: Effect of diethylstilbestrol on C. elegans average speed. 
L4 worms from synchronized populations worms were exposed to 0.01µM, 0.1µM, 
1µM, 10µM or 100µM diethylstilbestrol (DES) for 24 hours at 20oC where the negative 
control included worms treated with 0.1% DMSO which was used in the preparation of 
DES treatments. The video frames were captured in 24 well plates over a 15 second 
period. Data was generated from 60 worms with each treatment group containing 
between 7 and 12 worms and speed was measured in pixels per second (px/s).   
Statistical analysis was by One-way ANOVA (p=0.348).   
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Table 4.2: Comparison between two methods used for the assessment of 
DES effect on C. elegans speed 
Experimental design 
Developmental stage 
analyzed 
 
Synchronized L4 
 
Mixed 
DES exposure time in 
media 
 
24 hours in liquid 
medium 
 
4 hours in solid medium 
Medium in which speed 
was measured  
 
 
Liquid medium 
 
Solid medium 
Worms examined per 
treatment group 
 
 
15 
 
8 
Speed measurement 
technique  
 
Automated 
(Quantitative) 
 
Manual (Qualitative) 
Speed of 100µM DES 
prepared in 0.1% DMSO – 
group (SD)  
 
 
5.95 (2.78) 
 
 
++ 
Speed of 100µM DES 
prepared in 0.1% DMSO -
treatment group (SD) 
 
6.52 (2.97) 
 
++ 
The table compares speed of worms from a synchronized population of L4 worms with a mixed population. 
For the synchronized population, the ImageJ WrmTrack plugin was used to determine the speed of the 
worms in pixel per second (px/sec) while visual observation was used to investigate the speed of worms in 
the mixed population. The motion of the worms in the synchronized and mixed population was recorded in 
S medium solution and NGM agar respectively in the presence of E. coli OP50 as food source and an 
incubation temperature of 20oC. SD represents the standard deviation of brood size for the synchronized 
population. 
 
The box plot shows (Figure 4.4) the BBPM among each treatment group. There 
was no statistically significant difference in the BBPM of worms across the 
treatment groups but there was a steady increase in DES-treated worms with a 
steady increase observed at treatment concentrations of 0.1 an increasing 
number of 1µM and 10µM DES and above. 
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Figure 4.4: Effect of diethylstilbestrol on C. elegans average body 
bend per minute (BBPM) 
L4 worms from synchronized populations worms were exposed 0.01µM, 0.1µM, 1µM, 
10µM or 100µM diethylstilbestrol (DES) for 24 hours at 20oC where the negative 
control included worms treated with 0.1% DMSO which was used in the preparation 
of DES treatments . The video frames were captured in 24 well plates over a 15 
second period. Individual body bends per minute was calculated from computer 
tracking-generated body bend per second using the worm tracker plugin on ImageJ. 
Data was generated from 60 worms with each treatment group containing between 
7 and 12 worms. Due to the unequal variance among sample groups, ANOVA on 
ranks (H-test) was used for statistical analysis where H = 3.883 with 5 degrees of 
freedom (P = 0.718). 
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4.3 Discussion 
In the current research, DES treatments ranging 0.001µM and 10µM did not 
reveal significant difference in terms of lethality on worms when compared with 
controls (Figure 4.1). This suggests that the concentrations used in the 
experiments were not high enough to induce a lethal effect. The results correlate 
with the work of Maranghi et al. (2008) who reported that low doses of DES 
showed no sign of general toxicity in mice. Consequently, the concentrations of 
treatments were further increased to ranges between 100µM and 10mM but the 
results for survival of treated worms remained relatively unchanged. In fact, there 
seemed to be improved viability specifically the apparent increase in size of 
worms from some treatments when compared to controls (data not shown). The 
result would appear logical to support the use of DES to enhance the growth of 
agricultural animals as was the case about sixty years ago (Dinusson et al., 
1950). 
The concentration range maintained for the lethal toxicity analysis above was 
similarly used to analyse fecundity. Again, the results showed that there was an 
increase in brood size with DES treatment; although these differences were in 
comparison to the solvent control (0.1% DMSO) used in the preparation of the 
DES concentrations (Figure 4.2). Interestingly, similar results were obtained with 
a different experimental set-up using mixed populations of worms detailed in table 
4.1.  While only two DES concentrations were considered, the results seem to 
agree with the initial basis for the use of DES in the treatment of reproductive-
related conditions as it was generally used for preventing spontaneous abortion 
which was believed to be a result of reduction in oestrogen level (Smith 1948). At 
the point of investigating the effect of DES on fecundity, the requisite skill required 
for using computer–based tracking of offspring had not been acquired. This would 
have allowed the monitoring of multiple adult worms for their brood size. This 
limitation resulted in the use of manual counting of brood that can create errors. 
Whilst some scientists depend on the manual approach for brood count (Li et al., 
2014; Gonzalez-Moragas et al., 2015), the technique could be daunting (Polak et 
al., 2014) and the reproducibility of the technique could be subjective depending 
on the technical skill of the scientist.  
The results in figures 3 and 4 suggest that there is variability in the behaviour of 
the worms in terms of speed and body bends respectively. One major challenge 
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with the data analysed for behaviour is that it was generated from the computer 
worm tracking programme which is limited in accurately tracking every worm in 
an experiment. The algorithm for the tracking programme includes laying-off 
outliers from threshold of behaviour specification. For example, when two tracked 
worms overlay each other, the sequence of tracking in the two worms may be 
excluded from the data and this resulted in unequal worm number in each 
treatment group. One factor that can improve the output of the computer tracking 
system is the quality of plate preparation for camera capture. For instance, 
particle-free worm plates with moderate number of worms (20-30) might generate 
better data. Despite the challenges automated analysis of worm behaviour may 
pose, it is still more efficient than manual assessment. In table 4.2, a comparison 
between the automated and manual behavioural tracking system revealed that 
the latter could be qualitative and subjective, depending on the researcher’s 
observatory skills. More so, good C. elegans culture practice (GCeCP) would 
reduce the magnitude of errors in behavioural as well as other toxicity endpoint 
assessment. For example, in table 4.2, while the current research measured 
speed on liquid medium, solid medium would have served the purpose better as 
particles that vibrate in liquid medium due to worm movement may be 
misrepresented by the automation system as worms. Also, synchronized 
population would reduce the probability of error than mixed population.   
Another observation in behaviour was the initial twitching of larvae on exposure 
to treatments. This could have been as a result of the 0.1% DMSO. DMSO 
concentration as low as 0.25% could trigger twitch in the worms (Raizen et al., 
2012). 
The DES treatment exposure time (24 hours) used in the experiments is 
consistent with real life scenarios. For example, Karnaky (1949) administered 
daily doses of DES to women with high risk of abortion. However, it should be 
noted that DES usage, right from the 1940s (Shimkin and Grady, 1941) to the 
current decade ( Zhang et al., 2014) have shown that consistent exposure to the 
synthetic oestrogen can lead to reproductive disorders.  
It is not out of place to suggest that for C. elegans, DES appears to support 
reproduction and growth. This is not surprising as a report suggested that DES is 
at least five times more potent than the naturally occurring oestradiol; the most 
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potent oestrogen in mammals (Noller and Fish 1974). Also, since cholesterol is 
important in the fluidity of lipid bilayers and membrane permeability in C. elegans 
as with other multicellular organism, it is likely that the worm expresses enzymes 
that can utilize cholesterol (Kurzchalia and Ward, 2003) as well as other sterol-
like compounds converting them to usable compounds in order to meet its sterol 
requirement.  This possibility is likely because C. elegans cannot synthesize 
sterols de novo (Chitwood et al., 1983). It may be that DES is being modified by 
the nematode for its utilization. Further investigation such as the use of nuclear 
hormone receptor or oestrogen receptor mutant strains of C. elegans (Magner et 
al., 2013 and Lindblom et al., 2001) can be used to further understand the effect 
of the synthetic oestrogen on C. elegans.  
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Chapter Five 
5 Toxicity assessment and prove of concept of target-specific 
anthelmintics 
 
5.1 Part one 
 
5.1.1 Introduction to tubulin-specific derivatized anthelmintic toxicity 
assessment  
Anthelmintics are drugs or chemical compounds that selectively target helminth 
parasites in a host to inflict an effect that can halt reproduction and / or survival 
of the parasite while having minimal effect on the host. The selectivity of an 
anthelmintic can be influenced by its pharmacokinetic properties; which may 
cause the host to be exposed to lower concentrations of the drug than the 
parasite would. Anthelmintic selectivity can also be dependent on the inhibition 
of metabolic processes that are important for the parasite but not the host. In 
order for parasites to survive within their hosts, they require a steady diet, the 
ability to maintain homeostasis regardless of host immune response and the 
ability to reproduce successfully. Any interference to one or more of these 
processes may lead to the treatment and control of parasite infections. In other 
words, the compromise of the cellular integrity, neuromuscular coordination and 
/ or host immunity evasion mechanisms are the answers to effectively treating 
parasitic infections. However, the increased use of available anthelmintics is 
accompanied by increasing frequency of parasite resistance to them (Sutherland 
and Leathwick, 2011). Since most anthelmintics are classified either based on 
their chemical structure, their site of action or their biochemical mechanisms, 
resistance of a parasite to any member of a class may also mean resistance to 
other members of that class. Therefore, it is important to synthesize better 
targeted anthelmintics that can circumvent such resistance. Any mention of 
parasites hereon refers to helminth parasites. 
Some anthelmintics are able to disrupt the process of the effective 
communication of the nervous system with muscles in parasites leading to their 
paralysis and eventual flushing out from the host system. The anthelmintics that 
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induce this response do so by binding to two types of protein molecules; receptors 
and ion channels. One example is the nicotinic agonist that bind to the nicotinic 
acetylcholine receptor (nAChR) whose natural substrate is acetylcholine (ACh); 
a neurotransmitter that is commonly found in the central nervous system. When 
ACh binds to the nAChR it relays signal to the nerves to stabilize movement and 
balance. The nicotinic agonists also act on nAChR of some parasites by 
stimulating the ganglion activity in the parasite somatic muscle cells leading to 
paralysis following neuromuscular blockade (Martin and Robertson, 2010). A 
classical member of this group is levamisole. Another group of anthelmintics that 
disrupts neuromuscular efficiency are the glutamate-gated chloride channels 
potentiators. These include the macrocyclic lactone of which avermectin is a 
classical representative. They bind to the glutamate-gated chloride channel 
receptors (GluClR) in nerve cells of parasites to open the channel which allows 
an inflow of chloride ions. Due to the presence of different chloride channel 
subunits, parasites may show different responses to macrocyclic lactones as 
different parts of the parasites may be paralyzed. The most effective macrocyclic 
lactone usually paralyzes the pharynx of nematodes but the macrocyclic lactones 
do not affect cestodes and trematodes, probably because they do not possess 
GluClR. Although macrocyclic lactones are potent against parasites, some 
members like avermectin and other structurally related compounds can bind or 
modulate pentameric ligand-gated ion channel receptors of mammalian hosts 
(Lynagh et al., 2011 and Adelsberger et al., 2000); however with relatively low 
potency. One of the latest anthelmintics that affect neuromuscular efficiency are 
the amino-acetonitrile derivative (AAD). Monepantel is currently the only available 
member of this group that has been produced commercially. There are 
suggestions that it is an agonist that binds specifically to a nematode clade of 
AChR subunits precisely, a homomeric channel known as mptl-1 which belongs 
to the DEG-3 family of nAChR (Kaminsky et al., 2008). Depolarization of muscle 
cells in parasites occurs following a constant influx of ions and this leads to 
irreversible paralysis and eventual parasite death. The specificity of monepantel 
is high because the nAChR it binds to is only found in nematodes. 
Anthelmintics that disrupt cellular integrity such as benzimidazole and its 
derivatives are often used as the first line of action in the treatment of parasitic 
infections. This group of anthelmintics inhibit tubulin polymerization. They are 
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also likely responsible for the inhibition of cellular transport and energy 
metabolism. The result of their inhibitory characteristics is the depolymerization 
of microtubules that encourages the depletion of energy and constipation in 
parasites; thus, leading to death (Vinaud et al., 2008).  There are suggestions 
that the selectivity of benzimidazoles for parasite infection treatment is 
encouraged by the ability of the host cells to augment genetic adaptation that 
prevents the disruption of microtubules in the host following exposure to 
benzimidazoles (Aleyasin et al., 2014). 
 
5.1.1.1 Tubulin-specific anthelmintic targeting 
 
Colchicine is an anti-inflammatory derived from extracts of the flower Colchicum 
autumnale used generally for the treatment of gout. It is suggested that colchicine  
stops the assembly of microtubules leading to the disruption of inflammasome 
activation, leukotrienes and cytokine generation, phagocytosis and microtubule-
based inflammatory cell chemotaxis (Dalbeth et al., 2014). The information on 
colchicine reveals that it has a high affinity to bind tubulin and copolymerizes into 
microtubules rather than depolymerizing them. When colchicine binds to β-
tubulin, a curved tubulin dimer is formed because of the steric action between α-
tubulin and colchicine. This leads to the inhibition of microtubule assembly 
(Ravelli et al., 2004). While colchicine may not affect the mitochondrion directly, 
its action on microtubules disrupts the biogenesis of the mitochondrion 
(Heggeness et al., 1978). This is because the depolymerisation of microtubules 
is suggested to be responsible for the inhibition of mitochondrial content during 
the interphase of cell cycle (Karbowski et al., 2001). Apart from the generation of 
cellular energy, the mitochondrion produces reactive oxygen species (ROS) in 
form of by-products of the electron transport chain. The production ROS is a 
reflection of cellular oxidative stress level and it can influence the destruction of 
biomolecules in biosystems where antioxidants are not sufficient to neutralize the 
ROS. Thus, cellular oxidative stress which is implicated in cell death and aging 
can originate from mitochondrial dysfunction (Balaban et al., 2005).  In addition, 
the mitochondrion plays a pivotal role in cellular calcium balance as the 
accumulation of mitochondrial calcium takes part in the regulation of aerobic 
metabolism (Contreras et al., 2010). Furthermore, there are suggestions that 
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mitochondrial metabolic anomalies resulting from compromised or mutated 
mitochondrial DNA are factors that contribute to aging via apoptosis (Payne and 
Chinnery, 2015). Therefore, due to its role in cell life and death, the current 
research explores the mitochondrion as a viable target for colchicine in the 
treatment of parasitic helminth infections. Although colchicine is not an 
anthelmintic, it shares a similarity with benzimidazoles in that they both interact 
with the colchicine binding site in cells (Lacey, 1988; Lu et al., 2012) thus,  there 
is the prospect to develop colchine-based anthelmintics for the treatment of 
parasitic infections. 
A major challenge that colchicine would face as an anthelmintic is its low 
therapeutic index. In order to address this concern, an approach that can be 
exploited is to take advantage of the negative potential (150 -180mV) of the 
mitochondrion’s inner membrane (Zielonka et al., 2017). Finichiu et al. (2013) 
demonstrated that lipid bilayers of the mitochondrion allow the easy passage of 
lipophilic cations due to the dispersion of their charge over a large surface area. 
This and the potential gradient of the lipophilic cations support their accumulation 
into the mitochondrial matrix. Triphenylphosphonium (TPP), which is one of the 
most common lipophilic cations, was demonstrated to accumulate preferentially 
in the inner core of the mitochondrion (Armstrong, 2007). In comparison to other 
lipophilic cations such as thiopyrylium AA-1 and rhodamine 123 that inhibit 
mitochondrial ATP synthesis (Sun et al, 1994; Modica-Napolitano et al., 1984), 
TPP is less toxic to the mitochondrion (Modica-Napolitano and Aprille, 2001) and 
have been successfully used to facilitate the delivery of drugs to the mitochondria 
(Patel et al., 2010; Diers et al., 2010). Luque-Ortega et al. (2010) revealed that 
TPP derivatives can induce low toxicity on mammalian cells while inflicting lethal 
effect on the protozoan parasite belonging to the genus Leshmania. This is 
achieved by targeting complex II of the respiratory chain thus, leading to decrease 
in both cytoplasmic ATP and electrochemical mitochondrial potential. They also 
inhibit oxygen consumption rate by using succinate as substrate.  
Our collaborators at the chemistry department of Edinburgh Napier University 
have designed and produced prodrugs consisting of colchicine derivatives with 
TPP conjugates that can be activated within biological systems. The aim of the 
current research is to investigate the anthelmintic property of the prodrugs; 
precisely the colchicine derivatives and the enhanced activity of the colchicine-
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TPP conjugates. Also, we examine the suitability of C. elegans as a 
representative model of parasitic helminths. 
 
 
5.1.2 Results 
5.1.2.1 Effect of tubulin-targeting drugs on C. elegans survival 
Triphenylphosphonium (TPP) is a lipophilic cation which when conjugated with 
drugs delivers them to the mitochondrion. In order to show the effect that TPP 
has on  the efficacy of drugs, L4 adults from synchronized cultures of wild-type 
worms were exposed to varying concentrations of an anthraquinone derivative; 
NU:UB 238 (see section B of the appendix for structure) or a NU:UB 238 and 
triphenylphosphonium conjugate (NU:UB 238-TPP) for 24 hours. The results 
(Figure 5.1) revealed that at 100µM, NU:UB 238 treatment resulted in less than 
25% worm survival while NU:UB 238-TPP resulted in about 40% worm survival. 
On the other hand, 0.01µM, 0.1µM, 1µM and 10µM NU:UB 238 and NU:UB 238-
TPP were not significantly different from one another with more than 95% of the 
worms surviving after exposure. The results imply that at 100µM, worms exposed 
to NU:UB 238-TPP survived almost twice as much as worms exposed to NU:UB 
238. 
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Figure 5.1: Effect of an anthraquinone derivative and its TPP conjugate on C. elegans survival 
L4 worms from synchronized populations were exposed to 0.01µM, 0.1µM, 1µM, 10µM or 100µM NU:UB 
238 or NU:UB 238-TPP for 24 hours at 20oC where the control include untreated worms with percentage 
survival >98% (not shown). The number of live worms in each treatment group was divided by the total 
number of worms in the group and multiplied by 100 to get the percentage survival. The data was drawn 
from three separate experiments where 178 ≥ n ≥ 123 for each treatment group. 
While the aim of the results in figure 5.1 was to describe the effect of TPP on drug 
enhancement, the anthraquinone derivative used was originally designed for the 
inhibition of DNA topoisomerase I and II enzymes (Pettersson 2004) in cancer 
chemotherapy. However, because one interest in the current research is 
anthelmintic therapy, a colchicine derivative; MB2 and a MB2-TPP conjugate 
were designed to test their anthelmintic and enhanced anthelmintic properties 
respectively. In figure 5.2 the 100µM MB2 treatment resulted in about 50% worm 
survival while 100µM MB2-TPP resulted in about 95% worm survival. On the 
other hand, 0.01µM, 0.1µM, 1µM and 10µM MB2 and MB2-TPP were not 
significantly different from one another with more than 95% of the worms 
surviving after exposure. The results suggest that at 100µM, MB2 is more 
effective than MB2-TPP. 
Treatment
0.01µM 0.1µM 1µM 10µM 100µM
Pe
rc
en
ta
ge
 s
ur
viv
al
0
20
40
60
80
100
NU:UB 238 
NU:UB 238-TPP 
 103 
 
 
Figure 5.2: Effect of MB2 and MB2-TPP on C. elegans survival. 
L4 worms from synchronized populations were exposed to 0.01µM, 0.1µM, 1µM, 10µM or 100µM MB2 or 
MB2-TPP for 24 hours at 20oC where the control include untreated worms with percentage survival >97% 
(not shown). The number of live worms in each treatment group was divided by the total number of worms 
in the group and multiplied by 100 to get the percentage survival. The data was drawn from three separate 
experiments where 205 ≥ n ≥ 122 for each treatment group). 
 
Apart from the MB2 series of compounds, another series of colchicine derivatives, 
GEO1 and GEO2 (GEO1-TPP conjugate) were tested for their anthelmintic 
properties. More than 90% of worms exposed to 1µM, 25µM, 50µM, 75µM and 
100µM GEO1 or GEO2 survived with no significant difference among the groups 
of treatments (Figure 5.3). Unlike the observations in figures 5.1 and 5.2, there 
was no significant difference between the survival of worms treated with 100µM 
GEO1 and GEO2. 
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Figure 5.3: Effect of colchicine and colchicine-based drugs on C. elegans survival. 
L4 worms from synchronized populations were exposed to 1µM, 25µM, 50µM, 75µM or 100µM GEO1 or 
GEO2 (where GEO2 is GEO1-TPP conjugate) for 24 hours at 20oC where the control include untreated 
worms with percentage survival >99% (not shown). The number of live worms in each treatment group was 
divided by the total number of worms in the group and multiplied by 100 to get the percentage survival. The 
data was drawn from three separate experiments where 248 ≥ n ≥ 121 for each treatment group. 
 
5.1.2.2 Effect of tubulin-targeting drugs on C. elegans behaviour 
The behaviour of C. elegans is modulated in response to a number of stimuli 
including drugs. As a representative model of helminth parasites, the effect of 
derivatized anthelmintics was investigated in C. elegans. Having previously 
investigated the lethality of some colchicine derivatives (Figures 5.2 and 5.3), the 
effect of GEO compounds on worm body bend was investigated (Figure 5.4). 
While there is a random pattern in the concentration response of the worms to 
each treatment in figure 5.4, the trend for colchicine (COL), GEO1 and GEO2 
were similar. Generally, for the three aforementioned treatment groups, there was 
a percentage increase in the number of worm body bends at 400µM in 
comparison to the untreated group (12%, 16% and 33% for COL, GEO1 and 
GEO2 respectively).   
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Figure 5.4: Effect of colchicine and colchicine-based drugs on C. elegans body bend. 
First day adult worms were exposed to colchicine (COL), a colchicine derivative (GEO1), GEO1 
conjugated with a triphosphonium moiety (GEO2), a mixture of GEO1 and triphosphonium 
(GEO1+TPP), or triphosphonium (TPP) for 24 hours. The worms were from a synchronized 
population (20oC) and were captured in 60mm Petri plates over a 20 second period.   Individual 
worms were tracked and body bends per seconds were recorded using the worm tracker plugin on 
ImageJ. The mean of data from each treatment concentration was normalized by calculating body 
bend per minute (BBPM) and subsequently the percentage BBPM as a percentage of BBPM from 
untreated worms. The untreated worms were incubated in S medium. Data was generated from 403 
worms with each treatment containing between 1 and 53 worms. Due to the unequal variance among 
sample groups, ANOVA on ranks (H-test) was used for statistical analysis where H = 119.059 with 
19 degrees of freedom (P = <0.001). 
Also, within the three treatment groups, GEO2 seemed to have the highest 
percentage of body bends at all four concentrations (100µM, 200µM, 300µM and 
400µM). The additional effect of GEO1 and triphenylphosphonium (GEO1+TPP) 
was also investigated in the experiment and its concentration response pattern 
was similar to that of triphenylphosphonium (TPP) alone. 
Furthermore, the effect of GEO compounds on worm speed was investigated 
(Figure 5.5). There was a random pattern in the concentration response of the 
worms to each treatment in the trend for experiment with an inconsistent pattern 
across the treatment groups. One notable observation was that there was a 
percentage increase in speed of worms exposed to COL, GEO1 and GEO2 in 
comparison to the untreated group. 
 106 
 
Treatment
COL GEO1 GEO2 GEO1+TPP TPP
%
 co
ntr
ol 
av
er
ag
e 
sp
ee
d
0
50
100
150
200
100µM 
200µM 
300µM 
400µM 
 
Figure 5.5: Effect of colchicine and colchicine-based drugs on C. elegans speed. 
First day adult worms were exposed to colchicine (COL), a colchicine derivative (GEO1), GEO1 
conjugated with a triphosphonium moiety (GEO2), a mixture of GEO1 and triphosphonium (GEO1+TPP), 
or triphosphonium (TPP) for 24 hours. The worms were from a synchronized population (20oC) and were 
captured in 60mm Petri plates over a 20 second period.   Individual worms were tracked and speed was 
recorded in pixel per second using the worm tracker plugin on ImageJ. The mean of data from each 
treatment concentration was normalized by calculating the speed as a percentage of untreated worms’ 
average speed. The untreated worms were incubated in S medium. Data was generated from 465 worms 
with each treatment containing between 1 and 60 worms. Due to the unequal variance among sample 
groups, ANOVA on ranks (H-test) was used for statistical analysis where H = 97.254 with 19 degrees of 
freedom (P = <0.001). 
 
5.1.3 Discussion 
Anthelmintic derivatives made up of colchicine-based drugs and their 
triphenylphosphonium (TPP) conjugates were tested on C. elegans to investigate 
their anthelmintic properties. The conjugates are made up of the derivatized 
drugs which are linked to a TPP moiety with an ester bond. The in-house 
synthesized derivatized anthelmintic compounds were screened against C. 
elegans owing to its anatomical and physiological resemblance with the parasite 
helminth. For the colchicine-based drug; MB2 (Figure 5.2), it is likely that the 
compounds exhibit anthelmintic activity in a dose-dependent manner given that 
about 50% of the worms died at 100µM. On the other hand, while it was expected 
that MB2-TPP conjugate would be more effective than MB2, this was not the case 
as more than 90% of the worm survived. One possible cause of this observation 
is the solubility of MB2-TPP. Although, MB2-TPP dissolves in DMSO, its 
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administration to the C. elegans test samples resulted in reprecipitation in solution 
(observed during treatment preparation and microscopic investigation). This 
could have resulted in a reduction of the actual concentration of MB2-TPP in the 
treatment. A similar observation was noticed in the NU:UB compounds and this 
was also reflected in the results(Figure 5.1) which showed that NU:UB 238 was 
more effective than NU:UB 238-TPP conjugate. One difference between the 
lethal effect of NU:UB 238-TPP and GEO2 is that NU:UB 238-TPP seemed more 
potent than GEO2. This was expected as the NU:UB series of compounds are 
anthroquinone-based and were originally designed as cancer therapeutics so 
they are suspected to be naturally toxic to cells. The NU:UB compounds were 
only included in the current study to show the potential of TPP in enhancing drug 
delivery. 
The results of the GEO1 and its TPP conjugate (GEO2) suggest no lethal effect 
on the worms at 100µM following a 24h exposure (Figure 5.3). A further increase 
in concentration and incubation for 24h (i.e. 48-hour exposure) suggests that 
there was a clear difference between the GEO1 and GEO2-treated samples with 
more than 20% lethality observed in worms treated with 200µM to 800µM GEO2 
(observation with Dr. Rosa De Llanos). This suggests that the effect of the 
derivatized anthelmintics TPP conjugate (GEO2) is time and concentration-
dependent, and the TPP is likely responsible for the enhanced effect of GEO2 
due to the affinity of TPP for mitochondria. This is likely due to the ability of TPP 
to cross phospholipid bilayers without requiring a transporter allowing easy 
uptake of GEO1 (product of the conjugate following suspected cleavage of ester 
bond by worm esterase) into the mitochondria (Finichiu et al., 2013) thereby 
causing the disruption of the organelle and eventual death of the worm. One 
unanswered question with respect to high concentrations of the anthelmintic 
derivatives is the effect they may pose to the host and possibly the environment 
when discharged through waste products. 
A possible reason for the low anthelmintic effect of GEO series of compounds 
exhibited at 100µM may be due to the lack of characterization of the compound 
for predictive anthelmintic properties. Characterization of anthelmintic should be 
the first step in the design of anthelmintic drugs. Technological advancement in 
the development of techniques that can be used to acquire the atomic structure 
of protein-ligand interaction has created an avenue for the development of 
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molecules that target specific sites (Gore and Desai, 2014). This approach is a 
computer structure-based design of drugs. A common example of this is 
molecular docking which refers to the process of refining drug molecular structure 
by manipulating the separation between the drug and its target site whilst 
maintaining their relative fixed orientation and internal geometry at computational 
level (Kitchen et al., 2004) and (Meng et al., 2011). This helps to predict the best 
interaction between the drug and its target site. In the inhibition of enzymatic 
processes, ligand-binding is important, thus forming a foundation for strategy of 
drug design (Sliwoski et al., 2013). Molecular docking has been successfully used 
to design prospective antimicrobial agents against infections such as 
Mycobacterium tuberculosis (Obiol-Pardo et al., 2011) or Plasmodium falciparum 
(Guggisberg et al., 2014). This evidence suggests that molecular docking 
analysis of the anthelmintic derivatives described in this study might provide the 
feasibility of their efficiency in the treatment of helminth infections. 
For behavioural analysis, two endpoints; body bends per minute and the average 
speed of worms were investigated. The treatment of C. elegans with GEO 
compounds revealed that while there was variability in terms of concentration 
response to the GEO compounds, there was increased number of body bends 
per minute (BBPM) in GEO2 in comparison to GEO1; suggesting that the TPP 
enhanced the effect of GEO1 (Figure 5.4). GEO1+TPP were included in the 
experiment to show the unconjugated additional effect of GEO1 and TPP. The 
BBPM observed in in GEO1+TPP was relatively lower than that observed in 
GEO2. It was clear from the findings that the effect of GEO2 was not as a result 
of the additional effect of TPP to GEO1 but rather, the supposed release and 
accumulation of active GEO1 in the cell. Moreover, a close look at colchicine and 
GEO1 revealed similar behavioural activity in terms of BBPM. On the other hand, 
the average speed of treated worms (Figure 5.5) did not clearly reflect the 
observations of worm BBPM. One notion is that exposure to the drugs induced 
an effect which could be high or low speed. Specifically, the effect of drugs on 
worm tubulin would likely affect the functionality of the sensory cilia associated 
with movement (Hurd et al., 2010). 
Summarily, the behavioural analysis results reveal that BBPM is more sensitive 
and have a low variability when compared to speed as endpoints of toxicity.  
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5.2 Part two 
5.2.1 Introduction to legumain-specific anthelmintic targeting: A proof of 
concept 
From the ecological viewpoint, the effect of chemical substances on C. elegans 
can be used as a measure of toxicity on the biota of an ecosystem. Parasitic 
helminths may share a common ecosystem with C. elegans hence; chemical 
substances that have toxic effects on C. elegans may have similar effects on 
parasites from the same ecosystem. C. elegans can be used as a model for the 
study of anthelmintic properties. Parasitic helminths are difficult to keep alive over 
a long period of time outside their host and access to the infective stage parasites 
would require killing the host so; they are not best suited to be used directly in 
the study of anthelmintic properties. C. elegans has been used as an 
experimental model in the study of commercial anthelmintic effects and meets 
some requirements needed for testing as it can be easily genetically manipulated 
besides being cost-effective and readily available.  
Because C. elegans is a representative member of the phylum Nematoda which 
has some parasitic members, it is important to understand its relationship with 
the parasites in the phylum. Taxonomic classification of nematodes has been 
quite difficult as evolutionary relationships are challenged by constant reviews 
and ongoing discoveries; however, one classification is based on molecular 
phylogenetics which involves the use of a gene or genes from different taxa to 
construct a dataset of homologous traits. Specifically, C. elegans small subunit 
rRNA (18S rRNA) analysis suggests that the worm is closely related to parasitic 
nematodes in the order Strongylida (Fitch and Kelly-Thomas, 1997) which 
includes Teladorsagia and Haemonchus. As a result of successful molecular 
study on C. elegans, genetic similarities between the nematode and parasitic 
nematodes make it a potential model for the study of anthelmintics. 
Having described the challenges of anthelmintic resistance (chapter one, section 
1.5.5), there is a need to develop more effective or better-targeted drugs that 
would combat resistance. Cysteine proteases are common in C. elegans and are 
also conserved in some parasitic worms from the same class (Jasmer et al., 
2001). Specifically, it has been demonstrated that the cysteine protease; 
legumain is present in parasitic worms (Oliver et al., 2006).  It cleaves asparagine 
in the P1 position adjacent to the C-terminus of protein substrates (Chen et al., 
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1997). In order for active drug molecules to be released into a biosystem, 
legumain in the biosystem cleaves a prodrug consisting of an amino acid 
substrate and the active drug to release the active drugs into its locality. The 
current research hypothesizes that this would improve the target of such drug. 
There are some other rational approaches to developing more efficient 
anthelmintics such as targeting endosymbionts that are essential for parasite 
development (Slatko et al., 2010), protein-protein interaction (Taylor et al., 2011) 
or receptor binding (Sager et al., 2009). However, the choice of these anthelmintic 
candidates is sometimes flawed by the function, existence or conservation of their 
target in parasitic helminth species. These challenges can be overcome using the 
current legumain-target approach.  
The aim of the research is to show proof of concept that the legumain cysteine 
protease can be investigated as a potential for enhanced anthelmintic targeting 
using C. elegans as a representative model of parasitic helminths. We explore 
the use of the C. elegans and a probe containing a fluorophore which is used as 
a biomarker, attached to a tripeptide group that would serve as a quencher. 
Initially, the legumain-targeting probes were designed for the purpose of targeting 
cancer cells which express increased legumain compared to normal healthy cells 
(Jinq-may Chen et al., 1997). The probe is activated once legumain cleaves the 
tripeptide to release the fluorophore which would fluoresce. This would be 
measured by a fluorimeter. It is intended that this concept be replicated in the 
target parasitic helminth. The success of this would reduce the use of higher 
concentrations of anthelmintic drugs but improve the efficacy of the drugs. 
 
5.2.2 Results 
5.2.2.1 Legumain activation of TL11 probe by helminth homogenates 
In order to demonstrate legumain enzyme activity in helminths, homogenate of 
the free-living worm; Caenorhabditis elegans and the parasitic worms, 
Teladorsagia circumcinta and Haemonchus contortus were exposed to a 
fluorescein-based probe TL11 that fluoresces following cleavage by legumain 
(see introduction). Two cysteine protease inhibitors, Iodoacetamide and N-
phenylmaleimide that are specific inhibitors of legumain, and a general cysteine 
protease inhibitor (E-64) with no inhibitory effect on legumain (Barrett et al., 1992 
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and Chen et al., 1997) were introduced into the experiment. Fluorescence 
resulting from fluorescein after cleavage of the probe which acts as substrate is 
directly proportional to legumain activity in the homogenates. 
After 120 minutes of exposure to TL11 (Figure 5.6), fluorescence intensity was 
observed in all the treatment groups with a linear relationship maintained over the 
time course suggesting activation of TL11 probe by the C. elegans homogenate 
in all the treatments; however, the fluorescence intensity of the treatment group 
that had no inhibitor (CeT) was significantly higher (p < 0.001) than other 
treatment groups that contained inhibitors. At 120 minutes, fluorescence of the 
treatment group containing E-64 (CeET) was significantly higher (p < 0.001) than 
that containing N-phenylmaleimide (CeNT) which recorded the lowest 
fluorescence intensity; however, CeET was not statistically different from the 
treatment group containing Iodoacetamide (CeIT). CeIT and CeNT were similar 
in terms of their low fluorescence intensities. The reduction in the relative 
fluorescence intensity of CeIT and CeNP as compared to CeT suggests that the 
activation of the TL11 probe was inhibited. The speed of the increase in relative 
fluorescence intensity which is a measure of the rate of probe cleavage reaction 
was highest for CeT and lowest for CeNT. 
In order to determine enzyme activity following interaction of the fluorescein-
labelled probe with parasitic worms, T.circumcincta homogenate was treated with 
TL11 in the presence or absence of a legumain-specific inhibitor (Iodoacetamide) 
or a non-legumain inhibitor (E-64). The results in figure 5.7 revealed that 
fluorescence occurred following exposure of T. circumcincta homogenate to the 
probe suggesting activation of the probe by the homogenate, thus enzyme 
activity. Like the C. elegans homogenate, a linear relationship was maintained 
over a two-hour time course in the treatment group without the protease inhibitors 
(TcT) and the E-64-treated group (TcET). TcT recorded the highest fluorescence 
intensity at 120 minutes (approximately 5700 relative fluorescence unit (RFU)), 
while the rate of reaction of TcET was slower reaching around 3860RFU at 120 
minutes. The Iodoacetamide-treated group (TcIT) tended towards optimal 
fluorescence intensity at about 1160RFU suggesting the stoppage of reaction, 
hence an inhibition of enzyme activity.  
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Figure 5.6: Activation of TL11 by wild type C. elegans homogenate. 
Mixed population of homogenized C. elegans (approximately 3000 L4 worms in mixed culture) was treated 
with TL11 (10µM) probe   with or without either iodoacetamide (1mM), N-phenylmaleimide (1mM) or E-64 
(100µM). The final treatment volume of100µl per well in a 96 well plate was made up using 2-(N-morpholino) 
ethanesulfonic acid (MES) buffer at pH5. Controls (not shown) included fluorescein, TL11 in MES buffer, C. 
elegans homogenate in MES buffer and MES buffer alone. Treatments were incubated at 22oC in triplicate 
and fluorescence intensity with excitation and emission wavelength of 485nm and 520nm respectively, was 
monitored over a 2-hour period. Each treatment data recorded by the Omega fluorimetric software (Biostar) 
was normalized to a starting relative intensity unit of zero. Statistical analysis was performed using two-way 
ANOVA with error bars representing ±SD.  
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Figure 5.7: Activation of TL11 by T. circumcincta homogenate. 
T circumcinta homogenate was treated with TL11 (10µM) probe with or without either iodoacetamide (1mM) or 
E-64 (100µM). The final treatment volume of 100µl per well in a 96 well plate was made up using MES buffer 
(pH5). Controls (not shown) included fluorescein, TL11 in MES buffer, T. circumcincta homogenate in MES 
buffer and MES buffer alone. Treatments were incubated at 22oC in triplicate and fluorescence intensity with 
excitation and emission wavelength of 485nm and 520nm respectively, was monitored over a 2-hour period. 
Each treatment data recorded by the Omega fluorimetric software (Biostar) was normalized to a starting relative 
intensity unit of zero. Statistical analysis was performed using two-way ANOVA with error bars representing 
±SD. 
 
H. contortus homogenate was treated with TL11 in the presence or absence of 
Iodoacetamide or E-64 and the results (Figure 5.8) reveal that H. contortus 
homogenate without inhibitor treatment (HcT) was high and was not statistically 
different from homogenate treated with Iodoacetamide (HcIT) with the rate of 
reaction of both treatment groups tending towards an optimal relative 
fluorescence intensity of approximately 14000RFU and suggesting the activation 
of the probe molecules by enzyme in the samples was almost complete. At 120 
minutes, E-64-treated H. contortus homogenate (HcIT) recorded a relative 
fluorescence intensity of approximately 1600RFU that was significantly lower (p 
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< 0.001) than HcT and HcIT with the line of reaction tending towards a curve thus, 
indicating inhibition of reaction. 
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Figure 5.8: Activation of TL11 by H. contortus homogenate. 
H. contortus homogenate was treated with TL11 (10µM) probe and with or without either iodoacetamide (1mM) 
or E-64 (100µM). The final treatment volume of100µl per well in a 96 well plate was made up using MES buffer 
(pH5). Controls (not shown) included fluorescein, TL11 in MES buffer, H. contortus homogenate in MES buffer 
and MES buffer alone. Treatments were incubated at 22oC in triplicate and fluorescence intensity with excitation 
and emission wavelength of 485nm and 520nm respectively, was monitored over a 2-hour period. Each 
treatment data recorded by the Omega fluorimetric software (Biostar) was normalized to a starting relative 
intensity unit of zero. Statistical analysis was performed using two-way ANOVA with error bars representing 
±SD. 
 
5.2.2.2 Effect of pH on activation of LS9 probe by parasitic helminth 
homogenates 
According to Chen et al. (1998), the optimal pH at which mammalian legumain 
cleaves protein substrates best is pH5. In order to determine the sensitivity of 
parasite homogenate legumain activity to pH, four different pH levels were tested. 
This was necessary to accommodate the different pH in infection or parasitic 
worm localized sites of mammal hosts. Homogenate of T. circumcincta was 
prepared in phosphate citrate buffer of pH4, 5, 6 or 7 and incubated with LS9; a 
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rhodamine-based probe for two hour. The progress curve graph (Figure 5.9) 
revealed that at pH5, the reaction between T. circumcincta homogenate and LS9 
(TcL) maintained a distinct linear progression with approximately 2800RFU and 
the highest fluorescence intensity thus, the fastest rate of reaction at 120 minutes. 
For TcL at pH4, 6 and 7, the curves were approaching a non-linear part with pH4 
and 6 exhibiting was no statistical difference between the fluorescence intensities 
and reaching approximately 2000RFU.    
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Figure 5.9: pH effect on the activation of LS9 by T. circumcincta homogenate. 
T. circumcincta homogenate was treated with LS9 probe (10µM) using Phosphate citrate (PCB) buffer of pH4, 
5, 6 or 7 to make up a final volume of 100µl per well in a 96 well plate. Controls (not shown) included rhodamine 
in PCB buffer (pH 4, 5 6 and 7), LS9 in PCB, T. circumcincta homogenate in PCB and PCB buffer alone. 
Treatments were incubated at 22oC in triplicate and fluorescence intensity with excitation and emission 
wavelength of 544nm and 590nm respectively, was monitored over a 2-hour period. Each treatment data 
recorded by the Omega fluorimetric software (Biostar) was normalized to a starting relative intensity unit of zero. 
Statistical analysis was performed using two-way ANOVA with error bars representing ±SD. 
 
For H. contortus exposure to LS9 (HcL) at varying pH over a two-hour period 
(Figure 5.10), the highest intensity was recorded for HcL at pH5 which peaked an 
optimal fluorescence intensity of approximately 16000 RFU while at pH6 HcL 
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recorded the fastest rate of reaction but an optimal intensity around 12200RFU 
was recorded suggesting inhibition at pH6. HcL incubated at pH4 was the only 
treatment group that exhibited a linear progression after 120 minutes reaching 
approximately 13600RFU.  
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Figure 5.10: pH effect on the activation of LS9 by H.contortus homogenate. 
H. contortus homogenate was treated with LS9 probe (10µM) using PCB buffer of pH4, 5, 6 or 7 to make up a 
final volume of 100µl per well in a 96 well plate. Controls (not shown) included rhodamine in PCB buffer (pH 4, 
5 6 and 7), LS9 in PCB, H. contortus homogenate in PCB and PCB buffer alone. Treatments were incubated at 
22oC in triplicate and fluorescence intensity with excitation and emission wavelength of 544nm and 590nm 
respectively, was monitored over a 2-hour period. Each treatment data recorded by the Omega fluorimetric 
software (Biostar) was normalized to a starting relative intensity unit of zero. Statistical analysis was performed 
using two-way ANOVA with error bars representing ±SD. 
 
5.2.2.3 Legumain activation of LS9 probe in sheep plasma  
For the investigation of the presence of legumain in sheep plasma, dilution was 
made in phosphate citrate buffer (pH4, 5, 6 or 7), and incubated with LS9 probe 
for two hours (Figure 5.11). The result revealed no activity among the treatment 
groups as there was no significant fluorescence intensity (less than 40RFu) at all 
pH observed. This suggests that the probe was not activated by sheep plasma. 
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A repeat analysis on the sheep plasma experiment at pH5 was set up with H. 
contortus homogenate (HcL). The result showed ample difference in LS9 
activation with HcL almost peaking its optimal fluorescence intensity at 
approximately 15300RFU thus tending towards the completion of the reaction at 
about 120 minutes after incubation while no quantifiable change was seen in 
sheep plasma (Figure 5.12).  
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Figure 5.11: pH effect on the activation of LS9 by sheep plasma. 
Sheep plasma was treated with LS9 probe (10µM) using PCB buffer of pH4, 5, 6 or 7 to make up a 
final volume of 100µl per well in a 96 well plate. . Controls (not shown) included rhodamine in PCB 
buffer (pH 4, 5 6 and 7), LS9 in PCB, sheep plasma in PCB and PCB buffer alone. Treatments were 
incubated (22oC) in triplicates and fluorescence intensity with excitation and emission wavelength of 
544nm and 590nm respectively, was monitored over a 2-hour period. Each treatment data recorded 
by the Omega fluorimetric software (Biostar) was normalized to a starting relative intensity unit of zero. 
Statistical analysis was performed using two-way ANOVA with error bars representing ±SD. 
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Figure 5.12: Comparison between LS9 activation in H. contortus homogenate and sheep plasma. 
H. contortus homogenate or sheep plasma was treated with LS9 (10µM) probe. The final treatment volume of 
100µl per well in a 96 well plate was made up using PCB buffer (pH5). . Controls (not shown) included rhodamine 
in PCB buffer, LS9 in PCB, H. contortus homogenate in PCB and PCB buffer alone. Treatments were incubated 
at 22oC in triplicate and fluorescence intensity with excitation and emission wavelength of 485nm and 520nm 
respectively, was monitored over a 2-hour period. Each treatment data recorded by the Omega fluorimetric 
software (Biostar) was normalized to a starting relative intensity unit of zero. Statistical analysis was performed 
using two-way ANOVA with error bars representing ±SD. 
 
5.2.2.4 Legumain activation of LS9 probe in sheep liver tissue homogenate  
Having examined sheep plasma for LS9 activation, legumain activation in sheep 
liver tissue was investigated. The result (Figure 5.13) showed that at pH5, sheep 
liver tissue homogenate treated with LS9 in the absence of protease inhibitors 
(LTL) revealed the highest fluorescence intensity but progressed towards a non-
linear curve, however, a similar pattern was observed by liver tissue treated with 
E-64 (LTEL) but the reaction rate was slower and the progression into a non-linear 
curve was faster. The treatment containing iodoacetamide (LTIL) was beginning 
to reach its optimal intensity at 120 minutes following exposure. N-
phenylmaleamide-treated sample (LTNL) did not exhibit any fluorescence 
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suggesting complete non-activation of LS9 thus, no enzyme activity was 
observed. 
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Figure 5.13: Activation of LS9 by sheep liver tissue homogenate. 
Sheep liver tissue homogenate was treated with LS9 (10µM) probe and with or without E-64 (100µM), 
Iodoacetamide (1mM) or N-phenylmaleamide (1mM). Controls (not shown) included rhodamine in PCB 
buffer, LS9 in PCB, liver tissue homogenate in PCB and PCB buffer alone. The final treatment volume 
of100µl per well in a 96 well plate was made up using PCB buffer (pH5). Treatments were incubated at 22oC 
in triplicate and fluorescence intensity with excitation and emission wavelength of 485nm and 520nm 
respectively, was monitored over a 2-hour period. Each treatment data recorded by the Omega fluorimetric 
software (Biostar) was normalized to a starting relative intensity unit of zero. Statistical analysis was 
performed using two-way ANOVA with error bars representing ±SD. 
 
5.2.2.5 Localization of legumain enzyme in C. elegans 
Localisation of legumain is useful in investigating the specificity and successful 
delivery of the fluorophore-based prodrug to its target site (where legumain is 
expressed in the worm). C. elegans worm culture was exposed to TL11, LS9 and 
SM9 probes to investigate whether the probes were toxic to the worms and to 
observe if the probes could gain entry into the worms in vivo. Following a 22-hour 
exposure of young L4 and adult worms to 0.001µM to 1µM concentrations of the 
probes, there was no significant toxicity to the worms since the control sample 
and test samples had similar low mortality results (data not shown). For the 
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observation of fluorescence following treatment of the worms with the probes, 
after a 24 hour exposure period, images of SM9-treated (1µM)  worms revealed 
distinct patterns of intensities on the worms (Figure 5.14). The fluorescence was 
localized in specific regions of the worm; specifically areas around the pharynx, 
the vulva and close to the tail (Figure 5.14). On the other hand, TLL and LS9 
probes were not retained (images not shown).  
As part of the investigation to localize the legumain enzyme in C. elegans, we 
attempted to identify if the enzyme was water soluble (S1), membrane-associated 
(S2) or membrane-bound (S3) in fractions of the worm. Due to the unknown 
interaction of detergents used in extraction of the somatic fractions, the activity of 
recombinant legumain in the detergents; 0.1% Tween 20 and 2% Triton X which 
would mimic reactions for S2 and S3 fraction respectively, was investigated to 
ascertain if the detergents prevented legumain activity. The results (Figure 5.15) 
indicated that while recombinant legumain prepared at pH5 (RLL) maintained 
non-linear curve progressing toward a plateau at 120 minutes (approximately 
7000RFU), recombinant legumain in 0.1% Tween 20 at pH5 treated with LS9 
(RLT20L) produced low fluorescence intensity and thus; low enzyme activity while 
the recombinant legumain in 2% Triton X-100 solution at pH5 (RLT100L) revealed 
no activity. The result suggested that detergents hindered or reduced enzyme 
activity. 
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Figure 5.14: Rhodamine-based probe (SM9) uptake in C. elegans. 
Fluorescent imaging of cultured C. elegans exposed to (A) no treatment and (B) 1µM SM9 probe. Worms were treated for 24h in liquid medium. Uptake excitation and emission 
wavelengths were 544nm and 590nm respectively. All labelled points in panel B display distinct fluorescence intensities representative of observations from approximately 30 
worms per well of treatment in biological triplicates (n=3). HSN refers to hermaphrodite specific neurons and RVG refers to retrovesicular ganglion. The labelled regions are 
subject to confirmation.  
Preanal ganglion 
region 
HSN 
Neurosecretory motor 
neuron /RVG region 
Grinder 
A = Untreated worm B = SM9-treated worm 
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Figure 5.15: Detergent effect on the activation of LS9 by recombinant legumain. 
Recombinant legumain (250ng/100µl) was prepared in PCB (pH5) , 0.1% Tween 20 in phosphate-buffered 
saline (PBS) solution adjusted to pH5 or 2% Triton X-100 in PBS (pH5). Each sample was treated with LS9 
probe (10µM) using PCB buffer (pH5) to make up a final volume of 100µl per well in a 96 well plate. Treatments 
were incubated (22oC) in triplicates and fluorescence intensity with excitation and emission wavelength of 
544nm and 590nm respectively, was monitored over a 2-hour period. Each treatment data recorded by the 
Omega fluorimetric software (Biostar) was normalized to a starting relative intensity unit of zero. Statistical 
analysis was performed using two-way ANOVA with error bars representing ±SD. 
 
In order to recover the recombinant legumain from the detergents a detergent gel 
extraction was utilized using a resin-recovery technology (see methods). The 
resin-recovered recombinant legumain from recombinant legumain in 0.1% 
Tween 20 was exposed to LS9 (RR-RLT20L) for 120 minutes and the result 
(Figure 5.16) revealed that there was no significant difference between 
recombinant legumain (RLL) and RR-RLT20L as both fluorescence intensities at 
120 minutes were approximately 1800RFU compared to RLT20L which had 
reached its optimal fluorescence intensity (approximately 330RFU) at about 105 
minutes suggesting inhibition of enzyme activity.
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Figure 5.16: Activation of LS9 by resin-recovered (RR) recombinant legumain. 
Recombinant legumain (167ng/100µl) was prepared in PCB (pH5), 0.1% Tween 20 in PBS solution (pH5) or 
resin-recovered (RR) recombinant legumain (167ng/100µl) in 0.1% Tween 20 in PBS solution (pH5). Each 
sample was treated with LS9 probe (10µM) using PCB buffer (pH5) to make up a final volume of 100µl per well 
in a 96 well plate. Treatments were incubated (22oC) in triplicates and fluorescence intensity with excitation and 
emission wavelength of 544nm and 590nm respectively, was monitored over a 2-hour period. Each treatment 
data recorded by the Omega fluorimetric software (Biostar) was normalized to a starting relative intensity unit of 
zero. Statistical analysis was performed using two-way ANOVA with error bars representing ±SD. 
 
Having successfully shown above that samples could be recovered from 
detergents, C. elegans somatic fractions S2 and S3 were prepared with either 
homogenizing buffer (HB) or phosphate buffered saline (PBS) solution containing 
0.1% Tween 20 (for S2 extraction) or 2% Triton X-100 (for S3 extraction). The 
somatic fractions and their resin-recovered samples were exposed to LS9 probe 
for 2 hours. The results in Figure 5.17 reveal that samples prepared in HB had 
generally low fluorescence intensities (Figure 5.17a) when compared to their 
PBS-prepared equivalents (Figure 5.17b) with the HB-containing samples 
exhibiting distorted curve progression. Fluorescence though initiated at the blank 
(zero point), did not visibly progress over time until approximately 15, 20 and 45 
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minutes for CeL, CeS3L and RR-CeS3L (Figure 5.17a). Figure 5.17b showed 
that the CeL in PBS was significantly higher (p < 0.001) and the reaction rate was 
faster than all other treatment groups in PBS while the other treatments were not 
significantly different from one another. Furthermore, although RR-CeS2L and 
RR-CeS3L prepared in PBS exhibited fluorescence, their detergent-containing 
equivalents did not reveal any fluorescence intensity (Figure 5.17b).  
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Figure 5.17: LS9 activation by somatic fractions of C. elegans. 
(A) LS9 activation in membrane-bound fraction (S3) of C. elegans extracted with 2% Triton X-100 prepared in homogenizing buffer (HB) at pH7.4. (B) LS9 activation in membrane-
associated fraction (S2) and membrane-bound fraction (S3) of C. elegans extracted with 0.1% Tween 20 and 2% Triton X-100 respectively prepared in Phosphate-Buffered Saline 
(PBS) solution at pH5. For graph A, C. elegans homogenized in HB, S3 fraction of C. elegans homogenized in HB or resin-recovered (RR) S3 fraction of C. elegans homogenized in 
HB was treated with LS9 probe (10µM) using PCB buffer (pH5) to make up a final volume of 100µl per well in a 96 well plate. For graph B, C. elegans homogenized in PBS solution, 
S2 fraction of C. elegans homogenized in PBS solution, S3 fraction of C. elegans homogenized in PBS solution, RR S2 fraction of C. elegans homogenized in PBS solution or RR S3 
fraction of C. elegans homogenized in PBS solution was treated with LS9 probe (10µM) using PCB buffer (pH5) to make up a final volume of 100µl per well in a 96 well plate. Treatments 
were incubated (22oC) in triplicates and fluorescence intensity with excitation and emission wavelength of 544nm and 590nm respectively, was monitored over a 120 minutes’ period. 
Each treatment data recorded by the Omega fluorimetric software (Biostar) was normalized to a starting relative intensity unit of zero. Statistical analysis was performed using two-way 
ANOVA with error bars representing ±SD. 
B A 
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5.2.3 Discussion 
5.2.3.1 Legumain activity in C. elegans 
In Figure 5.6, high fluorescence intensity was observed in C. elegans 
homogenate suggesting the presence of legumain in C. elegans. Iodoacetamide 
and N-phenylmaleimide; two known legumain inhibitors lowered the release of 
fluorescence from the probe (TL11) presumably by reducing legumain activity. 
While there was no total inhibition of fluorescence, the results showed that N-
phenylmaleimide exhibited a stronger inhibitory property. Also, E-64 which 
inhibits all other protease enzymes but not legumain had some inhibitory effect 
on probe activation though, this effect was significantly lower than Iodoacteamide 
and N-phenylmaleimide effect.  Since legumain was not isolated or characterized 
from the C. elegans homogenates as with other analysed samples in the study, 
the term ‘legumain-like’ activation is preferred to ‘legumain’ activation. Although 
the legumain-specific inhibitors did not result in total inhibition of probe activation 
and E-64 seemed to have reduced probe activation as should not be the case, 
the trend in Figure 5.6 suggests that a legumain-like type of reaction occurred in 
C. elegans. Whilst it could be argued that the relative fluorescence intensity in 
Figure 5.6 did not attain the optimal value; that is, the cleavage of the entire probe 
molecule thus, end of the reaction, it should be noted that the experiment was 
stopped after a defined time (120 minutes). This was due to two reasons; the first 
was to enable the velocity of the reaction to be calculated. It is this velocity that 
helps compare the reactions within sample groups in an experiment; however, 
velocity is only extrapolated from a linear curve which is characteristic in Figure 
5.6 and the steepness of the slope on the progress graph quantitatively defines 
the activity of legumain in the experiment (Bisswanger, 2014). The second reason 
for the stopped assay is that, if the assay is allowed to continue after 120 minutes 
of reaction, the fluorophore might begin to lose its integrity due to photobleaching 
(Zondervan et al., 2003); leading to errors in the experiment. The results in figure 
5.6 demonstrate that a legumain-like enzyme in C. elegans was responsible for 
the cleavage of TL11 resulting in the emission of fluorescence. This also implies 
that the TL11 probe and subsequently a prodrug could successfully be delivered 
to target legumain in C. elegans.  
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5.2.3.2 Legumain activity in parasitic helminths 
The progress of the experiments utilizing C. elegans further encouraged attempts 
on the parasitic nematodes T. circumcincta and H. contortus. In Figure 5.7, there 
was a similar trend of fluorescence reaction between T. circumcincta sample with 
and without E-64 as was observed with C. elegans in Figure 5.6 and their 
progress curves were also linear at the end of the timed reaction. It is not known 
why E-64 inhibition occurred since it does not inhibit legumain and serine 
proteases apart from the clan PA serine proteases(Barrett et al., 1982; Chen et 
al., 1997). On the other hand, the progress curve of the Iodoacetamide-treated 
T. circumcincta homogenate had begun to deviate outside the linear range and 
into optimal fluorescence production at about 60 minutes of probe-homogenate 
interaction suggesting inhibition of legumain. Contrastingly in Figure 5.8, the 
progress curve of H. contortus effect on the TL11 cleavage was close to optimal 
level suggesting the activation of most of the probe molecules by H. contortus 
homogenate hence, a likely presence and activity of legumain (Oliver et al., 
2006). Interestingly, the H. contortus homogenate treated with Iodoacetamide 
appeared to have exhibited a competitive inhibition suggesting that the legumain 
concentration in the H. contortus homogenate was not sufficient to convert the 
whole probe into active product (measured by fluorescence in this case) and 
allowing Iodoacetamide which should naturally inhibit legumain from the probe 
probably though alkylation of the probe. E-64 seemingly inhibited the activity of 
legumain as the rate of reaction and fluorescence were significantly low. A 
possible explanation of this unexpected observation with E-64 is likely that there 
may be serine proteases present in H. contortus that allowed E-64 to react with 
the functional thiol group in the enzymes thus modifying the enzymes to cleave 
the probe. Another plausible explanation is that substrates are commonly 
assumed to be specific for an enzyme. For example, Z-ala-ala-asn-MCA is 
commonly assumed to be a legumain-specific substrate (Teng et al., 2010), but 
this is likely to be relatively rather than absolutely so.  This assumption is mostly 
on the basis of being the available substrate and the lack of studies screening 
the enzyme substrate against other proteases. Nevertheless, some other 
endoproteases, for instance, one with cathepsin-like abilities cannot be excluded 
because they may cleave peptides as small as a dipeptide (Almeida et al., 2001). 
Thus, if some non-legumain cleavage is seen, it does not mean it occurs at the 
C-terminus of asparagine. However, aminopeptidases, carboxypeptidases and 
 128 
 
several endopeptidases including those with matrix metalloproteinase-like activity 
can be excluded because they would require a larger peptide sequence in the 
substrate. It should be noted that these submissions are from a human enzyme 
perspective and it is probable that nematodes like C. elegans, H. contortus or T. 
circumcincta have different enzyme substrate specificities. As reassuring as that 
may be, a comparison between H. contortus and T. circumcincta activity show a 
substantial difference in the parasite legumain activities and this suggests again, 
the possibility of various types of enzyme substrate specificity. Notwithstanding, 
legumain activity seems relatively conserved across species (Alvarez-Fernandez 
et al., 1999). 
It is necessary to state with caution that while the composition of the 
homogenates is not known, it is not likely to influence the pattern for the selective 
protease inhibitor E-64 between T. circumcincta and H. contortus.  A comparative 
measure that we had for the T. circumcincta and H. contortus homogenates was 
the total protein which was 2.27mgml-1 and 2.91mgml-1, respectively though 
individual protein concentrations are not necessarily dependent on total protein 
concentration. Since the investigations at this stage is only to show legumain 
activity, there is no intention to purify legumain in the parasites. 
 
5.2.3.3 pH effect on parasitic helminth activation 
Parasitic helminths depend on the chemical environment of the infected site of 
their host for survival. Also, legumain responds to environmental factors like pH 
(Dall and Brandstetter, 2016). The arguments put forward so far were based on 
nematodes in an acidic environment (pH5.0). A comparison to investigate the 
stability of legumain over a broad range of pH (4-7) was performed. The 
interaction of T. circumcincta and H. contortus homogenates with a rhodamine-
based probe; LS9, was investigated at pH4, 5, 6 and 7 over a similar time period 
(120 minutes) using the fluorimetric assay as mentioned earlier.  LS9 was chosen 
over the previous TL11 probe because of its sensitivity to emission; covering a 
wider fluorescence emission spectrum. In a consistent manner, as was observed 
in Figure 5.7, T. circumcincta maintained a linear curve over 120 minutes at pH5 
while the rate of reaction at pH4, 6 and 7 was slow and deviating from a linear 
curve towards a non-linear. This was observed as early as 20 minutes into the 
experiment (Figure 5.9). This suggests that pH5 is the optimal for legumain 
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activation of LS9 in T. circumcincta. Also, the H. contortus interaction with LS9 
was optimal at pH5 (Figure 5.10) and the progress curve was consistent with the 
one described in Figure 5.8 for TL11 at pH5. While the rate of reaction was initially 
faster at pH6 the reaction was optimal at a significantly lower RFU than at pH5. 
A challenge in the experimentation for pH evaluation was that the incubation time 
should have been increased at least to the point where all reactions would reach 
optimal peak, however, the photobleaching of the probe’s fluorophore could be 
problematic in the experimental design. Agreed that recombinant mammalian 
legumain works best at pH5 ( Chen et al., 1997) and does not show significant 
activity at pH7 as observed in one of our experiments (not shown), the same 
conclusion cannot be reached for helminths. More so, if the incubation time in the 
Figure 5.10 graph was extended for H. contortus homogenate treatment at pH4, 
there is the likelihood that the optimal relative fluorescence intensity would 
exceed pH5. Nonetheless, one could infer that helminth parasites can survive at 
different sites of the host under different chemical situations. For instance, the 
localisation, growth and multiplication of microbes in the rumen are pH-
dependent. In the reticulum of ruminants, pH is between 6 and 7 and may be 
lower depending on the type of feed given to the animal. Also, the pH of the 
abomasum, which is the infective site of L3 H. contortus and T. circumcincta can 
be as low as 2 (Moran, 2005) depending on the degree of infection. So, the 
activity of legumain on the probes in these environmental scenarios may be 
stable. 
Cysteine proteases in parasites function in a broader chemical atmosphere than 
their mammalian host equivalent. The pH of cysteine proteases is rather unstable 
in mammals apart from cathepsin S which may be using a regulation mechanism 
to reduce or prevent undesirable proteolysis in cellular units (Turk et al., 1995). 
On the other hand, parasite cysteine proteases are more active and maintain their 
pH stability; a characteristic that is in line with their extralysosomal functions 
(Sajid and McKerrow, 2002), such as the digestion of blood meal.  
 
5.2.3.4 Legumain activity in Sheep plasma 
Having considered the pH range of parasitic helminth legumain, experiments 
were performed to determine the presence of legumain in the plasma of the 
healthy mammalian host. Healthy sheep plasma was analysed for legumain on 
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four pH ranges (4-7) using the rhodamine-based prodrug LS9 (Figure 5.11).  The 
legumain activation of LS9 was insignificant over the two-hour incubation period 
with some negative relative fluorescence intensities observed in the graph. Of 
course, there is nothing like negative fluorescence but one can assume that the 
data generated from the fluorimeter is no longer fluorescence but a corrected 
measurement of fluorescence, which is why it is appropriate to use relativity in 
context. The fluorimeter (fluorostar Omega, UK) is partly responsible for this 
negativity as the MARS data analysis software in the fluorostar machine performs 
an automatic background/baseline correction. Again, normality could be a 
consequence of this negativity since the direct plotting of data does not give a 
definitive interpretation on graphs. Generated data is normalized because the 
fluorimeter, in an attempt to perform baseline correction, does not differentiate 
the buffers and control samples from other samples; it performs the correction on 
the entire 96 well plate; so, we still need to normalize to compensate for these 
errors. Whether or not the sample data is normalized, the standard deviation only 
changes in decimal fractions. From here on, all observation on so called “negative 
fluorescence” should be addressed based on the factors above. More so, the 
anomaly of negative fluorescence in the result could most likely be an issue of 
the plasma composition rather due to experimental process. A comparison with 
H. contortus extract in Figure 5.12 showed a definite distinction that legumain is 
probably absent or in its inactive proenzyme form (Dall and Brandstetter, 2016) if 
present in sheep plasma. This suggests that legumain could easily be targeted in 
parasites infecting sheep especially in blood.  
 
5.2.3.5 Legumain activity in Sheep liver tissue 
The activity of legumain in sheep liver tissue following the interaction with the LS9 
probe suggests that legumain is present in sheep liver tissue. N-
phenylmaleamide seems to be more efficient in inhibiting legumain activity than 
Iodoacetamide. The trend was consistent for C. elegans and T. circumcincta 
legumain inhibition. The implication of the presence of legumain or any other LS9 
probe substrate-cleaving enzyme in the liver is that it might result in release of 
active anthelmintic in the liver via cleavage of proposed prodrug. This, however, 
can be prevented by the route of administration of the prodrug. In essence, the 
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design of the actual prodrug must accommodate consideration for the route of 
delivery. 
 
5.2.3.6 In vivo localization of legumain in C. elegans 
Exposure of worms to TL11 and LS9 probe in vivo did not reveal any 
accumulation and lethal toxicity of the probes in life worms. On the other hand, 
SM9 which is a slight modification of LS9 at the spacer linking the tripeptide to 
the quencher was retained in the worms following 24 hour exposure to 1µM 
concentration of the probe as high fluorescence intensity was localized in specific 
regions of the worm (Figure 5.14). This finding suggests that legumain is likely 
localized in these regions as fluorescence would only occur following the 
cleavage of the probe to release the rhodamine fluorophore. Initially, it is was 
assumed that the negative charge on the peptide group might have prevented 
permeability of LS9 into the worm. One assumption is that the chain could be 
modified such that the tertiary amide group (amino group on proline in the red 
circle (see Figure 5.18 below-should be in introduction) is modified to one which 
would cyclise to form a cyclic compound; leading to the impermeabilty observed 
in the rhodamine tripeptide chain . On the contrary, this was not the case as SM9 
absorption into the worm suggest two plausible explanations; either that the 
spacers (orange rectangles in Figure 5.18) could be responsible for the difference 
in interaction or as a result of errors in the experiments.  
The localization of the SM9 is suggested to be around the retrovesicular ganglion 
(RVG), the haemaphrodite specific neuron (HSN) and the preanal ganglion 
region, however; a discussion personal discussion with  Dr. Emmanuel Busch of 
the University of Edinburgh suggests that the probe could have affected the 
structural integrity of the worm as the grinder and pharynx seemed to have shifted 
towards the posterior of the worm. If this is the case, the morphological change 
could be a resulting sublethal effect of toxicity. Nevertheless, these localized  
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Figure 5.18: Structural representation of probes used for legumain localization. 
(A) LS9 containing rhodamine tripeptide linked to the anthraquinone (quencher) with a propyl spacer (1, 3-Diaminopropane) and (B) SM9 containing rhodamine tripeptide 
linked to the anthraquinone (quencher) with a (polyethylene glycol (PEG) spacer (1, 8-Diamino-3,6-dioxaoctane). 
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regions are very pivotal in improving the specificity of drugs. For example, 
neuromuscular collapse in the pharynx would result in prevention of feeding and 
eventual starvation of worms. Also, a compromise in HSN would affect 
reproduction. The localization above demonstrates the prospect for the 
development of better targeted anthelmintics but this would depend on the 
amenability of the tripeptide with the active anthelmintic compound.  
 
5.2.3.7 Legumain in somatic fractions of C. elegans 
In vitro analysis of the localization of legumain in C. elegans was performed to 
determine if it is membrane-soluble, -associated or membrane-bound. Using the 
fluorimetric assay described previously, a designed control experiment to recover 
legumain from detergents was performed due to the inhibition of legumain activity 
resulting from the presence of detergent (Figure 5.15). In the control experiment, 
the recovery of legumain using a resin detergent remover (Thermo Scientific) 
successfully recovered over 95% of legumain as observed on the fluorescence 
intensity progress curve where 0.1% Tween 20 was extracted from recombinant 
mammalian legumain. The result suggests that detergent inhibition of legumain 
activity was reversible. The implication of this is that the detergents act probably 
by competitively inhibiting or temporarily preventing active binding of the enzyme 
to the substrate (LS9 probe) pending extraction. In the actual experiment of 
extracting somatic fractions of C. elegans (Figure 5.17), whilst the linearity of the 
progress curve indicated activity, the fluorescence intensity was significantly low 
in somatic fractions compared to pure homogenate of C. elegans. In Figure 
5.17A, the homogenizing buffer (HB) developed in-house for somatic extraction 
did not encourage legumain activity probably due to the high pH of the HB (7.4) 
which exceeded the optimal activation pH for legumain. Conversely, the 
phosphate buffered salt (PBS) solution (pH5) seemed to reveal an increased 
yield, however, the differences between HB in Figure 5.17A and PBS in figure 
5.17B should be carefully interpreted because of the relative difference between 
the non-detergent homogenates (CeL) and their resin-recovered S3 fractions. It 
is most likely that future experiments with preparation of HB at pH5 would yield a 
similar relationship to that observed in the resin-recovered legumain control test 
(Figure 5.16). In addressing whether legumain is membrane-bound or –
associated, S3 fraction had a higher reaction rate and activity than the resin-
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recovered S2 fraction (Figure 5.17B). This suggests that the presence of 
legumain is higher in membrane-bound fractions of C. elegans than in its 
membrane-associated fraction. Hence, organelles like the mitochondrion and 
lysosome in C. elegans might have more legumain concentration than in the non-
membrane bound structures like the cytoskeleton, microfilaments and 
microtubules external membrane structure. Oliver et al. (2006) made mention of 
a 6-fold increase in legumain activity in membrane-bound fraction (S3) as 
compared to the water-soluble fraction (S1) in Haemonchus contortus although 
no mention was made of membrane-associated fraction (S2). There is the 
possibility that C. elegans shares similar legumain localization with H. contortus 
in terms of somatic association. Fasciola hepatica, legumain does not seem to 
be membrane-bound nevertheless, a PhD thesis from the University of Glasgow 
archive (McDougall, 2012) showed that it does, although the author believes his 
finding was inconclusive. 
In summary, the results above support the use of C. elegans as a representative 
model in the application of anthelmintic treatment for parasitic helminth infections 
as we have shown that legumain cysteine protease can be exploited as a 
potential for enhanced anthelmintic targeting in parasitic helminths. 
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Chapter Six 
6 General discussion 
The suitability of C. elegans, and the type of analysis, for toxicity assessment is 
dependent on the type of chemical to be investigated. For example, in the current 
research, the consideration for lethality as an endpoint is essentially the first point 
in assessing the effect of the chemicals. This is most important for the derivatized 
anthelmintics to ensure that they kill the worm as a representative of helminth 
parasites. While an endocrine disruptor like diethylstibestrol (DES) is not lethal to 
C. elegans, it would be acceptable that endpoints such as reproduction and 
morphology should be given priority when investigating the toxic effect of such 
chemicals. Notwithstanding, chemicals such as derivatized anthelmintics or DES 
can still find their way into the environment probably as unused waste from 
biological systems. For this reason, other endpoints for toxicity can be utilized to 
investigate the exposure scenarios.   
While C. elegans shares a high conservation of signalling pathways and genes 
with the mammalian system (Leung et al., 2008), its success as a toxicity model 
is highly dependent on good C. elegans culture practice (GCeCP) (Hunt, 2016). 
Consistency with the factors that support a good C. elegans culture such as 
sufficient food source, temperature and salt concentration are critical for reliability 
and reproducibility of toxicity assessment. Changes to any of these factors might 
alter toxic effects of tested chemicals. For instance, an increase in temperature 
may result in the induction of male phenotypes (Corsi et al., 2015) and males 
produce three times as many eggs than hermaphrodite worms following mating. 
The offspring would contain 50% male and 50% hermaphrodite that could skew 
data recorded from reproductive or morphological assays. Worm density is 
another factor influencing GCeCP and the reliability of toxicological assessment. 
Dense population of worms in media would result in lack of nutrients and could 
lead to epigenetic adaptation rather than death (Hall et al., 2010); thus altered 
toxicity results would be derived from such worm culture. pH can also affect the 
validity of C. elegans for toxicity assessment. While inconsistent pH in culture 
may not reflect in lethal endpoints, this may not be the case with sublethal 
endpoints. Culture pH should be checked for separate experiments and same 
batch samples should always be used for each experiment with different 
 136 
 
treatment groups. Again, poor worm synchronization process may result in 
increased stress resistance of hatched L1 larvae from hypochlorite treatment if 
not fed after 18 hours in non-nutrient M9 buffer (Jobson et al., 2015).  
Apart from GCeCP, the appropriate representation of C. elegans and / or its 
mutants in toxicity experimental design is important. For example, some scientists 
suggest that the use of transgenic C. elegans with a compromised cuticle would 
encourage easy permeability of chemicals (Dengg and Van Meel, 2004). This 
might defeat the purpose of toxicological analysis as chemicals like derivatized 
anthelmintics would most likely produce an expected effect since the natural state 
of the worm would be compromised. It is often forgotten that predictive 
assessment using such suitability further deviates from the actual prediction 
expected. It is implied that in real life scenarios, parasitic worms such as H. 
contortus or T. circumcincta would not require an anthelmintic to be displaced 
from their host if their cuticle is compromised. An argument for the use of 
transgenics would be better suited for development of biomarkers such as GFP 
strains which would give insight into mechanisms affected by chemicals in C. 
elegans.  
In the current research, not all chemicals considered were evaluated with the 
same endpoints (Table 6.1) and results varied depending on the chemicals. One 
major reason for not investigating all endpoints for the three chemicals examined 
was the available time for the current research. For example, the development of 
the techniques for accelerated embryonic development (AED) and bag of worms 
(BOW) phenotype tests, and automated behavioural assessment required 
several months to establish due to the use of stage-specific worms that required 
unlimited time and access to the laboratory. Although 24-hour access could have 
been granted, experiments were designed to accommodate working hour access. 
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 Table 6.1: Toxicological assessment of chemicals performed in the current research 
Type of 
toxicological 
assessment 
Endpoint 
category 
Endpoint sub-
category 
Endpoint Chemicals analyzed 
ZnONP DES DAH 
Lethal Lethality Survival 
 
√ √ √ 
Length 
 
√   
Width  
 
√   
Body bend frequency 
 
 √ √ 
Average speed 
 
 √ √ 
Fecundity 
 
 √  
BOW phenotype 
 
√   
AED phenotype* 
 
√   
Descriptive and 
Mechanistic 
Transgenic GFP 
expression 
sod-3 GFP expression √   
Gene expression sod-3 gene expression 
 
√   
Protein expression SOD-3 protein expression 
 
√   
MicroRNA expression MicroRNA array analysis 
 
√   
*AED phenotype endpoint was developed in current research.  ZnONP = Zinc oxide nanoparticle, DES = Diethylstilbestrol, DAH = Derivatized anthelmintics
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6.1 Lethality as a toxicological endpoint in C. elegans 
Lethality assessment in C. elegans varies from manual prodding of worms for 
movement to automated movement tracking. For whichever method, high 
concentrations of chemicals are required to induce a lethal effect on the worms. 
In the current research, a high concentration of ZnONP was required to induce a 
lethal effect on C. elegans. ZnONP concentrations of 12.5mM (approximately 
1g/L) and above were lethal to the worms. These concentrations seemed 
unrealistic in real life exposure scenarios; however, the dispersion of the ZnONP 
rather than the dissolution of its Zn2+ ions are a likely contributing factor to the 
high concentration needed to induce lethality. While Williams & Dusenbery  
(1988) already showed that the LC50 of C. elegans correlated with the relative 
order of some metal toxicity, these metals were in water-soluble forms; thus, this 
could have contributed to their observations. 
The dose of DES, which is a drug, administered to patients during the time of its 
use was based on the quantitative determination of hormonal levels throughout 
pregnancy (Smith 1948). Nair & Jacob (2016) explained that allometric scaling 
which is based on normalizing dose to body surface area can be used to calculate 
the relative amount of a drug required in a species other than humans but this 
has only been used for mammalian model systems. Again, conversion of dose 
based on body weight (mg/kg) may not be the appropriate approach due to the 
variation in biochemical functions among species as these may alter the 
pharmacokinetics of the drugs (Nair and Jacob, 2016). DES doses were not 
based on body weight of patients during its period of use (Reilly et al., 2010) but 
on how patients’ symptoms responded to its use (Karnaky, 1949). The amount of 
DES given to patients could be between 25 and 1000mg daily (Karnaky, 1949). 
In the current research, the highest concentration of DES used in the treatment 
of C. elegans was 100µM (26.8mg/L) and this seemed to improve the viability of 
the worms. One of the challenges with DES, as with some other chemicals, was 
the extrapolation of concentrations in C. elegans to dose administered to patients 
in real life treatment scenarios.  
In addition, variability was observed when analyzing lethality in response to 
tubulin-targeting derivatized anthelmintics and repeated analyses were not 
consistent for concentrations that induced lethal effect (200µM to 800µM) on the 
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worms. While there is no specific explanation for this, an observation of the effect 
of clorsulon ; a benzenesulphonamide, on C. elegans in a separate experiment 
within our laboratory revealed that worms exposed to concentrations from 150µM 
(57mg/L) and above experienced total immobility for three minutes immediately 
after treatment; however, at seven minutes, the worms regained mobility. Since 
total immobility is usually scored as dead (Burke et al., 2015; Graves et al., 2005; 
Rogers et al., 2015; Qiuli Wu et al., 2013), the results suggested that there was 
probably a ‘Lazarus effect’, a condition in which  C. elegans, can be described as 
in temporal paralysis.  
Due to the requirement of high concentrations of chemicals used in the current 
study for the induction of lethal effect, it is suggested that for toxicological studies, 
sublethal effect of chemicals could yield more sensitive results from lower 
concentrations that are relevant to real life exposure scenarios. On the other 
hand, from a pharmaceutical perspective, the requirement of lethality endpoint 
could be critical in determining the effectiveness of the drugs. Therefore, lethalilty 
as is currently measured in C. elegans may be an unreliable endpoint; thus, 
caution may be needed when interpreting data. 
 
 
6.2 Morphology as a toxicological endpoint in C. elegans 
Dhawan et al. (1999) concluded in their work, which compared sublethal 
endpoints to lethal endpoint, that chemicals can induce effects on C. elegans 
morphology and unlike lethality, morphological endpoints are easily reproducible, 
and more sensitive indicators of toxicity. In our study, the assessment of 
morphology in terms of body length and width of the worms revealed that 
nanoparticles such as ZnONP can affect the size of the worms. Although the 
measurement of size was relatively easy to accomplish manually using the worm 
image captured with a camera on a compound microscope prior to analyzing with 
imaging software, complete automation could have been used as it can measure 
more worms over a shorter period of time. However, one concern with automation 
is that errors from measurements could be underestimated. For example, a lower 
magnification is required for an image that can capture at least 50 worms in a 
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single shot while a higher magnification would accommodate fewer worms 
(typically one to two worms) with larger views. Automated measurement of 
multiple images with higher magnification would yield lower measurement errors 
than an image with lower magnification would yield higher measurement errors. 
Although controls could allay these concerns, the significant differences among 
treatment groups might still be misrepresented.  
One challenge of the assessment of ZnONP effect on C. elegans was that the 
dispersion of nanoparticles rather than their dissolution may have resulted in the 
worms consuming the nanoparticles which may block the gut; thus, their inability 
to feed properly with a consequence of becoming lean. This concern could be 
addressed in future experiments by tagging or coating the particles with probes 
and monitoring the uptake within the worm but this would require subtlety as the 
physicochemical properties of the nanoparticles can change; an observation 
reminiscent with the effect of different dispersant on ZnONP toxicity (see chapter 
three). Also, for a chemical like DES which was completely dissolved, E. coli 
OP50; the standard laboratory diet of C. elegans can be GFP-tagged to monitor 
its accumulation profile in the intestinal lumen of the worm after feeding in order 
to understand how this could affect the worm morphology. However, in the current 
research, worms exposed to DES appeared to be larger in length and width in 
comparison to the untreated control (data not shown).  
 
 
6.3 Behavioural endpoints for toxicological assessment 
The development of behavioural assessment in the C. elegans model was 
facilitated by the effect of drugs on the nervous system of the worms (Avery and 
Horvitz, 1990). One characteristic of C. elegans is its ability to change its 
behaviour in response to changes in its external environment and also changes 
in its internal physiological state. These behavioural alterations are achieved 
through the activities of the nervous system. C. elegans displays a robust 
behavioural response to changes in its environment. Such changes alter the 
worm’s movement in terms of the effect on locomotion velocity (speed) and 
turning frequency (body bends per time).  The movement of C. elegans is affected 
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by the presence of xenobiotics in its local environment and the worm’s 
neurosensory awareness about these environmental changes is driven by 
behavioural shifts that are central to survival. In order to understand the C. 
elegans behaviour, the knowledge of how the activity of its muscles translates 
into movement within the mechanical framework and physical environment is 
important. The forward movement of the worm is achieved by undulatory waves 
in a dorsal-ventral plane from head to tail and are affected by responses to 
conditions in the worm environment that determine the motion behaviour of the 
worm (Pierce-Shimomura et al., 2008). The alternate contraction and relaxation 
of two dorsal and two ventral muscle groups running along the length of the body 
of the worm creates its bending characteristic (Von Stetina et al., 2005).  
In C. elegans, the connection between the activities of the body wall muscle and 
the posture of the worm is subject to the environment of the worm. While worms 
that crawl on solid media display distinct sinusoidal movement patterns that have 
a wavelength which is shorter than the worm body length, worms that swim in 
liquid media exhibit bending postures and have longer wavelengths than the 
worm length (Fang-Yen et al., 2010; Karbowski et al., 2006). Due to the higher 
frequency of movement in liquid media (Pierce-Shimomura et al., 2008), there is 
sufficient information gathered on behavioural data over a short period of time (in 
this research; 15 or 20 seconds). This is one reason for the preference of 
behavioural tracking in liquid medium over solid medium in the current research.  
Previous experiments on motion tracking by other researchers demonstrated 
dose-dependent decrease in motion to some chemicals (Anderson et al., 2004) 
while some others observed increase in locomotion (Williams and Dusenbery 
1988). In the current research, the speed of worms in liquid media failed to 
produce consistent phenotypes following exposure to the derivatized anthelmintic 
drugs. This was consistent with the findings of Beron et al. (2015) who showed 
that a parameter like burrowing is a preferred behavioural assessment tool than 
speed which failed to produce conspicuous behavioural phenotypes. The results 
of the body bend frequency revealed a more consistent response. The results 
suggest that an increase in body bend frequency due to the derivatized 
anthelmintic drugs is generally concentration-dependent and the TPP-conjugated 
drugs seem to increase this frequency. The situation where the trend of bend 
frequency is not progressive is likely as a result of active swimming followed by 
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an episode of inactivity. Ghosh & Emmons (2008) showed that this dormancy 
appeared to be caused by high production of acetylcholine (ACh) and is believed 
to be partly controlled by command interneurons responsible for decision-making. 
Perhaps, the increased production of ACh which initially increases locomotion 
may stimulate a secondary process required to halt muscle contraction due to the 
activation of remote receptors that stop muscle contraction by excess ACh 
(Ghosh and Emmons, 2008). Another possibility is that the colchicine molecules 
in the colchicine-based anthelmintics which disrupt the activity of tubulin (Takao 
& Kaziro, 1977 and Lin & Hamel, 1981) inhibited ACh receptor stimulation of G 
protein GTPase activity (Ravindra and Aronstam, 1991). Ravindra & Aronstam 
(1991) further observed that colchicine only inhibited ACh-stimulated GTPase at 
concentrations below 100µM. Since tubulin influences cellular signalling and by 
virtue of its activity in the cystoskeleton network, the successful binding of 
colchicine to tubulin may alter the activity of ACh receptor thus resulting in the 
inhibition of ACh receptor-G protein coupling. This would evidently affect 
neurotransmission and locomotion behaviour. 
With these possibilities in mind, it is likely that while the worms respond to the 
drug exposure by increasing their body bend frequency; they have the ability to 
accommodate lower concentrations and attempt to evade the drugs but as the 
concentration increases more ACh is produced and a reduction in body bend 
frequency ensues. The body bend frequency of the worm seems to increase with 
increasing drug concentration.  
The variances in the literature of behavioural tracking data is a reflection of some 
challenges with the techniques and practices involved in performing the test. 
These include the type of media in which worms are assessed, either solid versus 
liquid medium; the technique of assessment either manual (Wu et al., 2013) or 
automated (Truong et al., 2015); the number of worms analysed either random 
sampling of equal number of worms per treatment (Swierczek et al., 2011) or  
unequal sample size (Yemini et al., 2013); depending on technique used, single 
worm assessment (Gomez-Marin et al., 2016; (Contreras et al., 2014);  whether 
or not the worm populations are synchronized (Dhawan et al., 2000), and the time 
period for monitoring behavioural analysis (Swierczek et al., 2011; (Jiang et al., 
2016). Whilst the current research reveals a common trend with two different 
approaches (see chapter four section 4.2.4). The results are better analyzed 
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qualitatively rather than quantitatively as change in behavioural endpoints such 
as speed and body bend frequency can lay on either side of the control group. In 
addition, it is likely that the combination of neuronal assessments such as calcium 
imaging with other behavioural endpoints would provide an ideal assessment tool 
for the effect of chemicals on C. elegans behaviour.  
 
 
6.4 Reproductive and developmental toxicity endpoints should 
be classified in terms of embryogenesis and egg-laying  
Most reproductive toxicity assays in C. elegans lay emphasis on the activities of 
the gravid adult worm (McVey et al., 2016; Walker & Tsui 1968) from the 
fertilization of its eggs through the process of egg-laying. On the other hand, 
developmental assessment of the embryo would provide further evidence of the 
effect of chemicals on reproduction. Reproductive endpoints in the current 
research included fecundity, bag of worms (BOW) phenotype and in-utero 
embryogenesis. While these endpoints are considered generally as reproductive 
toxicity endpoints (Seidel and Kimble, 2011), the current research showed that 
the bag of worms phenotype; which is an egg-laying defective phenotype that 
involves in utero hatching, can be induced by the exposure of the adult worms to 
ZnONP. The finding suggests that the BOW phenotype can be developed to 
understand the impact of nanoparticles as well as other chemicals on the 
reproductive process. The BOW phenotype endpoint was more sensitive in 
identifying toxicity of ZnONP with easy reproducibility and lower variation among 
repeated experiments in comparison to lethality. 
For the first time, a state which was initially thought to be a process leading to the 
BOW phenotype was identified. While adult worms treated with ZnONP prepared 
in cationic or anionic dispersants (CZNP or AZNP respectively) revealed BOW 
phenotypes, adult worms treated with ZnONP prepared in molecular grade water, 
E. coli OP50 supernatant or 0.1% FBS (WZNP, SZNP or FZNP respectively) 
retained embryos that had developed to the ex utero egg development stage. 
These embryos had the three-fold elongation which usually develops 
approximately between 7 and 9 hours after egg-laying. This implied an 
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accelerated development of the embryo in the gravid adult which was eventually 
released; preventing the occurrence of BOW. We have termed the phenotype; 
accelerated embryonic development (AED) phenotype. Although it is not yet 
known how the AED phenotype occurs, the results revealed that is likely the most 
sensitive of all the toxicity endpoints used in the current research because it was 
detected in ZnONP treatments that otherwise did not reveal BOW phenotypes or 
morphological defect; for example, ZnONP prepared in E. coli OP50 supernatant 
(SZNP)-treated worms had similar morphology to the untreated control groups. 
For fecundity assessment, the DES treatment results revealed that despite the 
increase in brood size of the worms with increasing concentrations of DES, the 
variances in repeated experiments were wide. It is likely that the BOW and AED 
phenotype assays would serve as more accurate endpoints because it would take 
into account the BOW or AED adult instead of the surviving progeny which could 
either be from a BOW or AED adult. Another advantage of the BOW and AED 
endpoints as toxicological assessment tools in C. elegans is that their 
combination is representative of reproductive and developmental toxicity 
assessment of both the adult worm and its offspring. Furthermore, the variance 
in progeny number in repeated fecundity experiments is avoided in BOW and 
AED phenotype assessment because the results in the latter are qualitative 
assessments; hence reproducibility would be more efficient.  
As suggested by Harlow et al. (2016), since chemical exposure is experienced 
by the hermaphrodite adult, the combination of egg-laying and embryonic toxicity 
assessment such as the ones used in the current research is in a way 
representative of embryonic exposure through maternal contact with the chemical 
as observed in mammalian tests. Although it is expected that there will be 
limitations based on differences between C. elegans and mammals, the worm 
still shares a number of developmental processes with mammals. While the BOW 
and AED phenotypes endpoints mentioned above may be classified as 
reproductive endpoints, they should in fact be referred to as reproductive and 
developmental endpoints. This classification is encouraged because the BOW 
phenotype relates to the viability of the adult hermaphrodite while AED focuses 
on the viability of the embryo.  
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Following exposure to ZnONP, while the offspring survives in BOW phenotype 
probably due to the altruistic action of the hermaphrodite adult worm (Chen & 
Caswell-Chen, 2004) and in AED phenotype, there is an indication of 
unfavourable condition resulting from exposure to ZnONP. Although the BOW 
and AED phenotypes can be measured quantitatively, we propose that qualitative 
BOW and AED phenotype endpoints can be valuable elements of predictive tools 
not only for environmental toxicity but also mammalian developmental toxicity.  
 
 
6.5 Transgenic GFP-reporter expression analysis 
Generally, the use of GFP stress reporter strains of C. elegans can offer an 
outline of the patterns of gene response to toxic chemicals and the results are 
easily amenable to more direct interpretation, due to the existing characterization 
of some of these genes and their functions. The relevance of GFP-reporter 
responses is that they can be used as initial screening tools in the identification 
of patterns of responses which could subsequently be extensively examined 
using miRNA microarray analysis as applied in the current research. Although 
more extensive details on mechanisms of action would be available using miRNA 
microarray analysis as described in section 3.3.7 of chapter three, this would be 
expensive for testing multiple chemicals; for instance, in this study, the ZnONP in 
four different dispersants. 
The current research presents the response patterns of transgenic sod-3::GFP 
C. elegans strain. ZnONP induced the oxidative stress enzyme superoxide 
dismutase reflecting the increased levels of reactive oxygen species but only 
CZNP-treated L1 larva revealed reporter responses among the group of treated 
L1 larva. This suggests that transgenic reporter L1 larva of C. elegans could be 
used in the investigation of the subtler toxic effect of chemicals. There was 
increased fluorescence in L3 larva treated with AZNP and CZNP but not BZ which 
seem to imply that the dispersants in which the ZnONP were prepared influenced 
the responses observed at a specific worm larval stage of development. The 
reason for this is likely to be the dissolution of Zn2+ ions in the dispersant and also 
the level of expression at different developmental stages of the worm. Using the 
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gene expression atlas (Kapushesky et al., 2009, Petryszak et al., 2014), 
microarray and RNA-sequencing data of the sod-3 expression profile suggest 
that of the four developmental stages (L1, L3, L4 and gravid adult) considered, 
L1 larva has the highest baseline level of sod-3 expression with 4 fragments per 
kilobase of exon model per million reads mapped (FPKM) while L3 and L4 larva 
have a baseline expression of 3 and 2 FPKM respectively. The baseline 
expression for sod-3 in gravid adult is below the cut off.  
Some drawbacks to the sod-3::GFP reporter technique described here include  
the challenge of developing most GFP-reporter strains. For example, because 
transgenics like sod-3::GFP are developed using transcriptional fusions and 
stable GFP variants (Libina et al., 2003), the induction of stress-response gene 
expression is reliable but responses that involve the stability of messenger RNA 
or protein might be missed.   The possible explanation for this is that  
transcriptional responses only become recognized as increased fluorescence 
after a time lag between the translation of GFP and its autoxidation in the process 
of becoming fluorescent (David et al., 2003). This might explain the requirement 
for high concentrations (millimolar) of ZnONP to induce a reporter response in 
the current research and may be a reflection of a requirement for C. elegans gut 
ZnONP uptake. 
Another challenge is the limitation of covering all gene families that are implicated 
in oxidative stress induction. While transgenics, like sod-3::GFP strains, can 
elucidate the indication of toxic exposure, its predictive power is limited due to 
the number of possible mechanisms that are implicated. For example, in the 
current study, a MnSOD (sod-3) GFP expression was investigated in transgenic 
C. elegans exposed to ZnONP. While sod-3 seemed appropriate considering 
Cu/ZnSOD GFP-marked worm (sod-1) could yield false positive results because 
of its natural affinity for Zn2+ ions (Valentine et al., 2005), sod-3 could be 
redundant in function as it can be substituted by sod-2 which is more abundant 
in the whole organism (Doonan et al., 2008). Furthermore, because sod-3 is 
regulated by daf-16 (Oh et al., 2006) and elt-3 (Zhou et al., 2011) which both play 
important roles in ageing, mechanistic toxicity analysis cannot be complete 
without investigating transgenic worms designed for these regulator genes.  
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One way of overcoming this challenge is to investigate chemical or toxicant-
specific responses. An example of this is the aip-1 gene which is induced by 
arsenite (Sok et al., 2001). Another approach is the utility arrays of biomarkers 
and knock out strains are likely to offer improved predictability and would facilitate 
high-throughput screening of chemical effects across multiple stress pathways. 
GFP reporter strain endpoint assessment such as the use of sod-3::GFP C. 
elegans in this case, may result in the misinterpretation of oxidative stress 
assessment based on the array of genes implicated in controlling oxygen balance 
in the worm. Following a personal correspondence with Prof. David Gems of the 
University College London (UCL), an array of GFP reporters and other mutants 
that can elucidate the descriptive toxicity assessment of chemicals and inform 
our understanding of possible biochemical pathways implicated in the process of 
toxic induction was designed; thus, addressing partial mechanistic toxicity 
assessment. Table 6.2 below describes a rationale for this approach with regards 
to understanding the effect of induction of oxidative stress by chemicals.  Daf-2 
and daf-16 both act as positive regulators for SOD genes among other genes 
such as metal binding metallothionein and heat shock protein-regulating genes 
(Murphy et al., 2003). Consequently, there is cross-regulation of different stress-
response pathways by these master regulator genes in C. elegans. The 
amenability of C. elegans, makes it possible to investigate the whole stress-
response network provided the transgenics can be constructed. For example, the 
extracellular sod-4::GFP has not been constructed because GFP could not be 
detected in the sod-4::GFP lines, probably as a result of the extracellular 
localization of SOD-4 which leads to the diffusion of GFP; however, its sod-4 
knockout could give information on its importance in free oxygen radical 
detoxification (Doonan et al., 2008). 
 148 
 
Table 6.2: Rationale for the use of transgenic strains for toxicity assessment of chemicals 
C. elegans 
Strain 
 
Mutant description Availability 
(e.g. CGC) 
Relevance of use in toxicity assessment (oxidative stress assay) 
Null (KO),  
Hypomorphic (H) or 
GFP 
GA504   sod-1::GFP  UCL GFP expression suggests cytosolic superoxide dismutase (SOD) is produced to 
detoxify drugs/ ZnONP  
GA187 sod-1 KO CGC Survival of strain following treatment suggests possibility that sod-1 is not 
fundamental in drugs/ ZnONP detoxification or sod-5 complements its activity.  
GA509 daf-2 H with sod-
1::GFP  
UCL GFP expression in live strain serves as control for sod-1 expression in daf-2 
compromised GA504 strain (treatment could have an effect on daf-2). 
GA510 daf-16 KO and  daf-2 H 
with sod-1::GFP 
UCL GFP expression in live strain serves as control for sod-1 expression in daf-2 and daf-
16 compromised GA504 strain (treatment could have an effect on daf-2 and daf-16). 
    
GA429   sod-2::GFP  UCL GFP expression suggests mitochondrial SOD is produced to detoxify drugs/ ZnONP  
VC498 sod-2 H CGC Survival of strain following treatment suggests possibility that sod-2 is not 
fundamental in drugs/ ZnONP detoxification or sod-3 complements its activity. 
GA459   daf-2 H with sod-
2::GFP  
UCL GFP expression in live strain serves as control for sod-2 expression in daf-2 
compromised GA5429 strain (treatments could have an effect on daf-2). 
GA460 daf-16 KO and  daf-2 H 
with sod-2::GFP 
UCL GFP expression in live strain serves as control for sod-2 expression in daf-2 and daf-
16 compromised GA429 strain (treatments could have an effect on daf-2 and daf-16). 
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The colour-coded rows represent the smallest array of SOD transgenic C. elegans strains suggested for the investigation of toxicity. Strains were supplied 
by (Doonan et al., 2008) from the University College, London (UCL) and the Caenorhabditis Genetics Centre (CGC). 
CF1553 sod-3::GFP CGC GFP expression suggests mitochondrial SOD is produced to detoxify drugs/ ZnONP  
GA186 sod-3 KO CGC Survival of strain following treatment suggests possibility that sod-3 is not 
fundamental in drugs/ ZnONP detoxification or sod-2 complements its activity. 
CF1580 daf-2 H with sod-
3::GFP  
CGC GFP expression in live strain serves as control for sod-3 expression in daf-2 
compromised CF1553 strain (treatments could have an effect on daf-2). 
CF1588 daf-16 KO and  daf-2 H 
with sod-3::GFP 
CGC GFP expression in live strain serves as control for sod-3 expression in daf-2 and daf-
16 compromised CF1553 strain (treatments could have an effect on daf-2 and daf-
16). 
    
GA416 sod-4 KO CGC Survival of strain following treatment suggests possibility that extracellular SOD is 
not fundamental for drug/ ZnONP detoxification 
    
GA411 sod5::GFP  UCL GFP expression suggests cytosolic SOD is produced to detoxify drugs/ ZnONP  
GA503 sod-5 KO CGC Survival of strain following treatment suggests possibility that sod-5 is not important 
in drugs/ ZnONP detoxification or sod-1 complements its activity. 
GA412 daf-2 H with sod-
5::GFP  
UCL GFP expression in live strain serves as control for sod-5 expression in daf-2 
compromised GA411 strain (treatments could have an effect on daf-2). 
GA414 daf-16 KO and  daf-2 H 
with sod-5::GFP 
UCL GFP expression in live strain serves as control for sod-3 expression in +++daf-2 and 
daf-16 compromised GA411strain. Treatments could have an effect on daf-2 and daf-
16. 
    
GA480 sod-2 KO and sod-3 
KO 
CGC Death of strain following treatment suggests that mitochondrial SOD is important in 
drugs/ ZnONP detoxification. 
 150 
 
 
Previous research has focused on multiple toxicity assessments classified as 
either descriptive or mechanistic assessment assays, the use of transgenic C. 
elegans strains combines both (Table 6.2) and would improve initial insight to 
chemical toxicity in comparison to humans and their environment as well as the 
quality and time spent on performing the assessments. Whilst the current 
research with transgenic strains focused on ZnONP toxicity , the same technique 
can be used for exploring complex patterns of stress responses (Anbalagan et 
al., 2012) in other nanoparticles (Ma et al., 2009; Blinova et al., 2010) and even 
drugs like DES and anthelmintic derivatives to give insight into the mechanisms 
by which they work. 
In terms of reproducibility of transgenic GFP reporter assays, seemingly 
inconsequential environmental changes can be misrepresented as toxic, while 
toxic conditions may go undetected or there might be a wide variability among 
repeated experiments. For example, in the work of Power et al. (1998) control 
values in expression responses may differ by as much as 4-fold between repeat 
experiments. This could be as a result of subtle changes in environmental 
conditions such as temperature or oxygen content. Whilst all experiments are 
performed under the same conditions, these subtle changes cannot be 
completely eliminated and although data can be normalized to controls for 
standardization, it is better to run experiments concurrently as with qPCR analysis 
to avoid wide variations in data.  
Conclusively, the GFP-reporter expression assay offers an extensive prospect 
for stress-gene expression patterns in the assessment of chemical toxicity which 
would otherwise require expensive gene arrays. The data generated can be used 
to determine the process by which chemicals cause adverse effect to biological 
systems.  Future work will extend this approach as a predictive tool via reference 
of already investigated or tested chemicals and, where information is not 
sufficient, the parameters investigated could be increased accordingly to cover a 
desired theme. The continuous update of the library of assessed chemicals would 
become progressively more accurate over time thus leading the reduction in the 
used of animal models for toxicity assessment. 
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6.6 MiRNA expression as a biomarker for toxicity 
Some studies have utilized miRNA expression as a tool for toxicological 
assessment in the C. elegans model system (Wu et al., 2015, Yang et al., 2016, 
Zhao et al., 2016) but there is not enough information on how microarray analysis 
of miRNA expression can be maximized as a biomarker for chemical toxicity. The 
current research was conducted to investigate the use of miRNA expression as 
a marker of toxicity. Previous studies have shown that chemicals can induce 
genotoxic effects on biological systems (Eom et al., 2013, Kim et al., 2016, Park 
and Choi 2017). In most of these studies, the quantification of RNA transcripts 
using real-time PCR (qPCR) in combination with protein assays like western blot 
are considered as the definitive endpoints for genes implicated in toxicological 
pathways. In the current research, there was no change in superoxide dismutase 
III (SOD-3) protein and gene expression, where SOD-3 was used as a marker of 
oxidative stress resulting from exposure to ZnONP. On the other hand, the 
confidence of the microarray analysis of miRNA expression as a useful biomarker 
was strengthened by its consistency with the results obtained from sub-lethal 
endpoint assessments in the evaluation of ZnONP. Many genes and biochemical 
pathways are implicated in chemical toxicity and this places miRNA microarray 
analysis at an advantage over gene or protein analysis because the number of 
miRNAs describing a marker of toxicity is less than the number of genes 
implicated in that production of the marker. For example, miRNAs implicated in 
the regulation of sod-3 are less than the number of genes associated with sod-3. 
Although a lot is yet to be understood about miRNAs, it could be adopted for 
predictive assessment of chemical toxicity. Furthermore, target mRNAs of 
miRNAs implicated in toxicity can be investigated to understand the pathways 
involved for specific chemicals. 
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6.7 Designing realistic exposure scenarios 
The present study suggests that the dispersants used in the preparation of 
ZnONP may influence the adverse effect of ZnONP on C. elegans. The low effect 
of ZnONP prepared in E. coli OP50 supernatant or 0.1% FBS on C. elegans 
morphology in comparison to the adverse effect of ZnONP prepared in proprietary 
ionic dispersants suggests that a likely protein-coating of ZnONP by the 
dispersants alleviated the toxicological effect of the ZnONP in comparison to the 
proprietary ionic dispersants. This was previously demonstrated by Tiedemann 
et al. (2014) who showed that serum-coated gold and silver nanoparticles 
reduced the toxic effect of the nanoparticles. While E. coli OP50 supernatant and 
0.1% FBS may likely mimic a protein corona that coats nanoparticles; their 
availability in the environment could be contrary to the controlled exposure 
scenarios simulated in the laboratory.  Of course, a controlled environment allows 
for reproducibility and standardization of methods, however, there would be 
unavoidable differences compared to real environmental situations. Also, 
synthetic dispersants such as the proprietary ionic dispersants used for ZnONP 
preparation (CZNP and AZNP) are not likely present in actual environmental 
scenarios. From a domestic point of view, cosmetic products such as sunscreens 
contain about 155mg/g ZnONP and the major emission routes for such products 
are air, surface water, waste water and soil waste (Boxall et al., 2007). These 
routes accommodate different concentrations of ZnONP; for example, a 
simulation predicted that if 10% of sunscreen products in the United Kingdom 
market are used, the ZnONP content that would be released into water would be 
less than 80µg/L and more than 3.1 mg/kg in the soil (Boxall et al., 2007). While 
the current research on ZnONP may not be appropriate for environmental water 
exposure scenarios; unless in accidental or disaster situations like spillage, it 
could be better suited for soil exposure scenarios.  
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6.8 The C. elegans model in the application of anthelmintic 
drug delivery  
C. elegans appears to be an acceptable model for the development of a novel 
drug delivery system against helminth parasites. Assessment of legumain activity 
in C. elegans as well as nematode parasites, using fluorophore-labelled 
prodrugs, suggests that legumain is present in C. elegans as well as in parasitic 
nematodes. The experiments carried out so far point to legumain being the 
effector or activator of the prototype fluorogenic probes.  Moreover, legumain 
activity seems to be conserved across species due to the similarities in the 
inhibitor profiles of C. elegans, H. contortus and T. circumcincta. Also, legumain 
is not present in the water-soluble fraction of C. elegans but in H. contortus and 
T. circumcincta is active at acidic to neutral pH. Again, there are suggestions that 
sheep plasma does not contain legumain.  Under such circumstances, legumain 
would be a possible target for drugs and its delivery. 
 
 
6.9 Conclusion 
The current research revealed that C. elegans is a suitable model system for the 
evaluation of chemical toxicity but different toxicity endpoints would be required 
depending on the type of chemicals evaluated. Toxicological sub-lethal endpoints 
are likely to be more sensitive than lethal endpoint by order of the requirement 
for lower concentration of chemicals. The accelerated embryonic development 
(AED) phenotype is classified for the first time and is exclusive of the bag of worm 
(BOW) phenotype.  The AED phenotype can be utilized with the BOW phenotype 
as reproductive and developmental toxicity endpoints. Furthermore, microarray 
analysis of miRNA expression is a suitable biomarker of chemical toxicity. We 
therefore propose that an AED phenotype test and microarray analysis of miRNA 
expression be developed and incorporated into toxicological evaluation 
techniques. 
Also, we have shown that the C. elegans model system can be developed to 
show proof of concept for anthelmintic drug delivery against helminth parasites. 
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The findings in the current research point to legumain being the effector or 
activator of the prototype fluorogenic probes that are representative of 
anthelmintic prodrugs; therefore, more research will continue to refine and define 
structure-activity relationships and to determine the effect of the novel agents on 
worm viability.  
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Appendices 
Appendix A: Synchronization 
C. elegans synchronization is important in the current research because it could 
help monitor if the stage-specific effects resulting from exposure to toxicants. 
Also, as a helminth parasite model, the worm can easily be used to mimic the 
target parasite’s infective stage since this is usually difficult to isolate and 
maintain successfully outside the host. This is a significant attribute of C. elegans 
over using helminth parasite directly in experiments. A description of the 
procedure for synchronization is seen below.  
1. Worms were chunked onto 3 E. coli OP50-seeded 60mm NGM plates. The 
worms were allowed to grow for 3 days  
2. On the third day, with the number of eggs/adults on the plates increased, 
5ml of M9 was poured into each of the plates and gently swirled to dislodge 
the worms.  
3. Using a 5ml pipette, the worms were transferred to a 15ml conical tube 
and centrifuged for 2 minutes at 5000rpm to pellet the worms. 
4. This was followed by aspiration of 14.5ml of the M9 without disturbing the 
worm pellet. 
5. A 14.5ml volume of 20% NaOCl solution was added to the tube. 
6. The tube was mixed by inverting gently for approximately 5 minutes or until 
a decrease in the number of intact adult worms was seen. The bleaching 
should not exceed 5 minutes or the eggs would be killed. 
7. Once most of the bodies had dissolved, the tube was centrifuged at 
maximum speed for 1 minute.  
8. A 14.5ml volume of the 20% NaOCl solution (see section D of the 
appendix) was aspirated without disturbing the worm pellet.  
9. 14.5ml of M9 was added to the tube and mixed well.  
10. The tube was centrifuged again at 5000rpm for 2 minutes.  
11. Most of the M9 was aspirated without disturbing the worm pellet. 
12. Steps 9 -11 were repeated twice to take off the hypochlorite. 
13. 10ml of M9 was added and agitated to resuspend the pellet and this was 
transferred into a 250ml flask containing 40ml M9. 
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14. The eggs were allowed to hatch with gentle rocking at 160rpm and 20oC. 
15. After 8 hours of incubation, mid L1 larvae were observed to confirm 
hatching and worms were centrifuged and the pellets were collected. 
16. 7ml of S medium was added and agitated to resuspend the pellet, this was 
transferred into a 500ml flask containing 100ml S. medium inoculated with 
E. coli OP50 and incubated for 29 hours to allow the larvae develop into 
mid L4 stage.  
17. Dead worms, debris and waste were removed from the synchronized 
population by centrifuging at 5000rpm for 1minute and aspirating the 
supernatant containing living worms into a fresh tube. 
18. The tube containing living synchronized worms was place on ice for 10 
minutes to allow the worms settle. 
19. The supernatant is aspirated and the worms are collected at the bottom of 
the tube. 
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Appendix B: Anthelmintic derivatives 
 
C22H25NO6 
Mol. Wt.: 399.437 
Figure 1: Colchicine 
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O
 
GEO 1 
C24H30N2O6
Exact Mass: 442.21
Mol. Wt.: 442.50
C, 65.14; H, 6.83; N, 6.33; O, 21.69 
 Figure 2: Colchicine derivative  
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GEO 2 
C47H52BrN2O7P
Exact Mass: 866.27
Mol. Wt.: 867.80
C, 65.05; H, 6.04; Br, 9.21; N, 3.23; O, 12.91; P, 3.57 
Figure 3: Colchicine derivative + Triphenylphosphonium 
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Figure 4: Colchicine-prolinol 
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Figure 5: Colchicine-prolinol + Triphenylphosphonium 
 
 
 
MB2 
Mol. Wt.: 384 
Figure 6: Colchicineamide 
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MB2-TPP 
C44H46BrN2O6P
Exact Mass: 808.23
Mol. Wt.: 809.72
C, 65.27; H, 5.73; Br, 9.87; N, 3.46; O, 11.86; P, 3.83 
Figure 7: Colchicineamide + Triphenylphosphonium 
 
 
NU:UB 238 
C18H17NO3 
Mol. Wt.: 295 
Figure 8: 1-[(4-Hydroxybutyl) amino]-9,10-anthraquinone 
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SH1 
C41H39BrNO4P
Exact Mass: 719.18
Mol. Wt.: 720.63
C, 68.33; H, 5.45; Br, 11.09; N, 1.94; O, 8.88; P, 4.30  
Figure 9: 1-[(4-Hydroxybutyl) amino]-9,10-anthraquinone + 
Triphenylphosphonium 
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Appendix C: Fluorophore-based probes probes 
 
Figure 1: Chemical structure of TL11. Fluorescein-labelled probe. 
 
Figure 2: Chemical structure of LS9. Rhodamine-labelled probe. 
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Figure 3: Chemical structure of SM9. Rhodamine-labelled probe.  
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Appendix D: Reagents and treatment preparation 
I. LB agar preparation 
Four grams of LB (Oxoid; Basingstoke Hampshire, UK) was weighed into a 1 litre 
flask. A 200ml volume of deionised water was added into the 1 litre flask and a 
magnetic stirrer was used to dissolve the LB solute in the solution. The weighing 
balance was used to measure 2.4g agar (Agar technical number 3 from Oxoid; 
Basingstoke Hampshire, UK) into the flask and the solution was mixed using the 
magnetic stirrer and heating on the hot plate avoiding boiling while ensuring total 
dissolution of the agar. Aliquots of 20ml were transferred into 10 universal glass 
bottles and screwed loosely with their lid to avoid breakage during sterilization 
before placing the bottles in the autoclave and sterilizing at a holding temperature 
of 121oC for 15 minutes. After cooling in a water bath (50oC), each universal bottle 
carefully poured aseptically into Petri dishes. Once the agar was set after cooling, 
the plates were stacked appropriately and kept in the 4oC fridge for storage. 
II. NGM preparation 
Using a calibrated balance, 17g of agar was weighed into a 2-litre flask. The 
weighing balance was used to measure 2.5g bacterial peptone and 3g of NaCl 
into the 2-litre flask. The flask was filled with 975ml deionized water and aliquots 
of 200ml were transferred into 300ml Wheaton bottles with their lids loosely 
screwed to avoid breakage during sterilization. The bottles were autoclaved at 
121oC for a holding time of 15 minutes and allowed to cool in a water bath to 
50oC. Using sterile pipettes, 200µl each of sterilized 1M MgSO4, 1M CaCl and 
5mgml-1 cholesterol were added aseptically to each 200ml Wheaton bottle. Also, 
5ml of 1M KPO4 was added to each bottle aseptically and gently mixed avoiding 
bubbles. Aliquots of 15ml were aseptically poured into either 60mm or 100mm 
Petri dishes. The plates were allowed to set and carefully placed in an inverted 
position, stacked and stored in a 4oC fridge until needed for usage. 
III. Concentrated E. coli OP50 (Pellets)  
Twenty grams of LB Broth powder (Fischer New Jersey, USA) was weighed into 
a 2-litre flask. Deionized water was added into the 2-litre flask to a volume of 1 
litre to dissolve the powder. The flask was then placed on a hotplate and mixed 
using a magnetic stirrer to allow the powder to dissolve completely. Aliquots of 
100ml were transferred from the 2-litre flask into ten 500ml flasks. 
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The 500ml flasks were covered with a stopper and placed in the autoclave and 
sterilized at 121oC holding temperature for 15 minutes. 
After cooling in a water bath (50oC), colonies of E. coli OP50 were aseptically 
taken from a starter culture plate into the 500ml flask containing 100ml LB broth. 
The flask was incubated overnight in a shaker incubator at 37oC and 180rpm. 
After incubation, the broth culture was transferred into 50ml centrifuge tubes and 
centrifuge at 4000rpm for 15 minutes. The supernatant was aspirated, leaving 
about 1ml containing bacterial pellet. The 1ml culture from the 50ml tubes were 
transferred into 1.5ml Eppendorf tubes and centrifuged for 2 minutes at 
12,000rpm. The supernatant was aspirated and the pellets were kept in a -80oC 
freezer until needed. 
IV. M9 Buffer 
To make up 1L M9; 3g KH2PO4, 7.52g Na2HPO4.2H20 and 5g of NaCl were added 
into a 2L flask. 
The mixture was dissolved in 500ml deionized water and 1ml of 1M MgSO4 
(24.65g MgSO4.7H2O in 100ml deionized water) was added. 
Deionized water was added to make up a total volume of 1L in the flask and the 
preparation was sterilized by autoclaving at 121oC for a holding time of 15 
minutes. 
V. S Basal solution 
In order to make up 1L of S Basal; 5.85g NaCl, 1g K2HPO4 and 6g KH2PO4 were 
added into a 2L flask. 
The mixture was dissolved in 500ml deionized water. 
Having prepared 5mgml-1 cholesterol by adding 50mg cholesterol to 10ml of 99% 
ethanol, 1ml of the resulting cholesterol was added to the 2L flask and mixed with 
a magnetic stirrer. 
Deionized water was added to make up a total volume of 1L in the flask and the 
preparation was sterilized by autoclaving at 121oC for a holding time of 15 
minutes. 
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VI. Potassium Citrate (pH6) 
1M Potassium Citrate (200ml) was prepared by adding 4g citric acid monohydrate 
and 58.7g tri-potassium citrate monohydrate into a 500ml flask and adding 
deionized water to a make a total volume of 200ml. The preparation was sterilized 
by autoclaving. 
VII. Trace metal solution 
Disodium EDTA (1.86g), FeSO4.7H2O (0.69g), MnCl2.4H2O (0.2g), ZnSO4.7H2O 
(0.29g) and CuSO4.5H2O (0.025g) were measured into a 2L flask and filled with 
deionized water to a total volume of 1L. The preparation was transferred into a 
dark bottle and sterilized by autoclaving. 
VIII. S medium 
To make up 1.026 litres S. medium, 1L S basal solution was aseptically added 
into an already sterilized 2L flask by flaming the tip of the flask containing the S 
basal solution before transferring into the 2L flask. Trace metal solution (10ml), 
1M Potassium Citrate (10ml), 1M MgSO4 (3ml) and 3ml of sterilized CaCl2 (11.1g 
CaCl2 in 200ml deionized water) were aseptically added to the 1L S basal 
solution. The preparation is mixed carefully and not autoclaved. 
IX. 20% Sodium hypochlorite (NaOCl)  
To make up 150ml 20% NaOCl, 100ml of 1M NaOH was prepared by adding 4g 
NaOH to 100ml of deionized water. A 37.5ml volume of the 1M NaOH was added 
to a 250ml flask and 30ml of hypochlorite (Sigma Aldrich) was added. The flask 
was filled with deionized water (82.5ml) to make a total of 150ml of the 
preparation. 
X. Zinc Oxide nanoparticle treatment preparation 
Zinc Oxide nanoparticles (ZnO NPs) dispersed in either cationic, ionic and non-
ionic dispersants produced by Alfa Aesar were used. The manufacturer’s 
preparation contained 50% ZnO NP in water. In order to prepare stock for 
treatments, the molarity of the ZnO NPs in water was calculated thus: 
Since 50% ZnO is contained in water, this means 50g of ZnO NP in 100ml of 
water or 500g in 1L of water which is the mass concentration of the stock. Now 
𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 = 𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 𝑐𝑐𝑀𝑀𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑐𝑐 
𝑅𝑅𝑐𝑐𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑅𝑅𝑐𝑐 𝑚𝑚𝑀𝑀𝑀𝑀𝑐𝑐𝑐𝑐𝑚𝑚𝑀𝑀𝑀𝑀𝑀𝑀 𝑚𝑚𝑀𝑀𝑀𝑀𝑀𝑀 (𝑅𝑅𝑀𝑀𝑀𝑀) 
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Where Mass concentration of the ZnO NPs = 500g/L and RMM of ZnO = 
81.41g/mol. 
So Molarity = 500𝑔𝑔/𝐿𝐿
81.41𝑔𝑔/𝑚𝑚𝑚𝑚𝑚𝑚 = 6.14175M (𝑚𝑚𝑚𝑚𝑚𝑚𝐿𝐿 ) . 
In order to prepare 5ml of 1M solution for each ZnO NP type, 815µl of 6.14175M 
stock was diluted in 4.185ml filtered (0.2µm) deionised water. The calculation is 
as described below. 
Using   𝐶𝐶𝑀𝑀𝐶𝐶𝑀𝑀 = 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶  where 𝐶𝐶𝑀𝑀 = 1M 
𝐶𝐶𝐶𝐶 =6.14175M and 𝐶𝐶𝑀𝑀 =5ml, the volume of 1mM per treatment can be 
calculated. 
𝐶𝐶𝐶𝐶 = 𝐶𝐶𝑀𝑀𝐶𝐶𝑀𝑀
𝐶𝐶𝐶𝐶
 
𝐶𝐶𝐶𝐶 = 1𝑀𝑀 ∗  5𝑚𝑚𝑀𝑀6.14175𝑀𝑀 = 0.815𝑚𝑚𝑀𝑀 = 815𝑚𝑚𝑀𝑀 
1 part of 1M of each ZnONP (CZNP or AZNP) suspension was added to nine part 
molecular grade water to get 100mM working stock. A 5ml stock of 100mM 
solution for each ZnONP type was probe-sonicated for 30 minutes with a 15 
second pulse every 10 minutes.  
The ZnO NP concentrations investigated were 3.125mM, 6.25mM, 12.5mM and 
25mM in 1ml total volume of treatment and these were prepared as described 
below. 
Where 𝐶𝐶𝑀𝑀 =  1𝑚𝑚𝑀𝑀 ,𝐶𝐶𝑀𝑀 = 3.125mM, 6.25mM, 12.5mM or 25mM, and 𝐶𝐶𝐶𝐶 = 100mM 
ZnO NP 
For 3.125mM concentration: 
𝐶𝐶𝐶𝐶 = 3.125𝑚𝑚𝑀𝑀 ∗  1𝑚𝑚𝑀𝑀100𝑚𝑚𝑀𝑀 = 0.003125𝑚𝑚𝑀𝑀 = 31.25𝑚𝑚𝑀𝑀 
So 31.25µl of 1M ZnO NP is needed in 1ml C. elegans culture to get a total 
concentration of 3.125mM. 
For 6.25mM concentration: 
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𝐶𝐶𝐶𝐶 = 6.25𝑚𝑚𝑀𝑀 ∗  1𝑚𝑚𝑀𝑀100𝑚𝑚𝑀𝑀 = 0.00625𝑚𝑚𝑀𝑀 = 62.5𝑚𝑚𝑀𝑀 
So 62.5µl of 1M ZnO NP is needed in 1ml C. elegans culture to get a total 
concentration of 6.25mM. 
For 12.5mM concentration: 
𝐶𝐶𝐶𝐶 = 12.5𝑚𝑚𝑀𝑀 ∗  1𝑚𝑚𝑀𝑀100𝑚𝑚𝑀𝑀 = 0.0125𝑚𝑚𝑀𝑀 = 125𝑚𝑚𝑀𝑀 
So 125µl of 1M ZnO NP is needed in 1ml C. elegans culture to get a total 
concentration of 12.5mM. 
For 25mM concentration: 
𝐶𝐶𝐶𝐶 = 25𝑚𝑚𝑀𝑀 ∗  1𝑚𝑚𝑀𝑀100𝑚𝑚𝑀𝑀 = 0.025𝑚𝑚𝑀𝑀 = 250𝑚𝑚𝑀𝑀 
So 250µl of 1M ZnO NP is needed in 1ml C. elegans culture to get a total 
concentration of 25mM. 
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Table A1: Organisation of samples for qPCR for reference gene selection 
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Control 1 Heat Shock 1 Control 1 Heat Shock 1 Control 1 Heat Shock 1 
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Control 3 Heat Shock 3 Control 3 Heat Shock 3 Control 3 Heat Shock 3 
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Control 4 Heat Shock 4 Control 4 Heat Shock 4 Control 4 Heat Shock 4 
E 
CZNP-treated 1 Water CZNP-treated 1 Water CZNP-treated 1 Water 
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1 2 3 4 5 6 7 8 9 10 11 12 
A 
Control 1 Heat Shock 1 Control 1 Heat Shock 1 Control 1 Heat Shock 1 
B 
Control 2 Heat Shock 2 Control 2 Heat Shock 2 Control 2 Heat Shock 2 
C 
Control 3 Heat Shock 3 Control 3 Heat Shock 3 Control 3 Heat Shock 3 
D 
Control 4 Heat Shock 4 Control 4 Heat Shock 4 Control 4 Heat Shock 4 
E 
CZNP-treated 1 Water CZNP-treated 1 Water CZNP-treated 1 Water 
F 
CZNP-treated 2   CZNP-treated 2   CZNP-treated 2   
G 
CZNP-treated 3   CZNP-treated 3   CZNP-treated 3   
H CZNP-treated 4   CZNP-treated 4   CZNP-treated 4   
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Figure 1: Stability of C. elegans reference genes  
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Table A2: Organisation of 96 well plate for sod-3 qPCR  
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XI. Preparation of Phosphate-Citrate Buffer 
Phosphate citrate buffer was required for legumain-prodrug treatment and was 
prepared by mixing varying volumes of 0.2M Na2HPO4 and 0.1M citrate with 
deionized water. Below is a description of the preparation of the acid and base 
as well as the final buffer. 
0.2M Na2HPO4:  The preparation of 0.2M Na2HPO4 (500ml) was carried out by 
dissolving 14.2g Na2HPO4 in 500ml of deionized water in a 1 litre flask. The 
solution was filter sterilized into a 500ml hybex media bottle and stored at 4oC. 
0.1M citrate: This was prepared by dissolving 10.505g of citric acid in 500ml of 
deionized water in a 1 litre flask. The solution (500ml) was filtered into a 500ml 
hybex media bottle and stored at 4oC. 
Phosphate-citrate buffer: The table below illustrates the preparation of the 
Phosphate citrate buffer at pH of 4, 5, 6 and 7. 
pH 0.2M Na2HPO4 
(ml) 
0.1M Citrate 
(ml) 
Deionized water 
(ml) 
Total volume 
(ml) 
4 19.3 30.7 50.0 100 
5 25.7 24.3 50.0 100 
6 32.1 17.9 50.0 100 
7 43.6 6.5 49.9 100 
The pH values may vary slightly, so either the acid or base is added in drops to 
achieve the exact pH required by measuring with a pH electrode. The buffers 
were stored in the 4oC fridge. 
XII. Preparation of MES buffer 
MES buffer at pH of 5 was also used for legumain-prodrug treatment. In order to 
make 100ml of 100mM MES at pH 5, 1.95g of MES was added to a 250ml beaker 
with 70ml deionized water. A pH electrode was used to measure the pH and 1M 
NaOH was titrated into the beaker until the pH was adjusted to 5. Once pH of 5 
was achieved, the solution was transferred into a graduated cylinder and diluted 
to a final volume of 100ml. The final solution was filtered into a 100ml hybex 
media bottle and stored at 4oC. 
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XIII. Preparation of Cysteine Protease Inhibitors 
Three protease inhibitors; E-64, N-phenylmaleimide or iodoacetamide were used 
for legumain expression experiments. The inhibitors were provided by Dr. David 
Mincher’s laboratory at Edinburgh Napier University. Iodoacetamide and N-
phenylmaleimide are known to inhibit mammalian legumain while E-64 has no 
effect on legumain (Chen et al., 1997). The concentration of E-64 used in 
treatment was 100µM while N-phenylmaleimide and Iodoacetamide required in 
treatments had a concentration of 1mM.  
N-phenylmaleimide: In a total volume of 100µl per well, 1mM N-
phenylmaleimide was required from a 5mgml-1 (Relative molecular mass = 
173.17gmol-1) stock solution provided. The total volume of 5mgml-1 (28.87mM) 
stock solution of N-Phenylmaleimide needed in a total of 100µl treatment per well 
to give 1mM N-Phenylmaleimide is 3.5µl. 
E-64: 100µM E-64 (Relative molecular mass = 357.41gmol-1) was prepared from 
1mgml-1 (2.79mM) stock solution provided and the required volume of E-64 
needed to make up 100µl total volume of treatment was 3.6µl. 
Iodoacetamide: 1mM Iodoacetamide was prepared from a 27mM stock solution 
provided and the required volume in a total of 100µl to give a final concentration 
of 1mM concentration was 3.7µl. 
XIV. Preparation of LS9 and TL11 probes 
LS9: Given an 895.7µM stock solution, and a required 10µM concentration in the 
treatment, the volume of LS9 needed in a 100µl volume treatment was 1.1µl. 
TL11: Like LS9, 10µM TL11 was similarly prepared from a 902.5µM stock 
solution  
So the total volume of stock solution of TL11 required in a 100µl treatment is 
1.1µl. 
XV. Preparation of C. elegans treatments with different pH  
Homogenate or somatic fraction (40µl) from mixed population of worms was 
diluted in 58.9µl buffer (buffer with pH4, 5, 6 or 7) with 1.1µl TL11 or LS9 to make 
up a total of 100µl per micro well. Also, 40µl homogenates or ES from either L1 
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or L4 larvae was diluted in 60µl buffer (buffer with pH4, 5, 6 or 7) without TL11 or 
LS9 to make up 100µl per micro well.  
XVI. Preparation of nematode parasite treatments at different pH  
H. contortus or T. circumcincta lysate (40µl) was diluted in 58.9µl buffer (buffer 
with pH4, 5, 6 or 7) with 1.1µl TL11 or LS9 to make up a total of 100µl per micro 
well. Similarly, 40µl H. contortus or T. circumcincta lysate was diluted in 60µl 
buffer (buffer with pH4, 5, 6 or 7) without TL11 or LS9 to make up 100µl per micro 
well. 
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XVII. Legumain assay plate plan 
 
 
Figure 2: Schematic representation of treatment plan for legumain assay 
TREATMENT WELL 
Buffer---------------------- 58.9µl 
Sample-------------------- 40.0µl  
Probe----------------------   1.1µl 
                                      100µl 
Final volume in well contains 10µM probe 
TREATMENT WELL 
Buffer---------------------- 55.4µl 
Sample-------------------- 40.0µl 
N-Phenylmaleamide--    3.5µl 
Probe----------------------   1.1µl 
                                      100µl 
Final volume in well contains 10µM probe and 
1mM N-Phenylmaleamide 
  
TREATMENT WELL 
Buffer---------------------- 55.3µl 
Sample-------------------- 40.0µl 
E-64------------------------   3.6µl  
Probe----------------------   1.1µl 
                                      100µl 
Final volume in well contains 10µM probe 
and 100µM E-64 
 
TREATMENT WELL 
Buffer---------------------- 55.2µl 
Sample-------------------- 40.0µl 
Iodoacetamide----------   3.7µl   
Probe----------------------   1.1µl 
                                      100µl  
Final volume in well contains 10µM probe and 
1mM Iodoacetamide 
CONTROL WELL 
Buffer---------------------- 98.9µl  
Rhodamine---------------   1.1µl 
                                      100µl 
Final volume in well contains 10µM rhodamine 
CONTROL WELL 
Buffer---------------------- 98.9µl 
Probe----------------------   1.1µl 
                                      100µl  
Final volume in well contains 10µM probe 
CONTROL WELL 
R. Legumain------------- 98.9µl  
Probe----------------------   1.1µl 
                                      100µl 
Final volume in well contains 10µM probe 
CONTROL WELL 
Buffer---------------------- 60.0µl 
Sample-------------------- 40.0µl 
                                      100µl  
